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Abstract 
Proliferating cell nuclear antigen (PCNA) is an essential protein in the cell. It 
is involved in transcription and many types of DNA repair and replication. 
Homologues of this protein are found in all orders of life. The high level of 
conservation and essential nature of PCNA infers that it may be a potential drug 
target for anti-caner drugs in humans and also a potential anti-parasitic target. X-ray 
structures of PCNA from Homo sapiens (Hs), Schizosaccharomyces pombe (Sp) and 
Leishmania major (Lm) are now available and can be used as a template for structure 
based drug design.  
In this work PCNA from these three species have been prepared in milligram 
quantities for biochemical and biophysical studies. The previously unknown 
structure of LmPCNA has been solved in an uncomplexed form and also complexed 
with a dodecapeptide to a resolution of 3.0Å. A comparison of PCNA structures and 
their peptide complexes for the three species identifies structural differences which 
may be relevant in analysing thermodynamic contributions of binding.  
All eukaryotic PCNA molecules exist as ring shaped trimers which form 
around DNA. In this work the oligomeric state of LmPCNA has been determined to 
be hexameric both in solution and in the crystal. It has also been hypothesised that 
HsPCNA is hexameric however these would seem to form hexamers in which the 
trimeric rings associate “back-to-back” while LmPCNA trimers would seem to 
associate “face-to-face”. 
The binding affinities for these three PCNAs have been determined with a 
selection of peptides derived from the Hs p21 protein. This work has shown, using a 
selection of different techniques including Surface Plasmon Resonance (SPR), 
  ii 
Isothermal Titration Calorimetry (ITC) and Dynamic Scanning Fluorimetry (DSF); 
that HsPCNA and SpPCNA have similar affinities for a 12mer peptide (Kd of ~1µM) 
however LmPCNA shows significantly weaker interactions (Kd of ~10µM). This is 
most likely due to divergence in the sequence and structure of LmPCNA. 
A systematic investigation by SPR on the effect of peptide linker length on 
binding has been carried out using a series of synthesised peptides with different 
lengths of chemical spacer. The series of streptavidin immobilised peptides show that 
longer spacers are required for the recovery of the PCNA peptide binding affinity. 
The results presented in this work indicate that a linker length of at least 20Å is 
required for measurable protein binding activity. This interaction is improved with 
longer peptide spacers.  
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CHAPTER 1.  The interactions of PCNA in the cell cycle 
Proliferating Cell Nuclear Antigen (PCNA) is an essential and highly 
conserved protein. This protein is pivotal to the mechanisms of DNA replication and 
repair. The process of DNA replication can be inhibited by the direct interaction of 
proteins involved in cell cycle regulation. The stalling of DNA replication can allow 
DNA damage to be repaired.  
The successful inheritance of genetic information requires accurate 
replication of the genome and epigenetic information. Many of these processes are 
facilitated by PCNA which binds co-factors to orchestrate these activities 
(Tsurimoto, T. 1998). Selection between co-factors is mediated by a variety of 
mechanisms including PCNA modifications, competition, phosphorylation and 
ubiquitination driven degradation (Moldovan, G. L. et al 2007).  
PCNA forms a ring which surrounds DNA and coordinates other proteins. 
Interaction of PCNA with co-factors is mediated by a common binding interface 
(described in-depth in section 1.2.1). This interface is the most conserved area of the 
protein (Warbrick, E. et al 1998). Binding studies of peptides with three homologous 
PCNAs from human, yeast and Leishmania will be presented.  
1.1 Protein mediated biochemistry of DNA repair and replication 
PCNA is essential in the mechanisms of DNA replication, repair and 
chromatin conservation. DNA replication is a complex mechanism involving 
hundreds of proteins . DNA repair has been shown to require over 700 associated 
proteins in the DNA damage response pathways (Matsuoka, S. et al 2007). In this 
chapter. only those which interact with PCNA shall be discussed. The main forms of 
DNA repair; nucleotide excision, DNA mismatch and double strand break repair all 
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involve PCNA. As mentioned above, the mechanism of chromatin conservation is 
also facilitated by PCNA. These critical processes are all dependent on the presence 
of PCNA, this gives clear evidence as to the importance of PCNA within the cell 
cycle, as to why null mutations are lethal and this protein is a potential drug target. 
1.1.1 Protein mediated biochemistry of DNA replication  
The classical view of DNA replication involves a few proteins directly 
interacting with DNA to facilitate unwinding and replication (Stryer, L. 1995). To 
copy DNA, the double helix must be unwound by DNA helicase to reveal two 
complementary strands. The single strands of DNA are stabilised by single stranded 
DNA binding proteins e.g. Replication Protein A (RPA), preventing the re-annealing 
of the complementary base sequences (Liu, Y. Y. et al 2005). DNA polymerase 
replicates DNA molecules in a 5'=>3' direction; the lagging strand requires an RNA 
primer to initiate replication and create an Okasaki fragment (Huang, L. et al 1994). 
The 3' end of a newly synthesised section of one Okasaki fragment anneals to 
another one by the action of DNA ligase. This is a very simplified view of the 
proteins required for the replication of DNA as DNA replication is mediated by at 
least 130 proteins (Wood, R. D. et al 2001), many of which interact with those to be 
mentioned in tables 1.1 and 1.3, or have ancillary activities.  
In the course of replication the DNA helix becomes supercoiled. The 
enzymatic activity of DNA gyrase relieves supercoiling but can impose negative 
supercoiling aiding DNA helicase activity of the dissociation of DNA strands from 
one another (Zylicz, M. et al 1989). DNA replication is performed by DNA 
polymerase of which there are seven families, four in humans (table 1.1), polymerase 
α, β, δ, ε, γ, λ, σ, µ, ζ, terminal deoxynucleotidyl transferase (TDT) and translesion  
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Family Human protein Function 
A γ A mitochondria DNA polymerase 
α 
A priming polymerase, producing RNA primer 
followed by DNA nucleotides until removed by RFC 
δ Is the main DNA replication factor in Eukaryotes 
ε 
Has been demonstrated to substitute for polymers δ in 
the lagging strand 
B 
ζ Promotes replication through DNA lesions  (Prakash, 
S. et al 2005) 
β Common repair polymerase 
σ To date, has no known function 
λ & µ 
Involved in non-homolougous end joining to aid in 
repair of double strand breaks 
X 
TdT 
Expressed in lymphoid tissue to allow greater 
immunological diversity 
Y  TLS (ι, κ, λ & η) Repair polymerase for double stranded breaks 
Table 1-1. Human polymerases grouped by family and activity  
This table shows the four different families of DNA or RNA polymerases in humans. 
Within each family, there are differing numbers of polymerases, and each 
polymerase function is detailed here. Some functions are fulfilled by many 
polymerases like that of double strand break repair due to the complexity of this 
mechanism. The TLS polymerase complex exist for this one mechanism alone. 
Others are completed by the actions of a single polymerase e.g. the formation of a 20 
base RNA primer prior to the formation of an Okasaki fragment by RNA polymerase 
α. The A family of polymerases exists in order to replicate mitochondrial DNA and 
contains only a single polymerase. The B family of polymerases are primarily 
involved in the stable replication of DNA. The X family of polymerases are involved 
in common DNA repair mechanisms.The Y family of polymerases were determined 
to be a seperate family from X (Ohmori, H. et al 2001) and comprises of proteins 
essential for translesional synthesis (TLS), existing in all orders of life. Most of these 
polymerases have been shown to bind to PCNA. 





sythesis (TLS) polymerases (Burgers, P. M. J. et al 2001). The polymerases detailed 
here are present as homologues in other species, and in some speices novel 
polymerases also exist (Burgers, P. M. J. et al 2001). Replication Factor C (RFC) is 
also present in the DNA replicating complex, it is capable of dissociating DNA 
polymerase α, and facilitates the asssembly of the PCNA complex (Ellison, V. and 
Stillman, B. 2003; Gulbis, J. M. et al 1996; Stryer, L. 1995). RFC has been shown to 
be essential for the loading of PCNA onto DNA by the observation of DNA 
replication in circular DNA (Burgers, P. M. J. and Yoder, B. L. 1993).  
1.1.2 The role of PCNA in DNA replication  
PCNA is a DNA sliding clamp, holding DNA polymerase on the double 
stranded DNA molecule. During DNA replication, supercoiling occurs. This needs to 
be subsequently relieved by the activity of DNA gyrase, requiring DNA polymerase 
to dissociate from the DNA molecule.  The presence of PCNA allows DNA 
polymerase to dissociate relieving the effect of supercoiling without the loss of 
position of the polymerase (Krishna, T. S. R. et al 1994). This enables rapid re-
annealing of the polymerase to the correct position on the DNA molecule in order to 
facilitate DNA replication at a high rate (Waga, S. and Stillman, B. 1998). DNA 
replication occurs at average rates of 750-1000bp sec-1 for prokaryotes and 50-100bp 
sec-1 for eukaryotes. PCNA is involved in the replication of the Okazaki fragment 
from the RNA primer and proceeds to the next. FEN1 RTH complex associates to 
DNA in a PCNA-dependent manner and removes a 5' phosphate from the Okazaki 
fragment. DNA ligase can then anneal two Okazaki fragments together (figure 1.1 
modified from (Bambara, R. A. et al 1997). PCNA has also been shown to bind other 
polymerases for DNA repair and cell-cycle regulatory purposes (section 1.2.3). 
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Figure 1-1.  The DNA 
replication fork 
Panel 1, The replication 
fork, showing DNA 
helicase (yellow), DNA 
polymerase α & δ 
(white), RFC (red), 
PCNA (purple) and 
RPAs (blue). DNA 
polymerase α has 
created an RNA primer 
(scarlet) and some 
subsequient DNA 
(blue).  
Panel 2, DNA 
polymerase α has 
dissociated from the 
DNA strand and has 
been replaced with a 
DNA polymerase δ, 
RFC and PCNA 
complex to start 
creation of  an Okazaki 
fragment. 
Panel 3, Okazaki 
fragment has extended 
to the previous 
fragment and RNaseH1 
(yellow) is removing 
the previous RNA 
primer.  
Panel 4, RNase H1 
dissociates from the 
RNA primer and FEN1, 
RTH1 (green) enters the 
replication fork 
Panel 5, FEN1-RTH1 
binds the DNA in a 
PCNA-dependent 
manner and cleaves the 
5' phosphate from the 
previous Okazaki 
fragment.  
Panel 6, FEN1, RTH1, DNA polymerase δ, RFC, and PCNA complexes dissociate 
from the DNA strand and DNA ligase anneals the two new fragments.  










1.1.3 Protein mediated biochemistry of DNA proof-reading and repair  
There are four main forms of DNA repair. These are base excision repair 
(BER), nucleotide excision repair (NER), DNA mismatch repair (MMR) and double 
strand break repair (DSB) (Beckman, R. A. and Loeb, L. A. 1993). Base excision 
repair is most important during replication of the genome as bases can be deaminated 
or alkylated resulting in their improper incorporation. For example, deamination of 
cytosine will result in a uracil and alkylation of cytosine will result in 5'-
methylcytosine. In contrast deamination of 5'-methylcytosine will result in thymine 
and can not be repaired by this mechanism (Yoon, J. H. et al 2003). Deaminated 
bases will result in improper base pairing, and at this point, the DNA strand can be 
bent and allow the mutated base to be “flipped” out of the main body of the strand 
and excised by DNA glycosylase. The human DNA glycosylases include uracil-DNA 
glycosylase (UNG), selective monofunctional uracil-DNA glycosylase (SMUG1), 
thymine DNA glycosylase (TDG) and methyl-CpG-binding protein 4 (MBD4) 
(Beckman, R. A. and Loeb, L. A. 1993). This excision leaves the sugar-phosphate 
backbone in place, so it doesn’t allow a repair by DNA polymerases. Due to lyase 
activity by APlyases e.g. Ape1 the sugar phosphate backbone can be cleaved (Wood, 
R. D. et al 2001). This proceedure will leave a gap that can typically be filled by 
DNA polymerase β with the aid of PCNA, and the new 3' end can be ligated to the 
pre-existing 5' by the action of DNA ligase (Wood, R. D. et al 2001).  
1.1.4 Protein-mediated biochemistry of nucleotide excision repair  
Nucleotide excision repair (NER) exists in two different forms, global 
genome (GGNER) and transcription coupled (TCNER) (Sancar, A. et al 2004). 
GGNER involves a continual monitoring for helix distortions throughout the whole 
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genome at any time, TCNER only occurs on DNA strands being transcribed at that 
time (Sancar, A. et al 2004). These two pathways involve nine core proteins, XPA, 
XPB, XPC, XPD, XPE, XPF, XPG, CSA and CSB. Deficiencies in these proteins 
result in the diseases Xeroderma pigmentosum (XPA-G) and Cockayne syndrome 
(CSA-B). Other proteins involved in NER are ERCCI , RPA and Rad23. GGNER 
recognises damage by the XPC-Rad23B complex or DNA damage binding proteins 
(DDB1 or DDB2). TCNER uses RNA polymerase, stopping at e.g. thymine dimers, 
as well as CSA and CSB, then bind the DNA instead of the XPC-Rad23B complex. 
Once the damage is recognised, the pathways invoved in NER are the same for both 
GGNER and TCNER, and both XPB and XPD are subunits of the transcription 
factor 2H (TFIIH). XPB and XPD act as helicases, unwinding DNA at the point of 
damage, and XPG cleaves at the 3' side of DNA damage, while XPF-ERCC1 cleave 
the DNA on the 5' side of DNA damage (Wood, R. D. et al 2001). The gap between 
these two areas is typically of 25-30 bases, allowing the damaged section of DNA to 
be removed. Once this is accomplished, DNA polymerase δ or ε repairs the DNA 
strand with the aid of PCNA. RPA protects the template strand from cleavage as the 
damage is removed, and DNA ligase attaches the newly synthesised 3' end to the pre-
existing 5'. 
1.1.5 Protein mediated biochemistry of DNA mismatch repair 
DNA Mismatch Repair (MMR) repairs DNA strands where complementarity 
has been lost and can be referred to as long or short type. Long type MMR is 
primarly implemented in replication errors, but it can be used in all types of 
mismatches and can possibly replace up to a few kilobases (Sancar, A. et al 2004). 
Short patch MMR is used in third party damage, e.g. damage incured from UV 
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radiation, free radicals or carcinogens, and will usually only replace up to 
approximately 10 nucleotides. In this mechanism, the cell needs to determine the site 
of damage by detecting one of the eight types of mismatch, then determine the 
incorrect strand for excision, and finally repair the damaged section. In MMR, only 
the daughter strand will be excised, a process which is best understood in E.coli 
systems and is thought to be highly conserved (Sancar, A. et al 2004). In E.coli 
systems, there are three main proteins required for MMR: these are MutS, MutH and 
MutL. MutS is required to detect base-base mismatches along with short regions of 
deletions or insertions, MutH is used to determine the daughter from the parent DNA 
strand and to only cleave the daughter, MutL enhances the activity of MutS, MutH 
and DNA helicase (Mechanic, L. E. et al 2000). The section is cleaved by MutH, and 
if this cleavage were on the 5' side of damage, then RecJ or ExoVIII remove the 
DNA; if the cleavage is on the 3' side of the damage, then Exo1 is used. Finally the 
section of DNA is replaced using the DNA polymerase III, β subunit of which is a 
PCNA homologue. Once the DNA section is replaced it is rapidly methylated by 
Dam methylase.  
The human proteins currently known to be in this mechanism are MSH (a 
MutS homolog) and MLH (a MutL homolog), but yet no MutH homolog has been 
found. There are multiple forms of MSH and MLH (Gu, Y. et al 2002), MSH2-
MSH6 (MutSα) complex indentifies base-base mismatch, insertion and deletion 
mutations, while MSH2-MSH3 (MutSβ) complex recognises long insertion or 
deletion mutations (Jiricny, J. 2006). MLH has two main forms, MLH and PMS. 
MutLα is comprised of MLH1-PMS2 and coordinates MMR. MutLβ is a complex of 
9 
 
MLH1 and PMS1, MutLγ is a complex of MLH1 and MLH3; the functions of these 
complexes in humans are not yet well understood. 
1.1.6 Protein-mediated biochemistry of double stranded break repair 
Double strand break (DSB) repair also exists in two main forms Non-
Homologus End Joining (NHEJ) and Homologus Recombinational Repair (HRR) 
(Sancar, A. et al 2004). This process is most important prior to replication of the 
genome, and during cellular differentiation (Boulton, S. J. and Jackson, S. P. 1996). 
DSBs are detected by the activity of the Mre11-Rad50-Nbs1 complex (Lee, J. H. and 
Paull, T. T. 2005) and in NHEJ, the two free ends are rejoined by DNA ligase IV in 
combination with XRCC4 (Moore, J. K. and Haber, J. E. 1996; Wilson, T. E. et al 
1997). NHEJ requires DNA overhangs known as sticky ends to aid in accurate re-
alignment. HRR uses homologous sequences of DNA to find the appropriate end for 
re-attachment, for example a sister chromatid. 
1.1.7 Protein-mediated biochemistry of chromatin conservation 
The basic chromatin repeat unit consists of a nucleosome. This is an 
arrangement of 146 base pairs wrapped around a protein histone core (H2A, H2B, 
H3 and H4). These nucleosomes form higher order chromatin structures which 
regulate epigenetic control of genes and maintain chromosome integrity at the 
telomeres and centromere. For the chromosome to be replicated, the higher order 
chromatin structures and nucleosomes are required to be modified and removed. 
Once the DNA is replicated, nucleosomes are required to be replaced and the 
chromatin remodelled. The mechanisms for this are unknown, however there are 
some known classes of proteins which mediate these activities, some of which have 
demonstrated affinity for PCNA (Moldovan, G. L. et al 2007). 
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Prior to DNA replication, the chromatin is required to be destabilised from 
higher order structures to remove the histone core and linearise the DNA. The 
complete mechanism of this is currently unknown, however the imitation switch 
(ISWI) class of chromatin remodelling factors have been shown to assemble 
chromatin in-vitro (Becker, P. B. and Horz, W. 2002). ISWI has also been previously 
shown to mobilise nucleosomes and be present in many protein complexes, which 
can enhance or disrupt the formation of chromatin e.g. nucleosome remodelling 
factor (NURF), chromatin accessibility complexes (CHRAC) and ATP-utilising 
chromatin assembly and remodelling factor (ACF) (Bozhenok, L. et al 2002). 
Williams syndrome transcription factor (WSTF) has been shown to bind ISWI, and 
this WSTF-ISWI complex is known to bind PCNA (Poot, R. A. et al 2004). 
Once replication has taken place, the sister chromatids are refolded into the 
new chromatin forms. The H3-H4 dimers, stripped from the DNA strand, rebind to 
the sister chromatids rapidly after DNA synthesis (Polo, S. E. and Almouzni, G. 
2006). This is facilitated by different co-factors e.g. chromatin assembly factor 1 
(CAF I), which is known to bind PCNA (Maga, G. and Hubscher, U. 2003), and 
histone regulator A (HIRA) both of which complex to Asf1, a histone chaperone. 
CAF I, a known PCNA binder, has been shown to be involved in the delivery of 
histones to replicated DNA in drosophila embryos (Tyler, J. K. et al 1999; Tyler, J. 
K. et al 2001) and human cell lines (Smith, S. and Stillman, B. 1989). The CAF I-
Asf1 complex can assist the formation of nucleosomes immediately after DNA 
replication, during normal replication, or during DNA damage repair mechanisms.  
The epigenetic control of a gene is not only dependent on the presence of the 
nucleosome, but on nucleosome modification and cytosine methylation. The 
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methylation of cytosines can be achieved by DNA cytosine methyltransferase 1 
(DNMT1) (Hermann, A. et al 2004). DNMT1 methylates cytosine at positions of 
hemi-methylation, where one strand of DNA contains methylated cytosines. This 
protein is directed to the replication fork and stimulates activity by the binding of 
PCNA via an N-terminal PIP box (Iida, T. et al 2002). This recruitment of DNMT1 
has also been observed for DNA repair mechanisms (Mortusewicz, O. et al 2005). 
Epigenetic control of DNA is also mediated by nucleosome modifications including 
histone 3- lysine 9 (H3K9) methylation and histone acetylation.  The methylation of 
H3K9 promotes a repressed, higher ordered chromatin state and can be performed by 
the histone methyltransferases e.g. hetrochromatin associated protein 1 (HP1), G9a 
and SETDB1. G9a can associate with PCNA via interactions with DNMT1, which 
binds PCNA (Esteve, P. O. et al 2006). SETDB1 binds methyl-CpG binding protein 
MBD1 in the presence of methyl-cytosine. The SETDB1-MBD1 histone 
methyltransferase protein complex can associate to PCNA via CAF I. This 
association allows histones deposited after DNA replication to be rapidly modified 
(Sarraf, S. A. and Stancheva, I. 2004), which increases the conservation of epigenetic 
control. CAF I is associated to PCNA at the replication fork as mentioned above.  
The rapid re-formations of chromatin structures are due to the interaction 
with PCNA via the PIP box, present on some of these proteins (Sarraf, S. A. and 
Stancheva, I. 2004). This demonstrates the importance of PCNA for chromatin 
conservation.  
1.2 The structure of PCNA 
The structure of PCNA has been solved for a diverse number of species, from 
H. sapiens (Gulbis, J. M. et al 1996) to bacteriophage RB69 (Shamoo, Y. and Steitz, 
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T. A. 1999) (table 1.2). The PCNA sliding clamp proteins from these two sources are 
structurally similar, however sequence identity is only 16% as determined by 
LALIGN version 2.2 (Myers, E. W. and Miller, W. 1988). The monomer PCNA 
chains can vary in length from 218 amino acids (RB69) to 356 amino acids (E.coli). 
The alignment of the PCNA sequences from humans, mice, S. pombe, T. cruzi, T. 
brucei, L. major and bacteriophage RB69 is shown here (figure 1.2). Sequence 
identity between mammalian PCNA is very high e.g. humans and mice have a 
sequence identity of ~96%. Sequence identity between PCNAs from mammals and 
lower eukaryotes is significantly reduced e.g. humans and S. pombe PCNAs have a 
sequence identity of ~50%. The areas of greatest variance within eukaryotic PCNA 
are at a loop region (185-205) and at the C-terminus (figure 1.2). Sequence identity 
between eukaryotic and protozoan PCNA is lower e.g. humans and L. major have a 
sequence identity of ~39%. This lower sequence identity is due to an elongated loop 
region (185-205) which is present in protozoan PCNA (figure1.2). There is 
negligible sequence identity between eukaryotic and prokaryotic PCNA. This lack of 
sequence identity is a result of a dimeric rather than trimeric structural architecture 
(discussed below and in figure 1.5).  
The monomer of PCNA has a conserved topology. The predicted secondary 
structure (figure 1.2) agrees with that determined crystallographically (Gulbis, J. M. 
et al 1996). The PCNA monomer exists as two globular domains (figure 1.5) 
(Kelman, Z. 1997; Krishna, T. S. R. et al 1994). The globular domains are linked by 
the Inter-Domain Connector Loop (IDCL) (figure 1.2 and 1.3). These two domains 
each contain a repetition of two βαβββ folds (figure 1.2 and 1.3). This makes a total 
of four βαβββ folds in eukaryotic PCNA (Krishna, T. S. R. et al 1994). Between the  
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Species PDB code Complex state 
Homo sapiens 1VYM Native 
 1W60 Native 
 1AXC p21 (143-160) 
 1VYJ Pogo-Ligase peptide (1-16) 
 1U7B Flap endonuclease 1 (331-350) 
 1UL1 Flap endonuclease 1 (2-356) 
 2ZVK DNA polymerase η (693-712) 
 1U76 DNA polymerase δ, p66 (452-466) 
 2ZVL DNA polymerase κ (862-871) 
 2ZVM DNA polymerase ι (420-432) 
Saccharomyces cerevisiae 1PLR Native 
 1PLQ Native 
 1PLR Native 
 3GPM E113G mutation 
 3GPN E113G mutation 
 2OD8 Cdc 9 (35-45) 
 3F1W G178S mutation 
 1SXJ Replication factor C 
Arabidopsis thaliana 2ZVV p21 (139-160) 
 2ZVW p21 (139-160) 
Archaeoglobus fulgidus 1RWZ Native 
 1RXZ Flap endonuclease 1 (11mer) 
 1RXM Flap endonuclease 1 (12mer) 
Pyrococcus furiosus 1ISQ PIP-box 12mer 
 1GE8 M73L mutation 
 1IZ4 M73L, D143A mutation 
 1IZ5 M73L, D143A  D147A mutation 
Sulfolobus solfataricus 2IX2 Native 
 2HII Native 
 2IJX Native 
 2IO4 F2V mutation 
 2HIK Native heterotrimer 
 2NTI Native heterotrimer 
 2IZO Flap endonuclease 1 (5-349) 
 3FDS DNA polymerase IV (1-352) 
Sulfolobus tokodaii 1UD9 Native 
Human Herpes virus 1YYP DNA polymerase (1223-1242) 
 1DML DNA polymerase (1200-1235) 
Enterobacteria phage RB69 1B77 Native 
 1B8H DNA polymerase (893-903) 
Escherichia coli 2POL Native 
 1MMI Native 
 3D1E DNA polymerase II (505-510) 
 3D1F DNA polymerase III (2-10) 
 1OK7 DNA polymerase IV (1-16) 
 1UNN DNA polymerase IV (243-351) 
 3BEP DNA-bound 
 3D1G Bound small molecule inhibitor 
Streptococcus pyogenes 2AVT Native 
Table 1-2. Crystal structures of PCNA deposited in the PDB as of 20/5/09’ 
The 49 solved structures of the PCNA sliding clamp from various species. These 
structures illustrate the native forms of PCNA and the binding interaction with 
different peptides. 3BEP shows the interaction of PCNA with DNA within the ring 





H.sap           MFEARLVQGSILKKVLEALKDLINEACWDISSSGVNLQSMDSSHVSLVQLTLRSEG-FDT 59 
M.mus           MFEARLIQGSILKKVLEALKDLINEACWDVSSGGVNLQSMDSSHVSLVQLTLRSEG-FDT 59 
S.pom           MLEARFQQAALLKKLLDAIKELVTDANFDCNDNGISLQAMDSSHVALVSMLIKSDG-FEP 59 
T.cru           MLEAQVQQANLWKRLIECISGLVNEANFDCNPGGLSIQAMDTSHVALVHLLLRDDC-FTK 59 
T.bru           MLEAQVLHANLWKRLIECINGLVNEANFDCNPGGLSIQAMDTSHVALVHMLLRDDC-FTK 59 
L.maj           MLEAQVQYASLWKRLVECINGLVNEANFDCNPGGLSIQAMDSSHVALVHMLLRDDC-FVK 59 
RB69            --------MKLSKDTIAILKNFASINSGILLSQGKFIMTRAVNGTTYAEANISDEIDFDV 52 
                          : *  :  :. : .         *  : :   . .: .   : .:  *   
                  EEEE  HHHHHHHHHHHHHHH  EEEEE    EEEEEE    EEEEEEEE        
 
H.sap           YRCDRNLAMGVNLTSMSKILKCAGNEDIITLRAEDNADTLALVFEAPNQEKVSDYEMKLM 119 
M.mus           YRCDRNLTMGVNLTSMSKILKCAGNEDIITLRAEDNADTLALVFEAPNQEKVSDYEMKLM 119 
S.pom           YRCDRNIALGINLNALSKVLRCAQNEDLVTLKAEDTPEVLNLVFESEKNDRISDYDVKLM 119 
T.cru           YQCERNSILGLNLASLSKVLKIVEGSDSLTLHHEDDSDVVVLTSENVEKSRKCEYQLKLL 119 
T.bru           YQCERNSVLGLNLASLSKVLKIVEATDSLTLRHEDDSDVVTLTSENGERSRKCEYQLKLL 119 
L.maj           YQCERNIILGLNLASLSKVLKIVDGNDSLSLRHDDDSDVVTLTSENPEKTRKCEYQLKLL 119 
RB69            ALYDLNSFAEISMHTDG-NIKIADTRSTVYWPAADKSTIVFPNKPIQFPVASVITEIKAE 111 
                   : *    :.: : .  :: .   . :     * .  :               ::*   
                      EEEEE HHHHHHHHHH     EEEEEE     EEEEEEE     EEEEEEEEEE 
 
H.sap           DLDVEQLGIPEQEYSCVVKMPSGEFACICRDLSHIGDAVVISCAKDGVKFSASGELGNGN 179 
M.mus           DLDVEQLGIPEQEYSCVIKMPSGEFARICRDLSHIGDAVVISCAKNGVKFSASGELGNGN 179 
S.pom           DIDQEHLGIPDIEYDATITMPAAEFQRITRDLLTLSDSVTINASKEGVRFSCKGDIGNGS 179 
T.cru           EIEGEAMGIPEMEYGSTVTLSSQEFAKIVRDMSVFGETVTIEIRKEGVKFSSSGDVGEGY 179 
T.bru           EIETEAMGIPEMDYKSIVTLSSQEFAKIVRDMTVFGDTVNIEILKESVKFSSCGDVGEGY 179 
L.maj           EIEAESMGIPEMDYRSTVTLNSAEFAKIVRDMQVFGDTVTIAISKEGVKFSSSGDVGQGY 179 
RB69            DLQQLLRVSRGLQIDTIAITNKD--GKIVINGYNKVEDSGLTRPKYSLTLTDYDGSNNFN 169 
                :::         :              *  :     :   :   * .: ::  .  .:   
                E              EEEEE HHHHHHHHHHHH    EEEEEE   EEEEEE      EE 
 
H.sap           IKLSQT------------SNVDKEE-----------------------EAVTIEMNEPVQ 204 
M.mus           IKLSQT------------SNVDKEE-----------------------EAVTIEMNEPVH 204 
S.pom           TTLKQH------------TDLSDQD-----------------------QSIEISLTQAVT 204 
T.cru           AFLRAAGGAGRTVRT--APEVKKE---EDDDTPISRANASGTKNSHTAIGVEVRTDEPVT 234 
T.bru           ALLRASHAPTVDPRSKGESDVKTED--EEADACSVRTHSAKGKDGPLGIGVDVRTNEPIT 237 
L.maj           TFLQAAGVSDRSAKSEVKSEVKAEARDEDEHEPISRRYN-KAEGGNGAIGVEVAMEEPIT 238 
RB69            FVINMAN----------------------------------------------MKIQPGN 183 
                  :                                                     :.   
                EEEE                                             EEEEE     E 
 
H.sap           LTFALRYLNFFTKATPLSSTVTLSMSADVPLVVEYKIADMGHLKYYLAPKIEDEEGS 261 
M.mus           LTFALRYLNFFTKATPLSPTVTLSMSADVPLVVEYKIADMGHLKYYLAPKIEDEEAS 261 
S.pom           LTFSLKYLAQFTKATPLATRVTLSMSNDVPLLVEYKM-ESGFLRFYLAPKIG----- 250 
T.cru           LSFALRFMNVFAKGSTLSDRVSLKFAPDSPCMVEFNIDQVGYLRYFLAPKMDDVM-- 289 
T.bru           LSFALRFMNIFAKGATLSDRVSLKFAKESPCMVEYSIDQVGYLRYYLAPKVDDAE-- 292 
L.maj           LSFALRFMGIFAKGSTLSERVTLKFAKDSPCMVEYGIDNVGYLRYYLAPKVDDAE-- 293 
RB69            YKVMLWGAGDKVAAKFESSQVSYVIAMEADSTHDF---------------------- 218 
                 .. *      . .   :  *:  :: :     ::                       
                EEEEHHHHHHHHH      EEEEEE     EEEEEEE    EEEEEE           
 
Figure 1-2. Sequence alignment of PCNAs  
This figure shows an alignment of PCNA from seven different sources H. sapiens, 
M.musculus, S. pombe, T. cruzi, T. brucei, L. major and Bacteriophage RB69. The (*) 
denotes areas of conservation between proteins (:) denotes strong similarity and (.) 
denotes similar residues. Strong areas of conservation are common at areas 
incorporated at the active site or important structural bodies in the protein.  
Coloured residues in the human sequence are shown to be involved in the PCNA 
peptide interaction. Those coloured red are determined to be involved in the hydrogen 
bonding of PCNA to p21 peptide, and residues coloured blue are in contact with this 
peptide, as determined from the pdb file 1AXC, from (Gulbis, J. M. et al 1996). This 
figure also shows secondary structure as determined by PredictProtein (Rost, B. et al 
2004). E = β-strand, H = helical.  
This alignment also shows a large area of the protein (186-223 L.maj) which is 
conserved between the protazoan PCNAs, but not present in humans, mice and even in 
the distant relative RB69. This elongated loop region and has no know function. 
Determined using http://www.ebi.ac.uk/clustalw/ (Aiyar, A. 2000) 
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first and second βαβββ folds and the third and fourth βαβββ folds, there are short β-
strands (Krishna, T. S. R. et al 1994). The second and third βαβββ folds are joined by 
the IDCL (figure 1.2 and 1.3). Phylogenetic analysis has shown that this βαβββ fold 
exists in most orders of life (Iwai, T. et al 2000; Tsurimoto, T. 1998). The E.coli 
PCNA monomer contains three globular domains. The three repeating globular 
domains of a single E.coli PCNA monomer have an average sequence identity of 
14% (Kelman, Z. and ODonnell, M. 1995). The low sequence identity of the E.coli 
PCNA folds suggests that the repetition of this fold occurred early in evolutionary 
terms.  
The eighteen β-strands of each PCNA monomer form three main β-sheets and 
provide structural rigidity (figure 1.4A). The helices of PCNA are rich in basic 
residues and bundle together (figure 1.4B). As will be discussed later, the basic helix 
bundles associate with DNA. The β-sheets and α-helix bundle are present on the 
opposite side of the PCNA monomer. 
The monomers associate forming a ring structure (figure 1.5). Inter-monomer 
interactions forming the trimer are strong, showing a Kd of ~21nM in H. sapiens 
PCNA (Yao, N. et al 1996). The high affinity of this interaction is the result of core 
hydrophobic interactions, and the hydrogen bonding of two anti-parallel β-sheets 
from adjacent monomers (figure 1.6). Differences in the stability of homologous 
proteins are believed to be linked to the number of hydrogen bond interactions at this 
interface (Yao, N. et al 1996). Human PCNA is determined from crystallographic 
analysis to have eight hydrogen bonds (figure 1.6A) at the binding interface (Gulbis, 
J. M. et al 1996) and RB69 has only four hydrogen bonds at the binding interface 
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(figure 1.6B) (Shamoo, Y. and Steitz, T. A. 1999). RB69 has a less stable trimeric 
complex (Yao, N. et al 1996) due to the loss of these hydrogen bonds. 
The ring structure of PCNA is present as a trimer (eukaryotes) and dimer 
(prokaryotes) (figure 1.5). Despite the negligible sequence homology between 
prokaryotes and eukaryotes, the structural architecture of PCNA is conserved (figure 
1.5). At the centre of the PCNA ring, there is a circular opening of ~35Å diameter of 
sufficient size to surround a DNA helix (Kelman, Z. 1997). The PCNA helix bundles 
(figure 1.4) associate with DNA perpendicular to the phosphate backbone 
(Tsurimoto, T. 1998). The ring structure in both eukaryotes and prokaryotes both 
contain twelve βαβββ folds which account for the conserved structural similarities 
(figure 1.5) (Bruck, I. and O'Donnell, M. 2001).  
The first evidence of the ring structure of PCNA and its mode of DNA 
interaction was provided by size exclusion studies (Stukenberg, P. T. et al 1991). 
PCNA in the presence of RFC and ATP was loaded onto circular and linear DNA. 
The PCNA-DNA complexes were incubated and passed over a size exclusion 
column. It was shown that PCNA would co-elute with circular DNA however not 
linear DNA (Stukenberg, P. T. et al 1991). The theory that PCNA formed a ring 
structure was later confirmed by electron microscopy studies of the PCNA-DNA 
interaction (Gogol, E. P. et al 1992). This ring structure has been hypothesised to 
potentially form a dimer of rings (Henderson, D. S. et al 2000; Naryzhny, S. N. et al 





Figure 1-3. The topology diagram of HsPCNA  
Figure showing the topology of the HsPCNA monomer as shown in the structure 
1AXC (Gulbis, J. M. et al 1996). The four βαβββ are represented in dark blue, light 
blue, light green and dark green. The IDCL is shown in red and demonstrates the 
clear separation in the two domains. The lower β-sheets form the monomer-monomer 
binding interfaces at the magenta line. Generated using TopDraw (Bond, C. S. 2003). 
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Figure 1-4. The exploded view of PCNA showing the secondary structural motifs 
Figure showing the secondary structural motifs of H. sapiens PCNA in an exploded 
form. A) The arrangement of the β-strands into β-sheets in PCNA. This arrangement 
shows three main β-sheets coloured red, green and blue and provide structural 
rigidity to PCNA. Red and blue sheets aid in the inter-monomer binding interaction 
(detailed further in figure 1.6). The green β-sheet is involved in the PCNA-PIP box 
interaction (detailed further in figure 1.7). B) The arrangement of the four α-helices, 
coloured red, green, blue and yellow, into the helix bundle. This image shows 
hydrophobic residues toward β-sheet region and basic residues toward DNA. These 








      
 
Figure 1-5. Structural views of PCNA 
Figure showing the conserved structure of PCNA in different orders of life. These 
protein structures all demonstrate 12 βαβββ folds resulting in structural similarities 
A) A eukaryotic (H. sapiens) PCNA showing a trimeric form with peptide binding 
sites shown with bound peptide, from pdb file 1AXC (Gulbis, J. M. et al 1996).  
B) A prokaryotic (E.coli) PCNA showing conserved structural features however 
present in a dimeric form, from the pdb file 2POL (Kong, X. P. et al 1992), as stated 
above E.coli PCNA shares only 16% identity with H. sapiens PCNA.  
C :left) The structure of L. major PCNA demonstrating conservation of the structural 
features of PCNA. This protein is present as a trimeric form. This structure has been 
determined as in chapter 3. L. major PCNA shares 38% sequence homology with H. 
sapiens PCNA.  
C :right) As C :right rotated 90° through the vertical. Demonstrating elongated loop 
regions (red) discussed in figure 1.2 and not present in H. sapiens PCNA. These 
regions have not been determined crystallographically and are modelled into the 
structure. 






         
 
         
 
Figure 1-6. The monomer-monomer interface of H. sapiens PCNA 
Figure demonstrating the inter-monomer interactions in a PCNA ring. A) The 
hydrogen bonding network at the H. sapiens PCNA monomer-monomer interaction. 
There are a total of eight hydrogen bonds (black) resulting in the high affinity 
interaction. These hydrogen bonds occur between β-strands E107-K117 and L175-
S183 (from the pdb file 1AXC). B) The binding interface of RB69 PCNA monomer-
monomer interface. This figure shows four hydrogen bonds (black) between β-
strands R87-Y91 and K164-T169 (from the pdb file 1B77). C) The vacuum 
electrostatic representation of the binding interface of the H. sapiens PCNA 
monomer. The oval represents the hydrophobic core of the binding interface. Above 
the oval is the β-strand, required for hydrogen bonding, and below the positively 






1.2.1 The PCNA PIP box interaction 
The majority of binding partners to PCNA (discussed in section 1.1) are 
essential for successful DNA replication and repair. Most of the interacting proteins 
which bind PCNA were found to contain a consensus sequence. This consensus 
sequence has been termed PCNA interacting protein (PIP) box. Some proteins 
containing this consensus sequence are presented here and grouped by cellular 
function (table 1.3). 
The sequence of the PIP box was demonstrated in peptide studies (Warbrick, E. et al 
1995) and verified in D. melanogaster (Warbrick, E. et al 1998) and present in other 
organisms also. The PIP box is a conserved sequence of residues with the Q-x-x-h-x-
x-a-a motif, where (x) represents any amino acid, (h) any mildly hydrophobic amino 
acid and (a) represents an aromatic amino acid (Kontopidis, G. et al 2005).  
The PIP box has demonstrated specificity for a PCNA binding interface. The 
binding region for the PIP box is formed by an anti-parallel β-sheet and a loop 
region, termed the inter-domain connector loop (IDCL) (figure 1.2 and 1.6). A 
hydrophobic pocket is formed between the anti-parallel β-sheet and the C-terminal 
side of the IDCL (figure 1.7). The conservation of the residues which make up the 
PIP box binding surface suggests their importance (figure 1.2). These interactions 
have been demonstrated in crystallographic studies between HsPCNA and p21 
peptide (141-160) (Gulbis, J. M. et al 1996) (figure1.6) and through mutation 
analysis (Oku, T. et al 1998). In-vitro analysis by ITC of HsPCNA binding to p21 
(141-160) peptide has given a Kd of interaction of 87.7nM (Zheleva, D. I. et al 
2000). 27 hydrogen bonds are formed between the peptide and HsPCNA upon 




Activity Protein Binding sequence Note 
pol δ - p12 GRKRLITDSYPV  
         - p66 NRQVSITGFFQR  
         - p125 ATQCQLEADV  
FEN-1 STQGRLDDFFKV  
DNA ligase I  MQRSIMSFFHP  
RFC 1    MDIRKFFGV  
DNA replication 
PDIP 1 KKQTKVEFPEAR  
Pol η GMQTLESFFKP  
Pol ι AKKGLIDYYLM  
Pol κ PKHTLDIFFK  
Trans-lesion 
polymerases 
Pol λ ESVPVLELFSN  
MMR EXO 1 GLQIKLNELWKN Not Investigated 
UNG IGQKTLYSFFSP  
MPG MYFCMNISSQGD  
NTH 1  Not Found 
hMYH MGQQVLDNFFRS  
APE 1  Not Investigated 
APE 2 RGQKNLKSYFQP  
Pol β VEQLQKVHFIT  
XRCC 1  Not Found 
BER 
XPG QTQLRIDSFFRL  
TdT  Not Found 
PARP-1 QDLIKMIF  
WRN QWKLLRD  
hBLM QQRVKDFF  






DNMT 1 QTTITSHF  
HDAC 1  Not Investigated 
p300  Not Investigated 
Chromatin control 
ESCO 1/2 QLIIDAGQ  
Ctf 18  Not Investigated Chromatid cohesion 
CDK 2  Not Found 
EGFR  Not Investigated 
p21 QTSMTDFY  
p57 SGPLISDFF  
Cyclin D1  Not Investigated 
MCL 1 QRNHETAF  
p15 QKGIGEFF  
CDC 25C  Not Investigated 
ING 1b QLHLVNYV  
Gadd 45  Not Investigated 
MyD 118  Not Investigated 
CR 6  Not Investigated 
p53 QETFSDLW  
Cell cycle control 
MDM 2 QMIVLTYF  
Transposase RAR α  Not Found 
 
Table 1-3. The interacting partners of PCNA in humans 
Table of known PCNA binding partners in H. sapiens modified from (Moldovan, G. 
L. et al 2007) supplementary data (S1). Showing the activity and interacting 
sequence of the binding protein. 
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PCNA binding partners not only bind the main PIP box interface (figure 1.7) but also 
other regions of PCNA have been determined to be important in protein association. 
One of the most characterised regions required for PCNA protein interactions is the 
PCNA C-terminus. Deletion mutations of the PCNA C-terminus have demonstrated 
this section to be required for the loading of PCNA onto DNA by RFC in eukaryotes 
(Fukuda, K. et al 1995). E.coli DNA polymerase III, a homologue for eukaryotic 
DNA polymerase ε, interacts with the C-terminal region of PCNA (subunit β) 
(Naktinis, V. et al 1996). A series of point mutations were introduced to the C-
terminus of E.coli PCNA and were analysed by SPR. These mutations resulted in a 
reduced binding affinity for immobilised δ subunit of DNA polymerase III and DNA 
polymerase III core. This result was confirmed by phosphorylation analysis. A kinase 
phosphorylation motif was placed on the C-terminus of E.coli PCNA. The 
recombinant kinase target was protected from phosphorylation by the δ subunit of 
DNA polymerase III (Naktinis, V. et al 1996). These experiments demonstrate the 
importance of the prokaryotic PCNA C-terminus. The C-terminus of PCNA in both 
prokaryotes and eukaryotes is present at the hydrophobic pocket adjacent to the 
IDCL (figure 1.7), which may be the reason for its involvement in PCNA-protein 
interactions. The 27 hydrogen bonds facilitate the formation of the PCNA-peptide 
complex. 
Away from the PIP box interface of eukaryotic PCNA are two specific 
residues (aspartic acid 41 and aspartic acid 97) which are also highly conserved in 
PCNA (figure 1.2 and 1.6). These two residues have been determined to be important 
in the interaction with RFC. Mutation studies of these two aspartic acid residues to 





Figure 1-7. The PIP box binding interface of H. sapiens PCNA-p21 (141-160)  
The structure of the H. sapiens PCNA binding interface bound to p21 (141-160) 
peptide from the pdb file 1AXC (Gulbis, J. M. et al 1996). A) Cartoon form showing 
PCNA in green and p21 in red. The position of the helical region of p21 represents 
the hydrophobic pocket and is present between the anti-parallel β-sheet and the C-
terminal side of the IDCL. The IDCL presents the potential for hydrogen bonding 
contacts. Residues D41 and D97 are shown in stick form. D41 is located near the 
helical region of p21. D97 is located at the N-terminal side of the IDCL. B) The 
electrostatic representation of PCNA showing p21 in red, and a clear hydrophobic 






shown for aspartic acid 41 in mutation sensitivity studies (Ayyagari, R. et al 1995). 
D41 is located on a loop region near the hydrophobic pocket, suggesting that this 
residue may be involved in modifying the shape of this loop (figure 1.7A). D97 is 
shown to be at the N-terminal side of the IDCL and is potentially required for 
positioning the IDCL, or is in direct contact with the interacting partner (figure 
1.7A). 
It has been demonstrated that sections of PCNA not including the IDCL, 1-68 
and 195-261, can separately bind cyclin D (Matsuoka, S. et al 1994). This 
demonstrates that residues within these regions are involved in PCNA-cyclin 
interactions. 
1.3 PCNA as a potential drug target  
The essential nature of PCNA in DNA replication and repair (discussed in 
section 1.1) suggests that the modulation of PCNA activity may be a lead as a drug 
target. Structure based drug design can use the PCNA hydrophobic pocket as a 
template to create a small molecule ligand. The creation of a small molecule ligand 
of PCNA has been previously demonstrated in E.coli PCNA, with a molecule termed 
RU7, which presented a Ki of ~10µM (figure 1.8) (Georgescu, R. E. et al 2008).  
In normal cell lines, PCNA is up-regulated by the tumour suppressor protein 
(p53) (Xu, J. and Morris, G. F. 1999). When PCNA is present with low levels of p53, 
DNA replication takes place (Paunesku, T. et al 2001). High cellular concentrations 
of p53 stimulates the up-regulation of other proteins e.g. p21 (Radhakrishnan, S. K. 
et al 2006). p21 results in the stalling of normal replication and targets PCNA for 




Figure 1-8. A small molecule inhibitor represented in the binding pocket of E.coli PCNA 
Figure representing the first, effective small molecule inhibitor of E.coli PCNA. A) The schematic representation of the RU7 small molecule 
inhibitor. B) The small molecule inhibitor bound into the E.coli PCNA PIP box binding interface. The native structure of E.coli PCNA is 
represented in yellow and the complexed structure of E.coli PCNA is shown in white showing a shift in residue side chains. Distances are given 




p53, high p21 and normal PCNA, the cell undergoes apoptosis (Chen, J. J. et al 
1996b; Paunesku, T. et al 2001).   
The up-regulation of HsPCNA is a common marker of proliferating 
cancerous cell lines (Paunesku, T. et al 2001). High levels of PCNA are linked to 
malignant tumours and the inhibition of PCNA within these cell lines results in the 
induction of apoptosis (Paunesku, T. et al 2001). This has been demonstrated by 
treatment of cells with anti-sense oligonucleotides resulting in inhibition of 
cancerous cells with only slight effect in normal cells (Sakakura, C. et al 1994). This 
data suggests the HsPCNA can potentially be used as an anti-cancer target.  
The inhibition of PCNA by p21 is a suggested method of cancer suppression 
(Mattock, H. et al 2001). Mimicking this interaction by peptidomimetics could 
provide a route to a potential anti-cancer therapy (Kontopidis, G. et al 2005). A small 
molecule inhibitor, like that demonstrated in E.coli (Georgescu, R. E. et al 2008), 
targeted for HsPCNA, may provide a potential route to an anti-cancer therapy. 
1.3.1 Fungal related diseases  
S. pombe is a form of fission yeast used as a model organism for molecular 
biology. Yeasts are a type of fungi which are responsible for many ailments in 
humans e.g. Cryptococcus and Candidiasis. Not only are yeasts a form of pathogenic 
organism, but also a cause for food spoilage. Food spoilage occurs as a result of 
some yeasts (Zygosaccharomyces) ability to survive high concentrations of sucrose, 
ethanol, acetic acid, sorbic acid and benzoic acid; all of which are commonly used in 
the preservation of food (Corry, J. E. L. 1978). 
These lower eukaryotes have a cellular use of PCNA as a control system as in 
mammalian cells (Ayyagari, R. et al 1995). This similarity in mechanism implies that 
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the inhibition of S. pombe (Sp)PCNA results in the stalling of cellular division 
(Warbrick, E. 2006). The PCNA PIP box binding interface may present structural 
differences between HsPCNA and SpPCNA. The determination of small differences 
in the PCNA PIP box binding interface of PCNA between HsPCNA and SpPCNA 
may allow the creation of a species specific inhibitor. The goal is to allow the 
inhibitor to target non-human cell lines, thus targeting infection with little side 
effects. This suggests that a small molecule inhibitor for SpPCNA could present a 
potential lead for an anti-fungal treatment. 
1.3.2 Leishmania related diseases 
Leishmania is a protozoan pathogen spread by an insect vector. Infection by 
this parasite is referred to as leishmaniasis. Approximately 30 species of the 
phlebotomine sand fly can act as the insect vector. These insects live most commonly 
in tropical regions (World Health Organisation (WHO) 2009). This disease is most 
problematic in the developing world with 90% of all visceral leishmaniasis cases 
occurring in Bangladesh, Brazil, India, Nepal and Sudan; 90% of mucocutaneous 
leishmaniasis occuring in Bolivia, Brazil and Peru; and 90% of cutaneous 
leishmaniasis cases occuring in Afghanistan, Brazil, Iran, Peru, Saudi Arabia and 
Syria (World Health Organisation (WHO) 2009). As a result of this disease being 
most prevalent in poorer countries, many who require treatment can not afford it. 
This disease can present in three main forms, visceral, mucocutaneous and 
cutaneous. These three different forms of leishmaniasis arise from different strains of 
Leishmania. Leishmania major results in cutaneous leishmaniasis (Gonzalez, Urba et 
al 2008). 
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The life cycle of Leishmania major has two main stages (figure 1.9). These 
stages are the vector stage (when present in the sand fly) and the infections (when 
present in mammals). Leishmania are transferred to the sand fly during feeding and 
amasitgotes are released into the midgut. The amastigotes grow into promastigotes 
and can freely divide. These promastigotes  then migrate to the proboscis (Laskay, T. 
et al 2003). When the sand fly feeds again, the promastigotes are transferred to the 
mammal. Mammalian macrophages phagocytose the Leishmania promastigotes. 
These promastigotes revert to amastigotes and divide further. These amastigotes can 
lyse infected cells, and continue to infect other cells (Laskay, T. et al 2003). These 
amastigotes can then be transferred to another sand fly during feeding.  
Current drugs available to combat leishmaniasis are toxic to human hosts. 
These drugs are also losing efficacy due to increasing resistance of the parasites. 
These factors stress the requirement for more effective drugs to combat this disease 
at a lower financial cost (World Health Organisation (WHO) 2009).  
 A link has been shown between the occurrence of leishmaniasis and severity 
of HIV infections. Leishmaniasis can also be spread by the sharing of needles by 
intravenous drug users; moreover, an infection with each of these diseases can 
elevate the symptoms of both. This is because leishmaniasis will suppress the 
immune system causing an accumulative immuno-suppression with HIV; and the 
parasitic infection will stimulate replication of the virus. The symptoms of 
leishmaniasis are amplified in HIV carriers this is as co-infection rapidly activates 
disease in parasite carriers also (Olivier, M. et al 2003).  
 The protozoan cell cycle biochemistry has been shown to be similar to that of 




Figure 1-9. The life cycle of Leishmania major 
Figure showing the two stage life cycle of Leishmania major. In red, to the left, 
stages present in the sand fly and in blue, to the right, stages present in the 
mammalian host. 1) the infection of the human host during the feeding of the 
sandfly. 2) macrophages are invaded by promastigotes. 3) formation of amastigotes 
from promastigotes in macrophages. 4) the multiplication of amastigotes and lysis of 
macrophages resulting in the release of amasigotes. 5-6) the infection of the sand fly 
with amastigotes during feeding. 7) the growth of amastigotes into promastigotes in 
the midgut of the sand fly. 8) the replication of the promastigotes and migration to 
the proboscis 
 











important protein for the cell cycle in Leishmania similar to that of humans 
(Mottram, J. C. et al 1993). As stated above (section 1.3.1) if the structure of L. 
major (Lm)PCNA were solved, differences in the surface of the PIP box binding 
interface could be determined. Surface differences may potentially be exploited for 
the creation of species-specific PCNA inhibitors. This may create drugs capable of 
specifically targeting and destroying L. major cells and leaving H. sapiens cells 
intact. This infers that the creation of a small molecule inhibitor of LmPCNA could 
act as a potential anti-parasitic lead. The successful creation of a cheap anti-parasitic 
therapy may also aid in the alleviation of AIDS symptoms in developing countries. 
 The alignment and structures of LmPCNA (figures 1.2 and 1.3) show a loop 
region of protozoa PCNA, residues 194-228, which is not present in eukaryotic or 
prokaryotic PCNA. This loop region has an unknown function and may present a 
new target for ligand-binding. The elongated loop is present on the opposite side of 
the PCNA ring from the binding interface, implying that it is not required for the 
PCNA PIP box interactions (figure 1.4). 
 
1.4 Project outline 
 This project is based on the biophysical and structural investigation of the 
PCNA-p21 peptide interaction. X-ray crystal structures of LmPCNA have been 
solved and compared to the known structures of HsPCNA and SpPCNA. The 
biochemical interactions of HsPCNA, SpPCNA and LmPCNA with the p21 peptides 
will be determined by different biochemical techniques.  
 Using the well defined PCNA-p21 peptide interactions, the effect of different 
peptides can be analysed. These peptides can allow the thorough determination of the 
effect of a p21 point mutation. The effect of different biotin tags can be analysed to 
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better understand the effect of steric hinderance in peptide protein interactions 
analysed by SPR. 
1.4.1 Crystal structure solution of LmPCNA 
 The solution of the structure of LmPCNA required the purification and 
crystallisation of the protein. The solution of the structure demonstrated the level of 
structural similarity of LmPCNA with HsPCNA and SpPCNA. The structure solution 
failed to provide any information regarding the form of the elongated loop region and 
no evidence for its activity was determined. A co-crystal structure of LmPCNA with 
the p21 peptide has also been solved to demonstrate the PCNA peptide interactions 
present in the crystal. This solution has been used to explain possible differences in 
strength of interaction determined from the biochemical experiments. This structure 
is now available to allow the design of LmPCNA inhibitors by structure-based drug 
design. These novel inhibitors may lead to novel anti-parasitic drugs. 
1.4.2 Characterisation of the PCNA peptide interaction 
 The binding characteristics of HsPCNA, SpPCNA and LmPCNA to peptides 
can be determined by different biochemical methods. The binding affinity of these 
three PCNAs for the p21 peptide (141-152) has been determined by SPR, thermal 
shift assays and ITC. The interaction of the three PCNAs to p21 (141-152, F150A) 
mutant peptide has also been determined. The wild type and point mutant peptides’ 
binding characteristics have been compared. This data provides information 
regarding the thermodynamic contribution to the binding interaction of the six carbon 
ring of F150. The interaction of a variety of peptides with differing biotin tags to 
PCNA from these three species has also been studied (discussed in greater detail in 
chapter 7). 
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In this work, the association of the seven different peptides has been analysed 
for the affinity for the three PCNAs; HsPCNA, SpPCNA and LmPCNA. These seven 
peptides (figure 1.10) are shown here: 
 Peptide0 –                                  KKRQTSMTDFYHSKRRLIFS 
Peptide1 –                                  KRRQTSMTDFYH 
 Peptide2 –                           Bio-KRRQTSMTDFYH 
 Peptide3 –                  Bio-PEG-KRRQTSMTDFYH 
 Peptide4 –         Bio-PEG-PEG-KRRQTSMTDFYH 
 Peptide5 – Bio-PEG-PEG-Ahx-KRRQTSMTDFYH 
  Peptide6 –                  KRRQTSMTDAYH 
 
1.4.3 Effect of spacer lengths in SPR 
 A common method of affinity determination by SPR is to immobilise the 
ligand to a sensor surface by the Streptavidin-Biotin interaction. The ligand (peptide) 
is immobilised to the surface. Immobilisation to StreptAvidin can affect the 
interaction due to steric hinderance. PEG spacers can be used to relieve this steric 
hinderance, by separating the ligand from the biotin. The difference in spacer length 
results in changes in binding affinity between PCNA and immobilised peptide. This 
difference was confirmed to be due to the relief of steric hinderance, and not due to 
modification of the PCNA PIP box interaction. The affinities of these peptides with 
PCNA from three different sources, HsPCNA, SpPCNA and LmPCNA, have been 
determined with PCNA immobilised to an SPR sensor surface. These experiments 
determined the level of steric hinderance encountered due to linker size. The affinity 
of these PCNA peptide interactions have been verified by thermal denaturation 





Figure 1-10. The peptides investigated by SPR in this work 
Figure showing the peptides used in SPR experiments carried out in this study.  
Peptides 2-5 showing the biotin tags of the peptides for use with spacer investigation. 
The full chemical sequence of the linkers showing the biotin, PEG and hydrophobic 
(octanoic acid) spacers are represented. The additional spacers have their 































CHAPTER 2.  The molecular biology and purification of three PCNAs 
In this chapter, the cloning, expression and purification of PCNA from three 
organisms are described. A plasmid vector is required to be created containing a gene 
encoding the protein of interest and appropriate antibiotic selection marker. This 
plasmid vector is created using molecular cloning techniques. This vector is used in 
conjunction with bacterial expression systems which are commonly used for protein 
production for crystallography. These expression systems are acceptable, provided 
no post-translational modifications are required. 
PCNA from all three sources are required to be pure enough for 
crystallographic analysis (>97%) and with high enough yield (~2mg per 
purification). For each of these three PCNAs, the protein is required to be folded and 
capable of binding a peptide with a PIP box present.  
2.1 Principles of molecular cloning  
Cloning a target gene requires large quantities of the gene of interest to be 
amplified and have “sticky ends”. Sticky ends are a term for DNA overhang, a small 
section of single stranded DNA at the end of the DNA strand. These sticky ends can 
then allow ligation to required vector DNA with complementary sticky ends and 
form a circular plasmid. The final circular plasmid can then be transformed into an 
expression cell-line for protein production.  
Molecular cloning requires a large quantity of DNA. DNA concentration for 
ligation can be between 250µg ml-1 and 0.2µg ml-1 (Chang, A. C. Y. and Cohen, S. 
N. 1978; Shore, D. et al 1981). Low DNA concentrations can result in product levels 
too low for subsequent transformation and high DNA concentrations can result in 
DNA to be annealed in linear form. The optimal DNA concentration of ligation to 
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obtain sufficient levels of circular DNA for transformation is required to be between 
10µg ml-1 and 5µg ml-1 (Remaut, E. et al 1983; Sambrook, J. et al 1989). Insert DNA 
to vector DNA should have a ratio of ~3:1 respectively for optimal formation of 
circular plasmids with only single inserts. This quantity of insert DNA can be 
obtained by Polymerse Chain Reaction (PCR) using Thermus aquaticus (Taq) DNA 
polymerse (Saiki, R. K. et al 1988).   
2.1.1 Methods of molecular cloning 
Original methods for ligation would be to generate the insert as above and 
then subsequently cleave the short linear DNA to form sticky ends (figure 2.1). The 
vector plasmids are linearised by cleavage with the same restriction enzymes. The 
two fragments can be gel extracted to isolate only the insert and plasmids. These 
fragments would then be ligated as above (figure 2.1). This method has significant 
problems as each step results in the loss of insert DNA and a potential for the DNA 
to become damaged, reducing the probability of the final ligation event being 
successful. The cleavage of short strands of DNA also results in reduced efficiency 
as it is known that restriction enzymes have a reduced functionality when cleaving at 
the end of a DNA strand (Moreira, R. F. and Noren, C. J. 1995). This will result in a 
reduced quantity of insert DNA being capable of ligation. 
2.1.1.1 Modern methods for simple cloning procedures 
Modern techniques involve the use of a cloning vector. A cloning vector is a 
preformed linearised plasmid capable of annealing to PCR products immediately 
after the PCR reaction. Two of the most common cloning vectors in use are the 
pCR®2.1-TOPO® from the TOPO® TA cloning system (Invitrogen) and the 




















Figure 2-1. The general principles of the cloning of protein encoding genes 
This figure demonstrates the general steps involved in the cloning of a gene into a 
bacterial expression vector. The initial step requires the production of a PCR product 
with appropriate restriction sites (red). Modern cloning techniques allow this gene to 
be inserted into a cloning vector which can be freely produced for a large quantity of 
cleaved PCR insert. This doubly digested PCR product can then be inserted into a 
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These can then be used to produce large quantities of cleaved insert readily. 
The TOPO® TA vector is a self ligating system with Topoisomerase 
covalently bound at each end. This plasmid contains dual antibiotic resistance 
(Ampicillin and Kanamycin) and also the ability for blue/white selection (Messing, J. 
et al 1977; Norrander, J. et al 1983; Vieira, J. and Messing, J. 1982). Dual antibiotic 
resistance allows for the selection of cells with successful transformants. Blue/white 
selection allows for the selection of successful ligations due to disruption of the lacZ 
gene. For successful ligation, a 3’-A overhang is required which is added to the PCR 
product by the Taq polymerase. Proof reading DNA Taq such as VentR® or 
PfuTurbo® should ideally be used for cloning in order to reduce mutation rates; these 
polymerases however remove the 3’ overhang reducing the efficiency of TOPO® TA.  
The pJET1.2/blunt is a blunt end cloning vector which requires the further 
addition of T4 DNA ligase to the reaction for the ligation to occur. This vector only 
confers ampicillin resistance to allow selection for positive transformants. The 
Eco47I gene is also present in this cloning vector which is disrupted when the insert 
is present (figure 2.1). Should a cloning vector self-ligate, this gene will be active in 
the transformed cell and produce a restriction enzyme which is lethal to E.coli host 
cells. Due to the blunt end ligation system, the CloneJet vector requires the 3’-A 
overhang to be removed prior to ligation if other forms of Taq DNA polymerase are 
used.  
2.1.2 Materials and methods of the cloning of HsPCNA 
A PCR product of the HsPCNA gene was formed using Expand high fidelity 
Taq plus (Roche). A PCR mixture of high fidelity Taq 2.5U, 5µM each primer, 
50µM each deoxyribonucleotide, 1× high fidelity Taq reaction buffer, 1µg template 
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plasmid DNA, 1mM MgCl2 made up to 50µl with ddH2O was used to amplify the 
HsPCNA gene. The PCR was performed with an annealing temperature of 48°C, 
elongation temperature of 72°C, melting temperature of 92°C and was repeated 28 
times, in using a T1 thermal cycler (Biometra). The PCR product was gel extracted 
from a 1% agarose gel using the QIAquick gel extraction kit (QIAGEN) and the 
insert was eluted in 30µl ddH2O. 2µl of the gel extracted PCR product was used and 
the 3’-A overhang was removed as described in the in the CloneJet reaction for blunt 
end cloning handbook. The pJET1.2/blunt-HsPCNA plasmid was prepared from a 
DH5α culture using the QIAprep Spin miniprep kit (QIAGEN). pJET1.2/blunt-
HsPCNA and pET-28a plasmids were cleaved using 10 units of BamHI and 10 units 
of XhoI, 1× BamHI cleavage buffer (NEB), 1× BSA and made up to 50µl with 
ddH2O at 37°C for 3hours. Cleaved HsPCNA and pET-28a were ligated using the 
protocol from the T4 rapid ligation kit (Invitrogen). Clones were verified by colony 
PCR and double digestion, and the final product was sequenced at the University of 
Dundee sequencing service. 
2.1.3 Cloning of PCNA from three species  
A PCR product of the coding region was created using the forward primer - 
3’-GCTCGAGATGTTCGAGGCGCGCCTG-5’ 
and reverse primer - 
3’-GGGATCCTAGCCATATGTACTTAGAGGTAC-5’ 
with high fidelity Taq. Fresh PCR product was used with CloneJet cloning kit. 
Colony PCR of the resulting colonies verified the presence of insert. Plasmids were 
isolated from resulting colonies and analysed by double digestion with BamHI and 
XhoI and sequenced. The cleaved insert was ligated into cleaved pET-15b and 
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transformed into commercially competent DH5α cells. Resulting colonies were 
analysed by colony PCR and plasmids were double digested to verify the presence of 
insert. These purified plasmids were sequenced and verified to be accurate (figure 
2.2, top). This formed a recombinant N-terminal 6×HIS tagged HsPCNA.  
The SpPCNA plasmid was a gift from Conny Ludwig. This plasmid was 
verified, and the SpPCNA gene was present on the pQE-32 plasmid between the 
BamHI and SalI cleavage sites. This generates a recombinant N-terminal 6×HIS 
tagged SpPCNA.  
The LmPCNA construct was created at the University of Glasgow and was a 
gift from Jeremy C. Mottram, this was assigned pGL1583 from the L. major putative 
PCNA gene lmjF15.1450. PCR from genomic DNA was performed using the 
forward primer-  5'-CCATATGCTGGAGGCTCAGGTCCAGTACG-3'  
and reverse primer- 5'-GCTCGAGTCACTCCGCATCGTCCACC-3' 
The PCR product was inserted into pET-28a using NdeI and XhoI cleavage 
sites and the plasmid product was verified to be accurate by sequencing (appendix 
1.1). This formed a recombinant N-terminal 6×HIS tagged LmPCNA.  
2.2 Principles of protein expression 
Different methods of protein expression exist e.g. bacterial, yeast, 
baculovirus; each with different applications. In this work I will only discuss 
principles of recombinant protein expression in bacteria. Bacteria, commonly E.coli 
are primarily used for large scale protein expression for crystallisation. Different 
bacterial cell lines, expression vectors, expression media, expression conditions and 
expression time can be modified to increase the protein yield.  
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Figure 2-2. The cloning and expression of HsPCNA-
pET28a construct 
Top) The PCR and double digestion of the HsPCNA-
pET28a construct, verifying the presence of the 
HsPCNA insert with BamHI and XhoI restriction. 
Double digestion demonstrates an insert and plasmid of 
appropriate size, 800bp and 5.4kb respectively. 
 
Bottom) The constructs of the expression vectors for 
HIS-tagged PCNA from three species. HsPCNA was 
cloned into pET-28a using the BamHI and XhoI sites. 
SpPCNA has been inserted in pQE-32 vector between 
the BamHI and SalI restriction sites. The LmPCNA 
gene has been inserted into the pET-28a expression 



















BamHI SalI NdeI XhoI 
 42
2.2.1 E.coli cell lines for protein expression 
Different E.coli cell lines can be used in order to maximise expression by 
overcoming different problems encountered in the expression of different proteins. 
The (DE3) cell lines contain the bacteriophage λ DE3 lysogen in its genomic DNA, 
which encodes for the T7 RNA polymerase. This gene is regulated by the lacUV5 
promoter, which allows high recombinant transcription levels in the presence of 
Isopropyl β-D-1-thiogalactopyranoside (IPTG), an allolactose mimic. Cell lines are 
briefly represented in table 2.1. BL21 (DE3) cell lines are deficient of the Lon and 
OmpT proteases, reducing the level of protein degradation by protease activity 
(Studier, F. W. and Moffatt, B. A. 1986). BL21 (DE3) Star® are similar to BL21 
(DE3), the Star cell line refers to a mutated rne131 gene resulting in a defective 
RNase E protein. This mutation allows greater cellular levels of mRNA to 
accumulate within the cell in order to increase expression (Lopez, P. J. et al 1999). 
Rosetta (DE3) cell lines contain increased expression of tRNA required for 
translation. This cell line allows higher levels of all tRNA including those for rare 
codons. This allows proteins encoding greater numbers of rare codons to be produced 
freely (Baca, A. M. and Hol, W. G. J. 2000; Ikemura, T. 1981). The above cell lines 
can also contain a PLysS plasmid. This plasmid allows the weak repression of the T7 
promotor. The PLysS plasmid encodes for the T7 lysozyme which is capable of 
binding and inhibiting the T7 RNA polymerase (Moffatt, B. A. and Studier, F. W. 
1987). This can allow tighter control of recombinant protein production and is 




Strain Genotype Features 
BL21 (DE3) 
F– ompT hsdSB(rB–, mB–) 
gal dcm (DE3) 
Defective in Lon and 
OmpT protease 
BL21 (DE3) Star 
F– ompT hsdSB(rB–, mB–
) gal dcm rne131 (DE3) 
As BL21 (DE3) and 
defective in rne131 
resulting in ineffective 
RNase E 




gal dcm λ(DE3 [lacI 
lacUV5-T7 gene 1 ind1 
sam7 nin5]) pLysSRARE 
(CamR) 
Additional tRNA for all 
codons including those 
rare in bacterial cell lines 
PLysS plasmid pLysS(cmR) 
Produces a weak repressor 




Table 2-1. Table showing a selection of common bacterial expression cell lines 
Table showing a small selection of the major cell lines used for recombinant protein 
expression. The genotypes and main features of these cell lines are represented. The 





Promoter Affinity tag 
pT7-7 Ampicillin T7 None 
pQE Ampicillin T5 6×HIS 
pGEX Ampicillin T7 GST 
pMAL Ampicillin T7 MBD 
 
Table 2-2. Table showing a selection of common bacterial expression vectors 
Table showing a small selection of some expression vectors used for recombinant 
protein expression. The resistance, promoter and affinity tags of these expression 
vectors cell lines are represented.  
 
 
Media Ingredients Maximal Growth 
Luria-Bertani (LB) 
5 g  yeast extract, 10 g 
tryptone and 10 g NaCl 
~2Au 
2×TY 
10 g yeast extract, 16 g 
tryptone and 5 g  NaCl 
~3Au 
Overnight Express Proprietary information 
Greater than photo 
spectrometer range 
however 6 times biomass 
 
Table 2-3. Table showing a selection of common bacterial expression media 
Common growth media used with E.coli showing recipe and maximal growth 
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2.2.1.1 E.coli expression vectors used for protein expression 
Recombinant proteins can be cloned onto different expression vectors in 
order to optimise expression or allow the addition of an affinity tag. One of the most 
common expression vectors are the pET vectors (Novagen). These vectors contain 
the lacI gene for production of the lac repressor, the lacO DNA for the lac repressor 
binding, binding T7 promoter for use with DE3 cell lines, and the ampicillin 
resistance gene. Other vectors in use include the pT7-7, pQE, pGEX and pMAL 
represented in table 2.2. pT7-7 expresses native proteins under control of the T7 
promoter like that of the pET expression vectors. pQE, pGEX and pMAL express 
6×HIS, Glutathione-s-transferase (GST) and maltose binding domain (MBD) tags 
respectively. Protein expression of pQE expression vectors is controlled by the T5 
promoter, pGEX and pMAL expression vectors are controlled by the Ptac promoters. 
This allows the protein of interest different expression systems and different affinity 
tags which can facilitate increased expression and aid purification. 
2.2.1.2 E.coli growth media used for protein expression 
Expression of the protein of interest can be improved by the use of different 
growth media, these include, Luria-Bertani (LB), 2×tryptone and yeast extract 
(2×TY) and Overnight Express™ Autoinduction media (table 2.3). LB is the most 
common growth media used, providing a rich growth media to allow high 
concentration of cell densities (Anderson, E. H. 1946). 2×TY media is similar to LB 
media with double quantities of tryptone and yeast extract, which allows higher cell 
densities to be achieved. Autoinduction media does not require the introduction of 
IPTG for protein expression. This media also allows significantly increased cell 
densities, ~6fold that of LB (Grossman, T. H. et al 1998). 
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2.2.1.3 Standard methods of protein expression by E.coli 
During protein expression in DE3 cell lines the culture has IPTG added 
commonly at an optical density at a wavelength of 600nm (OD600) of 0.6AU. At this 
time, it can be advantageous to modify the temperature of the cell culture. IPTG is 
commonly used at a final concentration in the media of 1mM, optimal concentration 
for expression can be between 0.1 and 2mM. The maximum IPTG concentration for 
use is ~3mM as the number of RNA polymerase molecules in a cell is limited. The 
protein expression is commonly induced with IPTG when the cell suspension reaches 
an OD600 of 0.6AU, however can be between 0.4 and 1.0AU is suitable as cells at 
this OD are in the logarithmic growth phase and are most stable. Cells are grown at 
37°C and recombinant protein can be expressed at this temperature, some protocols 
however use a lower temperature of protein expression. An expression temperature 
of 20-30°C results in slower growth and an increased yield of folded protein. This 
can be influenced by the production of cold shock chaperone proteins to improve the 
expression of appropriately folded proteins (Schein, C. H. 1989). 
After protein expression by addition of IPTG, the cells can require differing 
lengths of time to reach optimal expression levels. During the initial analysis of 
protein expression, samples are removed at 1hour intervals and analysed by SDS-
PAGE, in order to determine the level of expression. This can demonstrate the length 
of time required for adequate levels of protein expression. 
2.2.2 Materials and methods for the expression of PCNA  
HsPCNA pET-28a construct was transformed into BL21 (DE3) PLysS and 
plated out onto ampicillin, 100µg ml-1, LB agar plates. A single colony was grown to 
an OD600 of 0.4AU in 50ml 2×TY media. 5ml of this culture was used to inoculate 1 
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litre of 2×TY, 100µg ml-1 ampicillin and 50µg ml-1 chloramphenicol, media pre-
warmed to 37°C; this culture is grown to an OD600 of 0.6AU. 1ml of 1M IPTG 
(Sigma-Aldrich) was added to the culture and the cells were left to express for 
3hours, at all times shaken to 180rpm. Cell lines were verified as expressing HIS-
HsPCNA by western blotting (Towbin, H. et al 1979) using an anti-poly-HIS 
antibody conjugated to alkaline phosphatase. The presence of the alkaline 
phosphatase enzyme was determined by the NBT/BCIP reaction (Roche). 
SpPCNA construct was transformed into BL21 (DE3) PLysS and plated out 
onto ampicillin, 100µg ml-1, LB agar plates. A single colony was grown overnight in 
50ml LB media. Overnight culture was used to inoculate 1 litre of LB, 100µg ml-1 
ampicillin and 50µg ml-1 chloramphenicol, media to an OD600 of 0.1AU. The media 
is pre-warmed to 30°C; this culture is grown to an OD600 of 0.7AU. 1ml of 1M IPTG 
was added to the culture and the cells were left to express for 7hours, at all times 
shaken to 180rpm. 
LmPCNA construct was transformed into BL21 (DE3) PLysS and plated out 
onto kanamycin, 50µg ml-1, LB agar plates. A single colony was grown to an OD600 
of 0.4AU in 50ml LB media. 5ml of this culture was used to inoculate 1 litre of LB, 
50µg ml-1 kanamycin and 50µg ml-1 chloramphenicol, media pre-warmed to 37°C; 
this culture is grown to an OD600 of 0.6AU. 1ml of 1M IPTG (Sigma-Aldrich) was 
added to the culture and the cells were left to express overnight (12-14hours), at all 
times shaken to 180rpm. 
Cells were harvested by centrifugation at 9000RPM (JLA9.1000), and pellets 
were stored as 1litre cultures in 50ml falcon tubes. These pellets were flash frozen by 
immersion in liquid nitrogen and stored at -20°C. 
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2.2.3 The expression of PCNA from three species in E.coli cell lines   
HsPCNA was expressed in BL21 (DE3) PLysS cell lines, grown in 2×TY 
media, 100µg ml-1 ampicillin. Cells were grown at 37°C to an OD600 of 0.6AU, 
expressed with 1.0mM IPTG and for three hours to achieve optimal expression 
(figure 2.3).   
SpPCNA was expressed in BL21 (DE3) PLysS cell lines, grown in LB, 
100µg ml-1 ampicillin.  Cells were grown at 30°C to an OD600 of 0.7AU, expressed 
with 1.0mM IPTG and for six hours to achieve optimal expression. 
LmPCNA was expressed in BL21 (DE3) PLysS cell lines, grown in LB media, 
100µg ml-1 kanamycin. Cells were grown at 37°C to an OD600 of 0.6AU. The 
temperature of the culture was then reduced from 37°C to 20°C, and expression was 
induced with 1.0mM IPTG and overnight to achieve optimal expression. 
2.3 Protein purification from bacterial cell lines  
Bacterial cells are lysed to release expressed proteins. The protein of interest 
is in a mixture of cell membranes, nuclei, other cellular organelles and cellular 
proteins. Larger impurities e.g. organelles can be removed by centrifugation, leaving 
a protein mixture. The protein of interest is then purified from other cellular proteins 
by various purification techniques, outlined below. 
2.3.1 Principles of protein purification  
Protein purification ideally starts with high expression levels to provide large 
quantities of protein. Each purification step results in a loss of the total protein yield. 
This loss is the result of protein denaturation and sample loss. At each stage of 
purification, the sample may be exchanged into a new buffer which may result in 



































Figure 2-3. The expression of HsPCNA  
Top) 12% gel showing the trial expression of HsPCNA-pET28a construct. These 
lanes show four trial expressions, in LB, 2×TY and at 20°C, 37°C. The lanes show 
the cell lines with 0mM, 0.5mM and 1mM IPTG. It is clearly shown that protein 
expressed at 37°C in 2×TY media with 0.5mM and 1mM IPTG show the greatest 
levels of expression. Visulalised by coomasie blue. 
Bottom) Western blot of the gel (middle) with anti-poly-HIS antibody, demonstrating 
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associating to filter membranes, and during purification methods, sample may 
associate to chromatographic resins irreversibly.  
  The protein of interest can be isolated from cellular proteins by many 
techniques, usually a combination of affinity chromatography (Lee, W. C. and Lee, 
K. H. 2004), protein precipitation “salting out” (Coen, C. J. et al 1995), size 
exclusion chromatography (Kostanski, L. K. et al 2004), ion exchange 
chromatography (Peterson, E. A. and Sober, H. A. 1956) and hydrophobic interaction 
chromatography (Vailaya, A. and Horvath, C. 1996). A final quantity of protein 
required for useful crystallisation and other biophysical studies is a minimum of 1mg 
at >97% purity. Careful purification from bacterial expression lines using affinity 
chromatography can commonly produce protein yields of 5-20mg. 
2.3.1.1 Methods of protein purification  
The purification techniques each allow different methods for increased purity. 
These different techniques will result in separation of the recombinant protein from 
bacterial cellular proteins by association, precipitation or molecular sieving. Most 
techniques use direct association of the protein of interest to a resin e.g. affinity 
chromatography, ion exchange chromatography and hydrophobic interaction 
chromatography (HIC). An example of protein separation by precipitation is salting 
out, and an example for molecular sieving is size exclusion chromatography.  
2.3.1.2 Affinity based purification techniques  
Affinity chromatography is one of the most common methods of protein 
purification, this method uses a proteins natural binding affinity for a ligand or 
requires the addition of an affinity tag associated to the protein of interest e.g. the 
6×HIS, GST or MBD tag. The affinity tag directly binds to a partner immobilised to 
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a solid resin and is held within the affinity column. Ni-NTA affinity columns bind 
specifically to the poly-HIS tag. The 6×HIS tag, used in this work, anneals to the 
resin via a Ni2+ ion immobilised to a Nitrilotriacetic acid (NTA) group (figure 2.4A). 
This Ni2+-6×HIS interaction can be dissociated by exposure to imidazole, mimic of 
the histidine ring structure (Hochuli, E. et al 1987). GST affinity columns are an 
agarose resin with glutathione immobilised. Proteins conjugated to the GST tag will 
specifically bind the immobilised glutathione (figure 2.4B) and bacterial proteins will 
not associate via this functional group. The immobilised GST can then be released 
form the agarose resin by the addition of high concentrations of reduced glutathione 
(Smith, D. B. and Johnson, K. S. 1988). Recombinant proteins, conjugated to the 
maltose binding domain, are capable of binding maltose with high affinity. Resin 
with maltose immobilised can be used for affinity purification and subsequently 
eluted using maltose (Diguan, C. et al 1988). 
2.3.1.3 Ion exchange purification techniques 
Ion exchange chromatography is a method of isolation based upon the net 
charge of the protein. This method immobilises the protein to a charged resin by 
modification of the pH; this will then allow other proteins to be removed based upon 
differences in pI. Samples are dialysed in a pH buffer that will confer a charge on the 
protein near the pI of the protein. Once proteins are immobilised to the resin, the 
buffer pH can be changed on a gradient and as the pH passes the proteins pI, the 
protein can dissociate from the resin (Luo, R. G. and Hsu, J. T. 1997). This is an 
accurate method of protein purification and is most beneficial as a second step after 








Figure 2-4. Images demonstrating differing purification techniques, showing functional 
groups and elution characteristics 
A) The NTA functional group, demonstrating the position of the association to resin. The 
Ni2+ is associated to NTA via the negative charges on the carboxylic acid groups. Created 
using Symyx®Draw. 
B) Crystal structure of the synthetic glutathione-S-transferase (GST) (1AGS) cartoon 
representation with glutathione represented in ball and stick form (Zeng, K. et al 1994).  
C) Functional groups present on hydrophobic interaction columns. Shows linear groups (top, 
middle) and phenyl groups (bottom). These functional groups are attached to the resin via a 
glycidyl-ether linker, modified from Amersham catalog (15/1/1993). 
D) The relationship of molecular weight to elution volume of a theoretical size exclusion 
column, with a void volume of 20ml and a porous accessible volume of 20ml. This 
demonstrates the linear portion of the size exclusion elution which can allow for the 





2.3.1.4 Hydrophobic interaction chromatographic techniques 
Hydrophobic interaction chromatography (HIC) isolates proteins based on the 
level of surface hydrophobicity. This method requires proteins to be dialysed into 
high salt concentrations to promote hydrophobic interactions; this can result in 
protein precipitation. The resin is commonly sepharose beads with functional groups 
coupled via an ether bond to a monosaccharide. There are a range of functional 
groups for HIC, comprising of long alkyl chains or an aryl ring (figure 2.4C). The 
selection between these groups is made based upon the structural features of the 
protein to be immobilised. Surface ring structures will associate to an aryl ring via π-
electrons and long alkyl chains will associate to broad hydrophobic surfaces, like 
those found in many protein-protein binding interfaces. As the protein solution is 
passed over the resin in solutions with high ionic strength, ~4M NaCl, ~1M 
(NH4)2SO4 (Ammonium Sulphate), proteins are likely to aggregate via hydrophobic 
surfaces. The hydrophobic groups allow the association of the protein to the resin 
and results in the sample to be held in the column. This sample can then be eluted by 
the use of buffers with lower ionic strengths, reducing the propensity of the sample to 
bind the resin and allowing the protein to pass through the column (Machold, C. et al 
2002). 
2.3.1.5 Salting out as a bulk purification technique  
Protein “salting out” is a method of protein precipitation and uses ammonium 
sulphate, pH or thermal precipitation. These methods precipitate proteins in the cell 
lysate using specific concentrations of ammonium sulphate, changes in pH or 
temperature shifts. Should precipitation of the protein of interest occur at higher 
ammonium sulphate, pH or temperature, then all protein precipitated at that point can 
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be removed by centrifugation. This is a common first step method as it rarely has 
sufficient specificity to achieve high purity. It is also cheap and allows a simple 
method for rapid removal of bulk impurities (Grover, P. K. and Ryall, R. L. 2005).  
2.3.1.6 Size exclusion chromatography purification techniques  
Size exclusion chromatography (SEC) is a method of separating proteins 
based upon size (Porath, J. and Flodin, P. 1959). There are many types of SEC resin 
e.g. Superdex, Superose, Sephacryl, Sephadex, Toyopearl etc. all of which are inert 
in order to reduce non-specific interactions. The resins are made of a variety of 
materials and compositions. Superdex resins are a composite of agarose and dextran; 
superose is a highly cross-linked agarose; sephacryl is a composite of dextran and 
methylenebisacrylamide; sephadex is cross linked dextran and toyopearl resins are 
hydroxylated methacrylic polymers. These resins are produced as small spheres that 
act as porous beads and can have different ranges of pores sizes to allow proteins of 
differing sizes to pass through. Proteins larger than the resin pore sizes will be unable 
to enter resin (reducing the volume accessible) and will pass around the resin 
relatively quickly. Small proteins will be able to enter the resin (increasing the 
volume accessible) and take longer times for elution. Selection of appropriate resins 
is accomplished using the molecular weight of the proteins that are to be separated, 
the elution of proteins from the size exclusion column occurs at a linear portion of 
retention volumes. When appropriately selected, the protein of interest will elute in 
this section to achieve the greatest resolution (figure 2.4D).  
Size exclusion chromatography also allows the approximation of a proteins 
molecular weight, based upon the elution volume (Dai, H. et al 1998). Molecular 
weights determined from this method are not based on mass but the hydrodynamic 
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radius (Stokes radius). The Stokes’ equation relates the radius of a hard sphere (rs) 
with the diffusion rate of the molecule in solutions of a specific viscosity at a specific 









where rs is the Stokes radius in meters, kB is the Boltzmann constant (1.38×10
-23 J K-
1), T is the temperature in kelvin, η is the viscosity of the solution in Pascal seconds 
and D is the diffusion constant in meters per second. This Stokes radius will be 
affected by the shape and solvation of the protein, so the Stokes radius is not 
necessarily an accurate representation of molecular weight. The elution volume of a 
protein can be affected by the shape and solvation but also the oligomeric state of the 
protein in solution. As demonstrated by equation 2.1, the value of the Stokes radius 
and elution volume can be affected by the temperature and viscosity of the buffer. 
Therefore all elution volumes determined in SEC are condition-dependant. The mass 
of globular proteins can be estimated by measuring elution rates of protein standards 
(Potzschke, H. et al 1996). Protein diffusion coefficients have been linked to 











where MW is the protein molecular weight from (Young, M. E. et al 1980). This is 
still an estimate for a globular protein (figure 2.4D).  
This method is not commonly used as a method of bulk purification as 
separation of proteins is only effective with an order of magnitude difference in size. 
This method can however determine the purity and homogeneity of the sample, and 
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determine if the protein is folded. These factors result in this method being employed 
more as an analytical technique. 
2.3.2 Materials and methods of Purification of three PCNAs  
Cells were resuspended in 30ml, ~10% (w/v), of Ni-NTA binding buffer 
(50mM NaH2PO4, 300mM NaCl, 10mM Imidazole, pH8.0) in which one mini 
EDTA-free protease inhibitor tablet (Roche) is dissolved. Cells are lysed by 
sonication with the Soniprep150 (MSE) at full power for 6x20seconds at 10second 
intervals. Cellular debris are removed by centrifugation at 23000rpm (Beckman 
25.50) for 30minutes at 4°C, then passed through a 0.2µm filter. Every step of the 
lysis of the cell cultures is carried out on ice. 
Cleared lysate was loaded on a Ni-NTA affinity column, pre-equilibrated 
with Ni-NTA binding buffer, and extensively washed to baseline with binding buffer, 
~8 column volumes. This is run at a flow-rate of 2ml min-1 and a maximum pressure 
0.3MPa. A 5 column volume step elution of 26mM Imidazole elutes bulk impurities. 
A gradient elution of 26-250mM Imidazole over 150mls elutes the protein of interest. 
Protein concentration was determined by the A280 assuming an extinction coefficient 
of 16305 M-1 cm-1, 9190 M-1 cm-1 and 20775 M-1 cm-1 for HsPCNA, SpPCNA and 
LmPCNA respectively as determined by ProtPram (Gasteiger, E. et al 2003). PCNA 
was concentrated to no more than 8 mg ml-1 and passed over the Superdex 200 
column 10x300 in HEPES biochemistry buffer (10mM HEPES, 150mM NaCl, pH 
7.4). LmPCNA prepared for crystallography is run in LmPCNA crystallisation buffer 
(25mM Tris, 25mM NaCl, 2mM DTT, pH7.5). Final purified protein samples were 
stored at 4°C for no more than 1 week prior to use.  
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 Figure 2-5. Analysis of the purified PCNA 
showing a greater than 97% purity and bands 
corresponding to appropriate sizes of 
recombinant PCNA 
 
Top) 12% SDS-PAGE Coomassie stained gel of 
5µg each of HsPCNA, SpPCNA and LmPCNA. 
This gel demonstrates the high level of purity 
achieved for each protein. The protein bands run 
to a slightly greater molecular weight than 
expected. 
 
Bottom) The full length mass spec analysis of 
HsPCNA, SpPCNA and LmPCNA from left to 
right respectively. The determined values of 
molecular weight gave good correlation to the 
predicted masses; 31.3kDa, 30.5kDa and 






























2.4 Conclusions of the purification of three homologous PCNAs  
The H. sapiens PCNA has been successfully cloned into pET-28a and PCNA 
from all three sources have allowed expression to a high level. This has allowed all 
three PCNAs to be purified to greater than 97% purity in large enough quantities to 




















CHAPTER 3. The X-ray structural analysis of LmPCNA 
The three dimensional structure of a protein can be solved by only a few 
techniques e.g. X-ray crystallography, nuclear magnetic resonance (NMR), cryo-
electron microscopy (Cryo-EM) (Sali, A. et al 2003). Computational approaches can 
also be used and a variety of programs exist which can predict the three dimensional 
structure of a protein e.g. homology modelling by 3DJigsaw (Bates, P. A. et al 
2001).  
The different methods of structure solution provide differing levels of 
information and each have different associated errors. X-ray crystallography can 
provide the best resolution (~1Å), however may not be an accurate representation of 
the protein in solution as the sample is restrained within the crystal lattice (Smyth, 
M. and Martin, J. 2000). NMR commonly provides a lower resolution (~3Å) and 
gives the average position of protein atoms relative to other protein atoms in 
solution. The size of the macromolecule to be solved is limited using NMR and also 
isotopic tags may be required (Sali, A. et al 2003). Cryo-EM is a technique which 
has become, in recent years, more widespread for protein structure determination; 
this is however usually at a lower resolution (~8Å) (Sali, A. et al 2003). In this work 
only X-ray crystallography has been implemented and will be discussed in detail.  
An overview of the steps involved solving protein structures using X-ray 
crystallography is given in figure 3.1. X-ray crystallography requires the protein of 
interest to be crystallised and good quality crystals are essential for high resolution 
diffraction (Wiencek, J. M. 1999). These crystals are commonly cryo-protected and 
frozen in order to increase crystal stability during data collection (Weik, M. et al 
2001). Frozen crystals are placed in a continuous nitrogen stream and maintained at  
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Figure 3-1. An overview of the steps involved in the solution of protein 
structures 
Figure showing an overview of the general steps in X-ray crystallography. 1) the 
crystallisation of the protein, 2) the collection of diffraction patterns, 3) reduction of 
the diffraction data, 4) phasing of experimental data, 5) density modification using 
known high resolution electron density to improve phases, 6) the building of protein 
structure based on electron density, 7) refinement of the built protein model with 
electron density, 8) validation of the determined protein structure based on fits to the 












          
 
Figure 3-2. The crystallisation of proteins by hanging drop vapour diffusion  
Figure showing the set up for crystal growth by the hanging drop method. This 
shows a protein solution with mother liquor in an air tight system. Grease seals at the 
cover slip prevent the system from completely drying, and water can migrate from 
the protein solution to the mother liquor, slowly increasing the protein and 
precipitant concentrations. The protein and precipitant concentrations are shown on 
the right where protein drops precipitate (red) and crystallise (blue) 
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100K in the beam path. In order to obtain a diffraction pattern, the X-rays used are of 
high energy (~1Å wavelength, commonly 0.7Å-1.7Å). This diffraction pattern is 
measured on a charge coupled device (CCD) detector. Only intensities and positions 
of Bragg reflections are captured and measured using the collection device and no 
“phase” information is available. The unit cell (the smallest unit by rotation and 
translation) dimensions of the crystal can be determined from the spacing of the 
Bragg reflections. Phasing can be accomplished by different experimental methods 
e.g. anomalous dispersion, isomorphous replacement or molecular replacement. 
Calculated electron density maps are used to fit the protein sequence. The final steps 
involve refinement and validation of the structure, as discussed below.  
3.1 Protein crystallisation for X-ray crystallography  
The crystallisation of a protein arranges the molecules into regular arrays. 
Protein is commonly crystallised using the slow dehydration of a high concentration 
protein sample (Wiencek, J. M. 1999). The protein is slowly dehydrated by the 
migration of water from the protein solution. The dehydration can be achieved by 
sitting or hanging drop methods (Mcpherson, A. 1985) in an air tight systems in 
which protein solutions are exposed to a dehydrating environment. The mother liquor 
is placed in a reservoir within this enclosed environment. The mother liquor is a 
solution containing required levels of precipitant, pH and additives. Water from the 
protein solution migrates to the mother liquor (figure 3.2A). Dehydration of the 
protein solution slowly increases its concentration. The increase in protein 
concentration increases the propensity for protein precipitation. Within precipitant 
e.g. PEG or ammonium sulphate, at a set pH, a protein will have a specific 
concentration for precipitation or crystallisation (figure 3.2B).  
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Forty-nine structures of PCNA from different species have been solved and 
deposited in the PDB. PCNA crystals have formed in a wide variety of conditions. 
Twenty crystals were formed in Poly-Ethylene-Glycol (PEG) of average molecular 
weights of 400Da (27.5-30%) through to 20000Da (7.5%). Nineteen PCNA crystals 
formed in ammonium sulphate (1.6-2.5M). Other precipitants have been used to form 
crystals, such as Methyl-2,4-Propane-di-ol (MPD) (25-30%), Na/K phosphate (1.4-
1.6 M, pH 9.0). The crystals for all solved structures were formed between pH 4.5 
and 9.0, commonly at pH 6.0. From these determined crystallisation conditions, it is 
inferred that LmPCNA can crystallise in a range of conditions. 
3.1.1 Results of the crystallisation of LmPCNA  
 LmPCNA was crystallised by the hanging drop method. LmPCNA was 
concentrated to 10mg ml-1. A precipitant solution of 10%w/v PEG 6000, 0.1M MES 
pH6.0 was used as a mother liquor. Hanging drops were prepared in a 2:2:0.5 ratio of 
LmPCNA, mother liquor and 0.1M tri-methyl-amine hydrochloride and crystals grew 
in 3-4 days; these crystals diffracted to 8Å resolution. Conditions were refined to 
12%w/v PEG 400, 0.1M MES, 0.1M tri-methyl-amine, pH6.5 at 4°C, crystals 
diffracted to ~7Å. LmPCNA crystals were ~0.5×0.5×0.2 mm in size (figure 3.3A).  
LmPCNA co-crystallised using protein at 10mg ml-1 with a final 
concentration of 10µM peptide 1 (H. sapiens p21 141-152) present in the protein 
solution. The LmPCNA peptide solution was incubated for 20minutes prior to 
mixing with mother liquor. Crystallisation drops were set up as above using the same 
mother liquor and additive in the same ratios. Crystals were of similar range of sizes 
and diffracted to a similar resolution.   
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 Figure 3-3. The crystal and diffraction 
pattern of LmPCNA 
 
A) Two crystals of LmPCNA in a 
hanging drop. These crystals grew in 
15%w/v PEG400, 0.1M MES, 0.1M tri-
methyl-amine, pH6.5; and required 3-4 
days to form. The top crystal is 
approximately 0.5×0.5×0.2 mm in size 
and not optically birefringent.  
 
B) The diffraction pattern of the 
LmPCNA crystals presented in A after 
the crystal dehydration. The crystal 
diffracted to 3Å and shows clearly 
defined diffraction spots. This diffraction 
pattern shows no strong ice rings and the 
frequency of the diffraction spots infers a 






3.1.2 Cryo-protection and dehydration of protein crystals in crystallography  
Crystals are used in high intensity X-ray beams in order to obtain a 
diffraction pattern. Exposure to high energy X-rays can cause the release of free 
radicals resulting in damage to the crystal. Damage to a protein crystal reduces the 
observed diffraction resolution. Damage to protein crystals by free radicals can be 
reduced by maintaining the crystal below 155K and commonly at 100K during the 
data collection process (Weik, M. et al 2001). In order to collect data at 100K, the 
sample needs to be flash frozen in liquid nitrogen after being removed from the 
crystallisation drop.  
Protein crystals contain a high percentage of solvent (~30-65%) (Matthews, 
B. W. 1968). Crystals with a high solvent content may form ice crystals when frozen. 
Ice formed in the protein crystal results in intense ice rings on the diffraction pattern 
which may obscure data from protein diffraction. The formation of ice within a 
protein crystal may reduce resolution by damaging the crystal lattice and increasing 
mosaicity.  
The formation of ice crystals can be prevented by cryo-protection. Cryo-
protection is the process of the removal of waters by either dehydration or 
replacement using a variety of different chemicals e.g. glycerol, PEG, MPD etc. The 
method of cryo-protection can damage crystals. A common method of dehydration is 
the slow removal of water from the whole drop and is accomplished by vapour 
diffusion. Replacement of water with other molecules is achieved by a series of small 
injections of cryo-protectant directly into the drop, slowly increasing the cryo-
protectant concentration (Heras, B. and Martin, J. L. 2005). 
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Dehydration of protein crystals can be used as a means to improve resolution 
(Heras, Bego a et al 2003). Protein crystal dehydration can be achieved by different 
means e.g. vapour diffusion over dehydration solution and direct addition of 
dehydration solution; both of which are described above as a means of cryo-
protection. In one example, direct contact to air has been used to almost completely 
dehydrate a crystal for 28 months and then was re-hydrated over crystallisation 
solution (Izasrd, Tina et al 1997). The Free Mounting System (FMS) is an instrument 
designed to control the dehydration of protein crystals whilst mounted on a 
goniometer system head. The FMS monitors the level of humidity at a standard cryo-
loop. The level of humidity can be altered and changes the solvent content of the 
crystal. Crystals can then be frozen in-situ at the optimum relative humidity. This 
dehydrated crystal can diffract at a higher resolution (Chotiyarnwong, P. et al 2007). 
3.1.3 Results of the cryo-protection of LmPCNA crystals for 
crystallography  
Crystals of LmPCNA were crystallised in 12% PEG 400 and dehydrated over 
30% PEG 400, 10%glycerol by vapour diffusion. LmPCNA crystals would not grow 
at 30% PEG 400. Crystals were not optically birefringent prior to dehydration. 
Dehydration treatment of crystals took ~12hours. Once dehydrated, these crystals 
could then rotate plane polarised light, indicative of the crystal becoming more 
ordered. The dehydration of LmPCNA crystals increased the resolution from 7Å to 
3Å. The increase in resolution may be explained by the increased regularity due to 
decreased solvent content of the crystal. LmPCNA co-crystallised with H. sapiens 
p21 (141-152) responded in the same way to dehydration as the un-complexed 
protein and resolution improved from ~8Å to ~3Å.  
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3.1.4 The X-ray sources for X-ray crystallography  
The wavelength of X-rays used in most protein crystal studies is between 0.7 
and 2.0Å, commonly at ~1.0Å. X-ray beam can be generated by different sources: X-
ray tubes, rotating anode sources and particle storage rings. A new generation of 
sealed X-ray tubes are commonly available and can be used for data collection. 
Rotating anode sources are the common “in-house” source and are ten times more 
powerful than most X-ray tubes. Modern rotating anode sources can acquire a 
complete data set in ~6hours (Delcueto, J. A. and Shevchik, N. J. 1978). The most 
powerful and versatile X-ray generators are the synchrotron radiation sources. 
Synchrotron energy allows complete X-ray data sets to be collected in minutes and 
usually at a  greater resolution (Sorensen, T. L. M. et al 2006). Data sets can be 
obtained from small crystals using synchrotron radiation (Sorensen, T. L. M. et al 
2006). The intensity at undulator beams in third generation synchrotron sources is 
sufficient for data collection from crystals of ~500µm3 size (Riekel, C. et al 2005).  
3.1.5 Results from the X-ray data collection of LmPCNA crystals  
Crystals of LmPCNA were studied by X-ray diffraction at the Daresbury 
synchrotron radiation source station 10.1. LmPCNA crystals were studied using 
synchrotron X-ray radiation at a wavelength of 0.97Å. Data were recorded using a 
CCD and diffraction images were taken for 0.5° over 180°. The samples were 
maintained at 100K in a continuous cryo-stream and diffracted to a resolution of 3Å. 
No strongly diffracting ice rings were apparent on the diffraction pattern (figure 
3.3B).  
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3.1.6 The diffraction of X-rays for X-ray crystallography   
High energy photons are scattered by the electron clouds of atoms within the 
protein crystal. The crystal is comprised of unit cells (the smallest repeating unit that 
can make up a crystal by translation). Within the unit cells is the asymmetric unit, the 
smallest repeating unit that can make up a crystal by rotation and translation. Each 
spot on the diffraction pattern can be regarded as the result of a reflection from a set 
of parallel planes within the crystal. These planes slice through each unit cell within 
the crystal, and the measured Bragg reflection provides an average signal from the 
whole crystal. If the reflected beams from the planes are in phase, the signal 
undergoes constructive interference and creates a diffraction spot, a Bragg reflection 
(figure 3.4). The position of observed reflections is a function of the unit cell 
dimensions. The reciprocal relationship between d (the spacing between the Bragg 
planes) and sin θ (figure 3.4 Bragg’s law) means that the larger the d-spacing, the 
smaller the Bragg angle (θ). Therefore, larger unit cells show a more crowded 
diffraction pattern; the Bragg reflections are closer together. The reflection intensities 
and phase of each spot contain information of the content of these unit cells. 
To collect a complete data set, the diffraction pattern for the crystal at a range of 
angles is required. The diffraction images are scaled to regularise the intensity of 
different frames and merged to give the position of repeated reflections and overall 
intensities at each spot (Powell, H. R. 1999). The diffraction image at different 
angles through the crystal can give the space group, unit cell dimensions and 
approximate solvent content. The space group and unit cell dimensions can be 
determined as discussed above. The solvent content can be approximated by the 
Matthews equation determined in 1968 (equation 3.1) (Matthews, B. W. 1968). 
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Bragg’s Law) 2 sinn dλ θ=  
 
Figure 3-4. An example of a diffraction grating demonstrating Bragg’s law 
Figure demonstrating the principals of Bragg’s law for the formation of diffraction 
spots and the equation for Bragg’s law. The diffraction grating, shown as two lines 
with a separation of distance d. The incident X-ray beams with angle of incidence 
and reflection, θ. The additional path length of the lower reflection can be 
determined by trigonometry if d, θ and λ are known (right angled triangles 
represented at positions A and B). If this path length is a whole number, n; then total 
constructive interference would occur. 





Figure 3-5. A sinusoidal wave representation of light to demonstrate phase 
Figure showing a representation of light as a wave. A) This figure shows the 
amplitude, wavelength (λ), crest and trough of the wave form. The phase of light is a 
representation of the position of the photon on this wave at any point in time. This is 
commonly represented as a circle, B) presenting the crest at 0° and the trough at 
180°. The numbers on the vertical line shown in the wave path correspond to 
numbers of the positions on the circle diagram. This position in the wave path is 
known as the phase. 

















where VM is the Matthews co-efficient, Volumeuc is the volume of the unit cell and 
Massuc is the mass of the unit cell. 
The study by Matthews was based on the evaluation of the crystal structures 
of 116 proteins (1968) and 226 proteins (1976) (Matthews, B. W. 1976). Based on 
the size of the unit cell and the molecular weight of the monomer, a series of 
potential monomer numbers are related to solvent content. The solvent content is 
related to the number of monomers within the unit cell by the Matthews co-efficient 
(equation 3.1). The Matthews co-efficient is the crystal volume per unit of protein 
molecular weight (Matthews, B. W. 1968). The Matthews equation was reassessed in 
2003 with a larger data set and was determined to be accurate (Kantardjieff, K. A. 
and Rupp, B. 2003). From this 2003 survey, it was possible to show a strong 
correlation between solvent content and the resolution of the X-ray data set. The 
higher the solvent content, the lower the resolution (the molecular weight of the 
protein per se does not necessarily reduce the resolution) (Kantardjieff, K. A. and 
Rupp, B. 2003).  
The completeness is the ratio of the unique reflections measured as a number 
of those theoretically measurable for a given resolution. If all data is present for this 
resolution, then the data is 100% complete. The multiplicity is sometimes referred to 
as redundancy. The multiplicity is the number of times each unique reflection is 
independently measured. Rmerge (shown in equation 3.2) demonstrates the similarity 
of the intensity of identical reflections measured independently. This gives a value of 
reliability for the diffraction data at that resolution. Higher resolution shells are 
commonly more error prone as the data are generally weaker. Incompleteness or 
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crystal damage may contribute to poor Rmerge statistics. This evaluation method may 
not be a genuine evaluation as to the quality of the data as this statistical analysis is 


















where Rmerge(I) is the Rmerge for a specific reflection, hklI  is the average 
intensity of symmetry related reflections from (Weiss, M. S. and Hilgenfeld, R. 
1997). 
The /I Iσ  is a relationship between signal and noise of different 
reflections. I  is the mean reflection intensity and Iσ  is the mean standard 
deviation of intensity. Low /I Iσ  infers poor quality data as data spots are 
similar to background (noise) levels.  
3.1.7 Results of the space group determination of LmPCNA   
Diffraction data from both un-complexed and complexed LmPCNA crystals 
were processed using MOSFLM (Leslie, A. G. W. 1999) in the P212121 space group. 
The frames were scaled using SCALA (Collaborative Computational Project, 
Number 1994).  
The un-complexed LmPCNA crystal gave 492387 observed reflections of 
which 44892 are unique. The unit cell dimensions have been determined to be: a = 
130Å, b = 149Å, c = 169Å; α = β = γ = 90.0°. Using the Matthews equation the un-
complexed LmPCNA crystal was determined to have a Matthews co-efficient of 5.05 
(Matthews, B. W. 1968). Assuming a protein molecular weight of 34.4kDa, the 
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Matthews co-efficient suggests there are six monomers in the asymmetric unit with a 
solvent content of ~70%.  
The LmPCNA complexed with H. sapiens p21 (141-152) crystal gave 
263630 observed reflections of which 69468 are unique. The unit cell dimensions 
have been determined to be: a = 132Å, b = 151Å, c = 173Å; α = β = γ = 90.0°. Using 
the Matthews equation, the un-complexed LmPCNA asymmetric was determined to 
have a Matthews co-efficient of 5.18 (Matthews, B. W. 1968). Assuming a protein 
molecular weight of 35.9kDa, the Matthews co-efficient suggests there are six 
monomer in the asymmetric unit with a solvent content of ~69% (the calculated 
molecular weight included that of the protein and peptide combined). The LmPCNA 
crystals contain a high solvent content, which can result in poor resolution. The high 
solvent content and the increase in resolution suggest that the dehydration of the 
crystal was an important step to obtain higher resolution data. 
The diffraction data gave a completeness of 100% for the un-complexed 
LmPCNA and 88.4% for the complexed LmPCNA structures. This reduction in 
completeness is linked to a decrease in diffraction strength of the complexed crystal. 
The high solvent content of the crystal may cause an increase in mosaicity and be 
linked to the poor resolution, which in the case of the complexed LmPCNA structure 
gave a reduced completeness when solved at 3Å. 
The Rmerge in this case is 9.9% and 23% for un-complexed and complexed 
LmPCNA respectively. The increase in Rmerge was associated with a decrease in 
multiplicity of the diffraction data (7.4-3.8), suggesting that this increase in Rmerge is 
an unbiased statistic and not the result of increasing numbers of reflections. The 
increase in Rmerge of the complexed protein is most likely a result of much weaker 
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diffraction. The /I Iσ  of the data sets were 17.4 and 6.0 for un-complexed and 
complexed LmPCNA respectively. 
3.1.8 Solving the phase problem of X-ray crystallography   
 The diffraction data from an X-ray crystallography experiment is recorded as 
a flat image. The diffraction data is a measurement of signal intensity and spot 
position and gives no information regarding the phase of the diffracted ray (figure 
3.5). The loss of this phase information is known as the phase problem. 
The phase problem can only be solved experimentally by interference 
experiments. Interference experiments commonly used for protein crystallography 
are isomorphous replacement (IR) and anomalous dispersion (AD). IR is based on a 
change in spot intensity between un-complexed crystals and those soaked with heavy 
atoms. The change in intensity with the addition of heavy atoms can allow the 
construction of a Harker diagram which can determine the phases of the diffraction 
spots  (Harker, D. 1956). Scattering of photons becomes anomalous if the electrons 
are tightly held in a lower electron shell. AD requires the absorption component 
(Cromer, D. T. and Liberman, D. 1970) and the dispersive component (Kronig, R. D. 
L. 1926) to be known. The scatter of anomalous dispersion and non-anomalous 
dispersion are affected differently by the addition of heavy atoms. Triple beam 
experiments are a method of partial phase determination and used to support IR and 
AD. This method is based on a single wave being reflected, which suffers 
interference from a second wave which has been subject of two reflections (Weckert, 
E. and Hummer, K. 1990). Phase determination by triple beam experiments are novel 
to IR and AD. Triple beam experiments can be very accurate, however they are time 
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consuming and return a small number of reflections phases’. This is more commonly 
used to support IR and AD (Soares, A. S. et al 2003).  
 Molecular replacement is a method of phase determination by purely 
computational means. The practical application of molecular replacement was 
outlined as early as 1962 (Rossmann, M. G. and Blow, D. M. 1962). A pdb file of 
similar three-dimensional structure is required.  
The Patterson map contains information about intramolecular interactions and 
intermolecular interactions. The intermolecular interactions can be the result of the 
repeating unit cell, a repeated asymmetric unit, non-crystallographic symmetry with 
another identical protein or a non-identical protein (Grosse-Kunstleve, R. W. and 
Adams, P. D. 2001). The technique involves rotating the Patterson map of the model 
structure against the Patterson map from the X-ray data, which can be calculated 
through reflection intensities alone (i.e. no phase information is required). The 
Patterson map calculated from the model can be rotated round orthogonal (or 
Eulerian) angles to exhaustively cover all possible orientations (Rossmann, M. G. 
and Blow, D. M. 1962). At each orientation, the overlap of the Patterson peaks is 
calculated. The best solution will have maximum overlap of the Patterson peaks 
between the model and the measured data.  
Once a good orientation is found, a translational search can be carried out 
(Rossmann, M. G. and Blow, D. M. 1962). The correct translational solution will 
give a consistent set of intermolecular Patterson vectors which should match peaks in 
the Patterson calculated from the measured X-ray data. 
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3.1.9 Results of molecular replacement for LmPCNA   
The molecular replacement of LmPCNA was first performed using the 
structure of HsPCNA, 1AXC (Gulbis, J. M. et al 1996). The use of this HsPCNA 
structure resulted in a poor fit to the data and failed to return a valid structure. Other 
structures of PCNA were attempted in both monomeric and trimeric forms and all 
searches were unsuccessful. A homology model of LmPCNA, based on the 1AXC 
structure (Gulbis, J. M. et al 1996), was generated by the use of the program 3D-
jigsaw and included the elongated loops (Bates, P. A. et al 2001). This homology 
model was used to create a trimeric ring structure (using the HsPCNA trimer as a 
template) and this trimer was used for molecular replacement. The program 
MOLREP (Vagin, A. and Teplyakov, A. 1997) was used to determine the position of 
the model by molecular replacement. Two trimeric rings were determined to be 
present in the asymmetric unit. The determined model underwent twenty rounds of 
refinement by refmac (Murshudov, G. N. et al 1997). The returned structure was 
examined to ensure a good fit to the determined electron density.  
The structure of LmPCNA complexed with H. sapiens p21 peptide (141-152) 
was also solved by molecular replacement. The search model used for the complexed 
protein was that of the un-complexed LmPCNA structure with a H. sapiens p21 
peptide (143-152) peptide modelled into the PIP box binding interface. The model 
was generated by the superposition of the 1AXC structure (Gulbis, J. M. et al 1996) 
over the un-complexed LmPCNA.  
Among the top twelve scoring rotation function solutions from MOLREP 
theta and phi angles were related by 3 fold rotation axes with little deviation around 
chi (data not shown). All the highest scoring molecular replacement results had very 
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similar translational values with the twelve different rotation function solutions. The 
rotation function solutions may be a representation of three fold symmetry of the 
PCNA trimer.  
The packing arrangement determined by MOLREP program showed two 
trimeric rings in the asymmetric unit packed face to face with the elongated loops 
extending out into the solvent (figure 3.6). 
 
Trimer θ φ χ Frac. x Frac. y Frac. z Rfactor Score 
1 180.00 0.00 0.50 0.448 0.073 -0.034 0.539 0.602 
2 136.33 -85.49 177.33 0.297 0.209 -0.222 0.476 0.708 
 
Best fit of trimers in the complexed PCNA crystal 
Trimer θ φ χ Frac. x Frac. y Frac. z Rfactor Score 
1 90.00 -179.93 180.00 -0.067 -0.083 0.045 0.525 0.486 
2 98.34 -91.45 99.31 -0.187 -0.197 0.212 0.435 0.656 
 
3.1.10 Structure refinement and model building from X-ray data   
The refinement of crystal structures commonly have methods of verification 
to determine the reliability of the solved structure; the main values for validation are 
the Rfactor, Rfree, Rmerge, Rsymm and the Ramachandran plot. 
The Rfactor (equation 3.3) is a determination of the reliability of the structure 
and how well the determined structure fits the data used to generate it. 
Eq. 3.3) 
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where Fobs is the intensity of the measured reflection and Fcalc is the intensity at the 
same reflection calculated from the structure. 
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Rfree is the reliability of the structure, similar to the value determined to the 
Rfactor. Data is removed from the structure determination process. Data which is not 
incorporated into the solution can be used as a comparison to reduce bias during 
refinement. This value is a comparison of a diffraction pattern based on the generated 
protein model to that of the removed data. A lower value represents increased 
similarity therefore, greater reliability (Morris, A. L. et al 1992).  
Rmerge demonstrates the similarity of the intensity of identical reflections on 
different frames; this gives a value of reliability for the structure at that resolution. 
Higher resolution shells are commonly more error prone as the data may not be 
complete or damage may occur during collection. This is a result of the crystal not 
demonstrating a sufficiently strong diffraction (described above in section 3.1.6). 
Rsymm (equation 3.4) is the agreement in signal intensities for each reflection 
between different diffraction images which are determined to be symmetry-related. 
Symmetry-related reflections should present identical intensities and variances in the 

















where Ihkl1 and Ihkl2 are the intensities of two symmetry-related reflections 
The Ramachandran plot determines the validity of the generated structure by 
the determination of residues demonstrating bond angles in the allowed regions. The 
structure can be determined to be true if significant numbers of residues are in the 
allowed regions as a result of the steric hinderance of the amino acid side chains. 
Prolines are restricted to smaller areas and glycines are significantly more flexible 
and are allowed to occupy almost any area of the Ramachandran plot. 
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3.1.11 Results of the model building and refinement of LmPCNA structures   
The structure created by the molecular replacement of the LmPCNA 
diffraction was examined for areas of poorly fitting structure. Amino acids not fitting 
the electron density were deleted or the side chains were rotated to better fit the data 
using the program COOT (Emsley, P. and Cowtan, K. 2004). After each successive 
COOT modification, the structure underwent 20 rounds of refmac. The final result 
was analysed with Procheck (Laskowski, R. A. et al 1993), this returned a final Rfactor 
of 24% and an Rfree of 29% for un-complexed LmPCNA with no residues in the 
disallowed portion of the Ramachandran plot. This gave a final model of the 
asymmetric unit represented in a unit cell (figure 3.6), a monomeric structure (figure 
3.7) and the data and refinement statistics (table 3.2). LmPCNA peptide complex has 
a final Rfactor of 25% and an Rfree of 32% with no residues in the disallowed portion 
of the Ramachandran plot (table 3.2). This structure shows the peptide PCNA 
binding is conserved and is in a similar form to HsPCNA. It should be noted that not 
all LmPCNA binding sites were occupied to the same level; three of the six binding 
interfaces were occupied in the asymmetric unit.  
The output structure of un-complexed LmPCNA was used as the molecular 
replacement model for the LmPCNA peptide complex data. The determined 
structures were validated using the program Procheck (Laskowski, R. A. et al 1993). 
The structure solution of this protein was similar to that of the un-complexed 
LmPCNA (figure 3.6). The structure of the monomer electrostatics and refinement 






Figure 3-6. The determined structure of LmPCNA 
A) Shows the structure of LmPCNA asymmetric unit presented within the unit cell of 
the crystal. This shows six monomers of LmPCNA per asymmetric unit however 
there was no data for the elongated loops which would branch out into solvent away 
from the two trimers (discussed in chapter 1). The lack of these loops is most likely 
due to the flexibility of these regions giving no consistent electron density. Both 
complexed and un-complexed structures shared these features. 
B) Three views of the determined structure of LmPCNA asymmetric unit. These 
three views show the clear trimeric ring formation and the potential hexameric form. 
1: The structure is rotated 90° along the vertical axis. 2: The structure is rotated 90° 






Figure 3-7. The crystal structure of the un-complexed LmPCNA 
This structure shows LmPCNA as an electrostatic potential determined by PyMOL 
(DeLano, W. L. 2002). This is a single monomer of the solved structure. 
 
Table 3-1. The crystallographic statistics of un-complexed LmPCNA solution 
 
Data Statistics  
Space Group P212121 




α = β = γ 90° 
Resolution range 30.4Å - 3.00Å 
Solvent content 75.4% 
Molecules per ASU 6 
Observed reflections 492387      (71019) 
Unique reflections 66702        (9606) 
I/σI 17.4           (2.0) 
Completeness  100%         (100%) 
Multiplicity  7.4             (7.4) 
Rmerge 9.9%          (84.3%) 
Refinement Statistics  
Rfactor 24% 
Rfree 29% 
Correlation coefficient 0.75 
No. of protein atoms 11650 
Mean B-factor 84Å2 
Residues in disallowed regions 0 
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Figure 3-8. The crystal structure of the LmPCNA peptide complex 
This structure shows LmPCNA (electrostatic potential) with the H. sapiens p21 peptide 
(143-152) bound (green). This is a single monomer of the solved structure. 
 
Table 3-2. The crystallographic statistics of LmPCNA peptide complex structure 
 
Data Statistics  
Space Group P212121 




α = β = γ 90° 
Resolution range 47.8Å - 3.00Å 
Solvent content 76.1% 
Molecules per ASU 11 
Observed reflections 263630      (37467) 
Unique reflections 69468        (10082) 
I/σI 6.0             (0.4) 
Completeness  99.3%        (88.4%) 
Multiplicity  3.8             (3.7) 
Rmerge 23%           (81%) 
Refinement Statistics  
Rfactor 25% 
Rfree 32% 
Correlation coefficient 0.76 
No. of protein atoms 11946 
Mean B-factor 88Å2 
Residues in disallowed regions 0 
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3.2 Conclusions from the X-ray crystallographic study of LmPCNA 
 The LmPCNA monomer shares a 38% sequence identity to HsPCNA and a 
sequence identity of 48% to SpPCNA; HsPCNA and SpPCNA share a 50% sequence 
identity. PCNA from these three species all have a trimeric structural architecture 
(figure 3.11).  
The secondary structure of LmPCNA shows four main helices and sixteen β-
strands. LmPCNA demonstrates a similar topology as HsPCNA and SpPCNA 
(described in section 1.2). The LmPCNA monomer exists as two globular domains 
(figure 3.10) connected by the LmPCNA IDCL (figure 3.9). An LmPCNA globular 
domain is made of two βαβββ folds (figure 3.10). There are four βαβββ folds per 
monomer and twelve in the trimer, identical to that of HsPCNA and SpPCNA. 
The sixteen β-strands of each monomer associate to form three β-sheets 
(figure 3.10). These three β-sheets provide structural rigidity to LmPCNA (figure 
3.10). The β-sheets also aid in the formation of the monomer-monomer (discussed in 
section 3.1.1) and PIP box binding interfaces (discussed in section 3.1.5). The four 
main helices associate and are supported by the β-sheets (figure 3.10). The secondary 
structural features of LmPCNA are similar to that of HsPCNA and SpPCNA.  
The PCNA monomers from different species can be superposed (figure 3.11). 
The level of structural similarity can be derived when analysing the superposition of 
the backbone atoms. Of the three PCNAs, SpPCNA and HsPCNA (using 912 atoms) 
are structurally the most similar (0.654Å “Root Mean Square Deviation” R.M.S.D.) 
and LmPCNA and HsPCNA (using 880 atoms) are the least similar (1.01Å 
R.M.S.D.) (figure 3.11). This trend in the R.M.S.D. of the determined structure of 
PCNA agrees with the level of sequence identity shown above.  
 81
 
Figure 3-9. The topology diagram of LmPCNA 
Figure showing the topology of the LmPCNA monomer. The four βαβββ are 
represented in dark blue, light blue, light green and dark green. The IDCL is shown 
in red and demonstrates the clear separation in the two domains.  
1) the central β-sheet of the LmPCNA monomer which forms the PIP box 
binding interface.  
2) 2&3) the β-sheets forming the monomer-monomer binding interfaces at the 






                         
 
Figure 3-10. The secondary structure of the LmPCNA monomer 
Figure showing the secondary structure of the LmPCNA monomer in an exploded 
form separating β-strands from α-helices. The dashed line of the monomer shows the 
separation of the two globular domains. 
A) The arrangement of the sixteen β-strands to form three β-sheets (red, green and 
blue). These three β-sheets provide structural rigidity to the monomer. The green β-
sheet aids in the formation of the PIP-box binding interface and the red and blue β-
sheets aid in the formation of the monomer-monomer binding interface. 
B) The arrangement of 4 α-helices, red, green, blue and yellow into a helix bundle. 
Hydrophobic residues are positioned facing the β-sheets and positively charged 







The RMSD of the alignment of PCNA monomers from three different species 
HsPCNA - SpPCNA HsPCNA - LmPCNA SpPCNA - LmPCNA 
0.65Å 1.01Å 0.905Å 
 
The RMSD of the alignment of PCNA trimers from three different species 
HsPCNA - SpPCNA HsPCNA - LmPCNA SpPCNA - LmPCNA 
0.73Å 1.11Å 1.05Å 
 
Figure 3-11. The structural alignment of HsPCNA, SpPCNA and LmPCNA 
 
Figure showing the alignment of PCNA from three different sources. Top) The 
alignment of PCNA monomers. Middle) The alignment of PCNA trimers showing 
HsPCNA (cyan), SpPCNA (magenta) and LmPCNA (green). Bottom) The R.M.S.D. of 
the alignment of PCNA monomers and trimers (Å). This shows a greater R.M.S.D. of 
trimers compared to monomers, suggesting a shift in the structural architecture. 
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3.2.1 The monomer-monomer binding interface of LmPCNA 
The LmPCNA-LmPCNA binding interface is comprised of twenty-three 
residues (figure 3.12A). Ten residues from one monomer interface are associated to 
thirteen residues from the neighbouring monomer (figure 3.12A). These twenty-three 
residues of the binding interface were defined as any residue within 4Å of the 
neighbouring chain, calculated by PyMOL (DeLano, W. L. 2002).  
The twenty-three residues for the LmPCNA-LmPCNA interaction have only 
a 26% sequence identity with HsPCNA and a 38% sequence identity with SpPCNA 
(figure 3.12A). This binding interface has a lower level of sequence identity then the 
average between PCNA from these species. Conserved sequences on one strand 
hydrogen bond with conserved residues on the opposing strand. Sequences with little 
conservation hydrogen bond with poorly conserved residues on the opposing strand 
(figure 3.12A) (figure 3.13). Retention of sequence identity at the PCNA-PCNA 
interface does not seem to be essential as the hydrogen bonds form primarily 
between backbone atoms.  
Hydrogen bonds form across an anti-parallel β-sheet between residues K108-
N115 and Q177-Q183 (figure 3.13C). HsPCNA forms this interface with β-strands 
from E109-K117 and L175-S183 and SpPCNA forms this interface with β-strands 
from I111-K117 and D174-T181 (figures 3.13AB). Away from the 18 residues 
making up these β-strands, there are a further 5 residues at the PCNA monomer-
monomer interface. These residues are on the neighbouring helix and provide 
additional hydrogen bonding (E143…R110) and create hydrophobic surfaces (V153 
and I81) (figure 3.13). The residues which form this binding interface vary between 
PCNA from these three sources. Changes in the sequence of the opposing  
 
 85
       107       81 
H.sap EKVSDYEMK C 
S.pom DRISDYDVK C   
L.maj TRKCEYQLK I   
        : .:*::* 
 
       174       143 146 150 153 
H.sap LGNGNIKLS E   R   D   H 
S.pom IGNGSTTYK E   R   D   T 
L.maj VGQGYTFLQ E   K   D   V 
       :*:*    . *   :   * 
 
Figure 3-12. A) Residues at the PCNA monomer-monomer binding interface 
Figure showing the alignment of residues at the PCNA monomer-monomer binding 
interface. These residues are shown to be involved in the binding interface in 
HsPCNA from (Gulbis, J. M. et al 1996). These residues form a β-sheet resulting in 
hydrogen bonds to form between E107 and S183 through to K117 to L175. This 
hydrogen bonding network facilitates the association of two monomers. This figure 
shows that the K117/L175 side of this β-sheet has the greatest level of conservation 
in both strands. Changes in residue composition at the E107 side of the β-strand may 
be compensated for by modifications to the S183 side of the associating strand. 
 
 
 27 29 40 44   67   97 118           131 208 232 234 250 252 
H.sap C  D  M  HVS  AMG  D  LMDLDVEQLGIP  Q   A   D   P   Y   APKI 
 
 27 29 40 44   67   97 118           131 208 232 234 249 251 
S.pom N  D  M  HVA  ALG  E  LMDIDQEHLGIP  I   S   D   P   Y   APKI 
 
 27 29 40 44   67   97 118           131 242 266 268 284 286 
L.maj N  D  M  HVA  ILG  D  LLEIEAESMGIP  M   A   D   P   Y   APKV 
    *  *  **:   :*  :  *:::: * :***      :   *   *   *   ***: 
 
Figure 3-12. B) Residues at the PCNA-PIP box binding interface 
Figure showing the alignment of residues at the PCNA-PIP box  binding interface. 
These residues are conserved showing a sequence identity of 43% and residues with 
similar shape and charge of 80%. The high sequence similarity of this binding 
interface suggests that LmPCNA has a similar binding motif as HsPCNA. Residues 
in red represent hydrogen bonding partners. This suggests that LmPCNA will have 
similar cellular activities. The chain of 12 residues starting at 118 is the IDCL.  
 
 
H.sap 181 KLSQT------------SNVDKEE----------------------EAVTI 197 
S.pom 181 TLKQH------------TDLSDQD----------------------QSIEI 197 
L.maj 181 FLQAAGVSDRSAKSEVKSEVKAEARDEDEHEPISRRYNKAEGGNGAIGVEV 231 
     EEE             HHHHHHHHHHH       HHH           EEE 
 
Figure 3-12. C) Residues at the LmPCNA elongated loop domain 
Figure showing the novel loop domain of LmPCNA. This loop has 41 
residues in LmPCNA opposed to 7 residues in HsPCNA. This additional loop 
domain is predicted to have a helical region in LmPCNA but not in either HsPCNA 
of SpPCNA. This could suggest this loop may act as a scaffolding domain. 
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Figure 3-13. The monomer-monomer binding interface of HsPCNA, SpPCNA 
and LmPCNA  
Figure showing the monomer-monomer binding interface of PCNA from H. sapiens, 
S. pombe and L.major. The interaction of these monomers is essential for ring 
formation. The number of hydrogen bonds has been linked to protein stability 
(section 1.2). A) The hydrogen bonding network of HsPCNA showing the potential 
formation of 8 hydrogen bonds. The hydrogen bonding of HsPCNA monomers 
occurs at β-strands E109-K117 and L175-S183.  
B) The hydrogen bonding network of SpPCNA showing the potential formation of 8 
hydrogen bonds. The hydrogen bonding of SpPCNA monomers occurs at β-strands 
I111-K117 and D174-T181.  
C) The hydrogen bonding network of HsPCNA showing the potential formation of 
10 hydrogen bonds. The hydrogen bonding of HsPCNA monomers occurs at β-





















K109 E111 Q113 
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strand or position of the hydrogen bonding network may compensate for a loss of 
sequence conservation (figure 3.12A).  
The hydrogen bonding between the monomers at this β-sheet is maintained in 
PCNA from all sources. The three PCNAs investigated here all demonstrate a 
trimeric structural architecture and similar binding properties at the monomer-
monomer interface (figure 3.13). The un-complexed structure of LmPCNA shows 
that twelve hydrogen bonds can be formed at the LmPCNA monomer-monomer 
interface (figure 3.13C).  The crystal structure 1AXC (Gulbis, J. M. et al 1996) and 
the crystal structure of SpPCNA (unpublished data) show that PCNA from these 
species form twelve and eight hydrogen bonds at the monomer-monomer interface 
respectively (figures 3.13AB).  
The LmPCNA monomer-monomer interaction buries 1370 Å2 of surface 
area, as determined by PISA (table 3.3) (figure 3.14) (Krissinel, E. and Henrick, K. 
2007a). The monomer-monomer interaction of HsPCNA and SpPCNA buries 1380 
and 1780 Å2 of surface area respectively (table 3.3) (figure 3.15). HsPCNA and 
SpPCNA have been shown to involve three and seven water molecules at the 
monomer-monomer interface. The position of one of these water molecules is 
conserved between HsPCNA and SpPCNA (figure 3.15). The electron density of the 
hexamer showed a potential water molecule at this position between chains E & D 
and A & C. The density for this potential water was poor and only occurred at a 
sigma level of 0.36, suggesting this may or may not be genuine. The SpPCNAs 
greater buried surface area and larger numbers of interacting water molecules may 
compensate for the reduced number of hydrogen bond interactions at the monomer-



















The following complexes appear to be genuine 
A3 ACE Yes 32340 4150 -14.0 4.9 
AB AF Yes  1200 -9.0 5.0 
C3 BBB Yes 34440 5350 -7.8 1.6 
CB BC Yes  1240 -10.0 6.2 
D3 MNO Yes 34990 4110 -15.0 2.4 
DB OH Yes  1450 -12.3 9.5 
The following complexes fall into a grey area and may or may not be genuine 
D6 EGIMNO No 68290 10020 -33.4 -2.0 
 
Table 3-3. The energetic properties of different binding interfaces as determined 
by PISA (Krissinel, E. and Henrick, K. 2007a) 
This table give the values of surface area and buried surface area (Å2) and the 
calculated ∆G of formation and dissociation (kcal mol-1) of different protein-protein 
interactions as determined by (Krissinel, E. and Henrick, K. 2007a). HsPCNA is 
represented by A and is the structure 1AXC as determined by (Gulbis, J. M. et al 
1996). SpPCNA is represented by C and is the solved structure of the complexed 
SpPCNA (unpublished data). LmPCNA is represented by D and is the solved 
structure with peptide bound. Values were also derived for the PCNA-p21 (R143-
H152) interaction with the three different PCNAs. The species are grouped by the 
complex validity of interaction.  
This determines an interaction to be genuine based on the buried surface area in 
relation to the size of the immobilised protein. The ∆G of formation should be 
negative and the ∆G of dissociation should be positive. 
PISA concluded that the trimeric ring structures are most likely a genuine interaction. 
The PCNA p21 (R143-H152) are a genuine interaction. The LmPCNA dimerisation 




Figure 3-14. The buried surface areas of LmPCNA binding interfaces  
Figure showing the buried surface areas of LmPCNA when complexed at the 
monomer-monomer interface (left), trimer-trimer interface (middle) and the PCNA-
p21(143-152) interface (right). These images show carbons (green) oxygens (red) 






Interactions at HsPCNA 
interface 
Interactions at SpPCNA 
interface 
Interactions at LmPCNA 
interface 
E143(SC)-K110(SC) R146-S81 E143-R110 
R146-K79 I175-K117 K(SC)146-I81 
R146-A82 N177-D115 Q177-Q115 (×3) (1×SCs) 
L175-K117 S179-D113 (×2) Y(SC)179-K(SC)111 
N177-E115 (×3) (1×SCs) T(SC)180-S(SC)112  Y179-E113 (×3) (1×SCs) 
N179-D113 (×2) T181-I111 (×2) F181-K111 (×2) 
K181-V111 (×2) K183-D109 Q183-T109 
S183-E109 D(SC)186-K(SC)107  
   
Interactions involving a single water 
D150(SC)-K110(SC) T(SC)181-I111  
R146(SC)-N84(SC) I175-K117  
L175-K117 N177(SC)-K117(SC)  
 T153(SC)-K77  
 T153-K77(SC)  
 R149(SC)-R80  
 D150(SC)-R80  
 
Table 3-4. The hydrogen bonds formed at the monomer-monomer interface of 
PCNA 
Table showing the hydrogen bond interactions at the monomer-monomer interface of 
PCNA. HsPCNA forms twelve hydrogen bonds at the interface and three hydrogen 
bonds through water. SpPCNA forms ten hydrogen bonds at the interface and seven 
hydrogen bonds through water. LmPCNA forms twelve hydrogen bonds at the 
interface however there was no density for water molecules in the crystal structure.  
 
 
Figure 3-15. The monomer-monomer binding interfaces of HsPCNA and 
SpPCNA showing water positions 
Figure showing the monomer-monomer binding interface of HsPCNA and SpPCNA 
with interacting waters shown as spheres. The position of waters determined by 
crystal studies have been solved and are shown to interact with the binding interface. 
The interacting waters associate near the edges of binding interface away from the 
hydrophobic core. The position of only one water molecule is conserved between 
these two crystal structures. SpPCNA forms fewer hydrogen bonds at the monomer 
monomer interface, this may be compensated for by the larger hydrophobic buried 
surface and greater numbers of interaction waters.  
 90
species, these monomer-monomer interactions forming the trimeric ring have been 
determined to be genuine by PISA (table 3.3). Values determined by PISA gave a 
∆G of formation of the monomer-monomer interaction. LmPCNA and HsPCNA 
have similar ∆G of formation, 19.5 kJmol-1 and 20.9 kJmol-1 (table 3.3). SpPCNA 
gave a ∆G of formation at the monomer-monomer binding interface of 10.9 ∆G 
kJmol-1 (table 3.3). This apparent reduction in the ∆G of formation from HsPCNA 
and LmPCNA to SpPCNA is a result of the reduced level of hydrogen bonding in 
SpPCNA. Trimer stability has been studied in solution and is discussed in chapter 6. 
  The R.M.S.D. of the monomeric PCNAs have been determined (section 3.1) 
by superposition of the backbone atoms alone. This can also be performed with the 
trimer backbone atoms of aligned residues. The superposition of the whole trimer can 
give information about the conservation of the quaternary structure. An identical 
R.M.S.D. of monomer (determined in section 3.1) and trimer superposition would 
suggest that there is no deviation in quaternary structure. Superposes of the trimers 
were performed using only the backbone atoms and the R.M.S.D. were compared to 
the R.M.S.D. of the monomer superposition. The trimer superposition of the three 
PCNAs gave a greater R.M.S.D. implying that there are indeed small differences in 
the quaternary structure. The greatest change in R.M.S.D. from monomeric super 
position to trimeric superposition was between SpPCNA and LmPCNA. This showed 
the monomeric superposition to have an R.M.S.D. of 0.91Å (using 931 atoms) and a 
trimeric R.M.S.D. of 1.05Å (using 2786 atoms) resulting in a change of +0.14Å 
(figure 3.11). The lowest difference between monomeric and trimeric superposition 
of PCNA was between HsPCNA and SpPCNA (using backbone 2732 atoms) 
resulting in a change of +0.071Å (figure 3.11). These values follow the trends in 
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sequence identity (section 3.2) between PCNA from these three species. The 
R.M.S.D. of the trimeric rings is only a slight increase from the monomer deviations, 
which suggests well conserved ring architecture. The maintenance of appropriate 
ring formation may be essential for optimal PCNA activity. 
The structure of LmPCNA shows a potential hexameric state (figure 3.13A). 
The hexamer interface of LmPCNA shows only four hydrogen bond contacts (figure 
3.13B). The potential hexameric state of LmPCNA was analysed by PISA (Krissinel, 
E. and Henrick, K. 2007a) in order to determine if this is a genuine interaction. The 
formation of the LmPCNA hexamer from two trimers results in a buried surface area 
of 1760Å2, and based on this analysis, it could not be conclusively determined if this 
interaction is stable (table 3.3). The potential hexameric state has been studied in 
solution (discussed later in chapter 5) to determine if this hexameric state of 
LmPCNA is a crystallographic artefact 
3.2.2 The central pore of the PCNA ring  
The central pore of the LmPCNA trimer (figure 3.16A) is a conserved feature 
in both HsPCNA (Kelman, Z. and ODonnell, M. 1995) and SpPCNA (unpublished 
data). HsPCNA has previously been determined to be ~35Å and of sufficient size to 
surround B-form DNA (Kelman, Z. 1997). The distance between the Cα of E17 and 
R149 of HsPCNA, SpPCNA and LmPCNA has been measured. This defined pore 
diameter gave LmPCNA a pore of ~37Å (figure 3.17A) compared to HsPCNA and 
SpPCNA of ~36Å. The residues which make up the inner lining of PCNA pore are 
positively charged to facilitate the association to DNA. The pattern of positively 
charged residues is conserved in PCNA from H. sapiens, S. pombe and L. major 





    
 
Figure 3-16. Structure of LmPCNA 
Figure showing the structure of LmPCNA in the asymmetric unit. There are 6 
LmPCNA monomers in the asymmetric unit and these form an apparent hexameric 
structure. A) Two homo-trimers of LmPCNA showing the potential dimer of trimeric 
rings as presented in the asymmetric unit. 1: The structure is rotated 90° along the 
vertical axis. 2: The structure is rotated 90° along the horizontal axis. 
B) The potential hexameric form of LmPCNA contains 4 hydrogen bonds at the 
binding interface, this structure shows a close up of two of these hydrogen bonds.  
 
 





                 13 20 77 80 146 149 210 217 
 H.sap           KK K  K  K  C   R   R   K  
 
                 13 20 77 80 146 149 210 217 
 S.pom           KK K  K  R  R   R   K   K  
 
                 13 20 77 80 146 149 244 251 
 L.maj           KR N  K  K  K   R   R   K  
                 *: :  *  :      *   :   * 
 
Figure 3-17. The pore of LmPCNA  
Figure showing the inner lining of the LmPCNA pore with a conserved architecture 
to that of HsPCNA. Top) LmPCNA pore with diameter of ~37Å is of sufficient size 
to surround DNA. The inner lining of the LmPCNA trimeric ring comprised of 12 α-
helices. Each helix has at least two positively charged residues for the association to 
DNA. There are 27 positively charged resides represented in stick form. Bottom) the 
conservation of the 27 positively charged resides which make up the surface of the 
pore. This demonstrates a high level of sequence identity and similarity within these 
residues. This high level of conservation suggests that these residues are essential for 
the action of PCNA within the cell. 
37.3Å 
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There are approximately two positively charged residues per helix lining the central 
pore which show a high level of conservation. The positively charged residues in the 
PCNA monomers have a sequence identity of 44% with (89% similarity) (figure 
3.17B).  
3.2.3 The elongated loop region (186-223) of LmPCNA  
An elongated loop region in protozoan PCNA exists in LmPCNA (section 
1.2, figure 1.2). This loop domain is not present in eukaryotic PCNA (figure 3.12C). 
Eukaryotic PCNA has a loop of 7 residues at this region. The loop domain in 
LmPCNA is 41 amino acids in length (figure 3.12C). The increased size of the loop 
may give LmPCNA another mode of interaction with DNA or other partner proteins.  
The elongated loop domain of LmPCNA has a flexible base and is protruding 
into solvent. (figure 3.18). The flexibility of this loop is the result of a glycine rich 
sequence at the N-terminal side of the loop domain and hydrophilic residues at the C-
terminal side (figure 3.12C). This loop branches from the second globular domain 
between the third and fourth βαβββ folds (figure 3.9).  
The corresponding loop in HsPCNA is not resolved in the structure of 
HsPCNA 1AXC (Gulbis, J. M. et al 1996). The structure of SpPCNA loop is seven 
residues in length and is solved (unpublished data). In SpPCNA, this region has a 
high B-factor (47Å2) indicative of a high degree of flexibility. The presence of the 41 
residue loop domain in LmPCNA results in the trimeric rings being separated, 
packing LmPCNA in the observed form. This reduces the proteins density and 
increases the solvent content of the crystal to ~76%. Crystals with high solvent 
content are linked to poor resolution crystal data (Souza, D. H. F. et al 2000). 
Electron density of this loop domain was observed in the crystal structure of both 
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Figure 3-18. The predicted position of the elongated loop region of LmPCNA 
Figure showing the model of LmPCNA generated using 3D-JIGSAW (Bates, P. A. et al 2001). This model was superposed onto each 
PCNA monomer of the structure 1AXC (Gulbis, J. M. et al 1996) generating a trimeric structure. Left) The ring form of the LmPCNA 
trimeric model showing the position of the loop helix (figure 3.19). This helix is in alignment with the helical bundle region of the 
LmPCNA trimer suggesting a potential interaction with DNA. Right) The trimeric model of LmPCNA with a 90° right handed rotation. 
This shows that the 41 residue loop region allows the helix to be held 35Å from the ring. 
35Å 
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complexed and un-complexed LmPCNA. Approximately three residues of the 
LmPCNA loop domain could be modelled in either LmPCNA structure. It was not 
possible to build the remaining residues of this loop domain resulting in the loop 
region not being resolved in either X-ray crystal structures (figure 3.16A). This loop 
is not resolved because (as described above) the base of the loop is likely flexible and 
disordered in the solvent. 
The elongated loop domain of LmPCNA was modelled using 3DJigsaw 
(Bates, P. A. et al 2001). and was predicted to contain an α-helix (figure 3.19A). This 
helix is not present in HsPCNA or SpPCNA (figure 3.12C) and the function of the 
loop in L. major cell lines has not been investigated. The predicted helical part of the 
loop is positively charged down one face and negatively charged down the other 
(figure 3.19B). This differential charge could allow association to DNA or other 
binding partners. The predicted loop is positioned near the helices lining the pore, 
protruding ~35Å from the N-terminal side of LmPCNA (figure 3.18). The theoretical 
helix may be near the path of the associated DNA molecule (figure 3.18). 
Association of the loop to the DNA molecule may create another binding interface in 
LmPCNA. 
3.2.4 The comparison of un-complexed and complexed structures of 
LmPCNA 
The crystal structure of LmPCNA has been determined with and without H. 
sapiens p21 (141-152) bound. The complexed protein-peptide crystal was formed by 
co-crystallisation using the same conditions as the un-complexed crystal. The un-
complexed and complexed crystals formed were of similar size and shape. The 
crystals belong to the same space group and have very similar unit cell dimensions, a  
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Figure 3-19. The predicted loop domain of LmPCNA 
Figure showing the novel loop domain of LmPCNA. This loop has 41 residues in LmPCNA opposed to 7 residues in HsPCNA. The loop 
which may be flexible and shows a large quantity of random coiled region. The loop is determined to contain a helix (left), contains three 
positively charged residues and four negatively charged residues. These residues are positioned on opposing sides of the predicted helix 
giving a differential charge. The surface electrostatics of this differentially charged helix (right) show a clear positive charge on one side 
which may facilitate DNA association. 
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result of the crystal packing. A neighbouring asymmetric unit sits near the PIP box 
binding interface. As a result of peptide association to the PIP box binding interface, 
the LmPCNA hexamers will be pushed apart. The separation of LmPCNA hexamers  
resulted in a slight increase in the solvent content of the crystals, 75.4% for the un-
complexed and 76.1% for the complexed. The resolution of the un-complexed and 
complexed protein crystals could be dramatically improved when the crystals were 
dehydrated (as discussed in section 3.1.3) from 7Å to 3Å.  
The structure solutions of un-complexed and complexed LmPCNA were very 
similar showing the trimeric and potential hexameric structures. Monomers, trimers 
and hexamers were superposed using backbone atoms only. The superposition of the 
un-complexed and complexed LmPCNA monomers gave a 0.615Å R.M.S.D. 
superposition of the trimers gave a 0.902Å R.M.S.D. and superposition of the 
hexamers gave a 6.64Å R.M.S.D. (figure 3.20). The large increase in the R.M.S.D. 
of the hexamer alignment infers that this potential hexamer of LmPCNA may be able 
to associate in different orientations. 
Both un-complexed and complexed structures have high B-factors and poor 
resolution as a result of the high solvent content. The un-complexed structure of 
LmPCNA gave an average B-factor of 84.3Å2 for all 5884 backbone atoms. 
LmPCNA from the complexed structure gave an average B-factor of 81.3Å2 for all 
5992 backbone atoms. The average B-factors for different regions of the protein were 
calculated. Flexible regions of the protein like the N-terminus, C-terminus, elongated 
loop domain branch points and IDCL showed on average the highest B-factors 
(figure 3.21, table 3.5). These B-factors show reasonable similarity between the two 




Figure 3-20. The superposition of un-complexed and complexed LmPCNA 
monomers, trimer and hexamers  
Figure showing the superposition of LmPCNA monomers, trimers and hexamers of 
un-complexed (green) and complexed (blue) LmPCNA. A) The superposition of 
monomeric LmPCNA with an RMSD of 0.615Å. B) The superposition of trimeric 
LmPCNA with an RMSD of 0.902Å. C) The superposition of hexameric LmPCNA 
with an RMSD of 6.64Å. This shows little conservation of the hexameric form 







B-factor of un-complexed 
structure (Å2) 
B-factor of complexed 
structure (Å2) 
Average of whole protein 84.3 87.6 
N-terminus 98.3 100 
α helicies 78.7 87.8 
β sheets 96.7 98.0 
IDCL 111 106 
N-terminus of loop 98.3 94.2 
C-terminus of loop 93.4 92.3 
C-terminus 104 102 
 
Table 3-5. Table showing the average B-factors of regions of LmPCNA in un-
complexed and complexed structures 
Table showing the B-factors of LmPCNA; in both un-complexed and complexed 
crystal structures. The B-factors of LmPCNA have been shown with regards to 
different regions of the protein with the greatest flexibility compared to the average 
secondary structure. It is shown that some regions demonstrate an increased B-factor 
in the complexed crystal structure e.g. N-terminus and secondary structures. The 
IDCL and C-terminus do show a reduced B-factor as a result of peptide binding. This 
is due to the involvement of these areas in the PIP-box binding site of LmPCNA 




Figure 3-21. Topology 
diagram showing areas with 
colour related to B-factor 
 
The topology diagram of the 
LmPCNA monomer with 
different areas (noted in table 
3.5) coloured by B-factor. The 
colours are (from high) red, 
yellow, green and blue (to low). 
The IDCL and C-terminus 
show the greatest B-factor and 
it is these areas which make up 
the PIP box binding interface.  
The N-terminus and elongated 
loop braches have high B-
factors and are solvent exposed. 
The helical regions are the most 
highly supported structures and 




these flexible regions than that of the un-complexed structure. This increase in B-
factor is likely the result of poorer resolution in the complexed structure. The IDCL 
and C-terminus had a slightly reduced B-factor in the complexed structure. This is 
the result of the peptide binding the PIP box binding interface which is formed by the 
IDCL and C-terminus. This binding event stabilised the IDCL and C-terminus giving 
the reduced B-factor in the complexed structure. 
3.2.5 Structural analysis of the PIP-box binding interface 
The PCNA PIP box binding interface (described in section 1.2.1) is 
comprised of 30 residues. These residues are required for association to the PIP-box 
sequence of partner proteins e.g. DNA polymerase. The interaction with partners 
involves both hydrophobic interactions and hydrogen bond interactions. These thirty 
PIP box binding residues of LmPCNA have a sequence identity of 58% (84% 
similarity) (figure 3.12B) to the equivalent residues in HsPCNA. The sequence 
identity between LmPCNA and HsPCNA over 261 residues is of 38% suggesting 
higher conservation at the PIP box binding interface.  
LmPCNA can bind the PIP-box sequence, demonstrated in biochemical 
studies chapters 6, 7 and 8. In this work, we have studied crystallographically and 
biochemically the LmPCNA complex formation with H. sapiens p21 (141-152). The 
conservation of this binding activity is due to the conservation of residues at the PIP 
box binding interface (figure 3.12B).  
The crystal structure of HsPCNA complexed with H-sapiens p21 (143-160) 
1AXC (Gulbis, J. M. et al 1996) showed out of the thirty PIP-box binding residues 
twelve were involved in forming hydrogen bonding contacts. The twelve residues 
involved in the hydrogen bonding of HsPCNA to the PIP-box are highly conserved 
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(figure 3.12B). Residues involved in hydrogen bonding at the PIP box binding 
interface have a sequence identity of 50% (75% similarity) with equivalent residues 
in HsPCNA. The level of sequence identity in the residues forming hydrogen bonds 
is no higher than the average of the PIP box binding interface (figure 3.12B).  
The structures of LmPCNA have been solved with and without peptide 
bound. Figure 3.22 shows the residues which make up the binding interface in stick 
form overlaid on a cartoon representation. The PIP-box binding interface is formed 
from the IDCL, central β-sheet, C-terminus and two loop regions (highlighted in 
figure 3.22). The PIP-box binding interface is shown with peptide bound. The 
binding interaction of H. sapiens p21 (141-152) shows a helix at the hydrophobic 
pocket (figure 3.22). This helix is a conserved feature in SpPCNA and HsPCNA 
(Gulbis, J. M. et al 1996).  
There are small structural re-arrangements of the LmPCNA PIP-box binding 
interface upon association of H. sapiens p21 (141-152). The bulk of these small 
rearrangements are the movement of amino acid side chains away from the 
hydrophobic pocket e.g. H44, M126, P129, D266 (figure 3.23). The C-terminus has 
previously been determined to be important for PCNA binding activity (Fukuda, K. 
et al 1995).  The solution of LmPCNA complexed to a PIP box peptide showed a 
significant structural rearrangement in the C-terminus as shown in figure 3.23, the 
Cα of D266 shifts over 8Å. 
Crystal structures of HsPCNA, SpPCNA and LmPCNA bound to H. sapiens 
p21 have been solved. HsPCNA has been solved with p21 (143-160) (Gulbis, J. M. 
et al 1996), SpPCNA has been solved with p21 (142-159) (unpublished data) and 




   
Figure 3-22. The PIP box binding interface of LmPCNA in structures 
determined both complexed and un-complexed forms 
Figure showing the PIP box binding interface of LmPCNA from two crystal 
structures. The green structure (top) is the PIP box binding interface of the un-
complexed form of LmPCNA. Residues involved in the interaction with p21 (143-
152) are shown in stick form. The blue structure (bottom) is the crystal structure 
complexed with p21 (143-152). Residues involved in the PIP box binding interface 
are shown in stick form and the p21 (143-152) peptide is shown in orange. 
 
HsPCNA (pep-PCNA) SpPCNA (pep-PCNA) LmPCNA (pep-PCNA) 
R143-I252 R143(CO)-I254(N) R143(εN)-D291 
Q144-A252 R143(N)-I254(CO) R143(CO)-V289 
T145(εO)-P253 Q144-A251 E144-K288 
T145(CO)-P253 Q144-P252 T145(CO)-P287 
M147-H44 T145-P252 T145(εO)-P287 
Y151-N131 M147-H44 M147-H44 
H152-G127 H152-G127 Y151-Y133 
Table 3-6. The hydrogen bonding network at the PCNA p21 (143-152) interface 
Table showing the residues involved in the hydrogen bonding to PCNA in the three 
species of interest. The first residue is the peptide position and the second is on the 






 Figure 3-23. The 
movement of amino acids 
in LmPCNA upon peptide 
binding 
Figure showing the changes 
in position of residues at the 
PIP box binding interface 
upon peptide binding. 
Comparison of the un-
complexed crystal structure 
(green) and complexed 
crystal structure (blue) 
showing residues involved in 
the PIP box binding interface 
in stick form. The greatest 
deviations are observed at 
residues H44, M126, P129 
and D266, the shift in the 
side chains of these residues 
are shown in Å. The C-
terminus demonstrated a 
significant shift in position. 
The movement of the C-
terminus was measured from 














sequence (Q-x-x-h-x-x-a-a) and PCNA is present in all (HsPCNA, SpPCNA and 
LmPCNA) co-crystal structures. The number of hydrogen bonds were analysed from 
structural information. Between the PCNA peptide (143-152) interaction seven 
hydrogen bonds were formed (figure 3.24), this was consistent in PCNA from all 
species (table 3.6).  
The hydrophobic pocket of the PIP box binding interface of PCNA is 
conserved in HsPCNA, SpPCNA and LmPCNA. A comparison of the thirty residues 
making up the PIP-box binding interfaces of the three PCNAs was made by 
superposition of the backbone and side chain atoms. Superposition of 97 atoms from 
HsPCNA and SpPCNA had the smallest R.M.S.D. (0.61Å). The R.M.S.D. of the PIP 
box binding interface of LmPCNA and SpPCNA is the greatest (2.00Å). This large 
increase in R.M.S.D. may be a result of the flexibility of the IDCL at poor 
resolutions.  
The structures of PCNA p21(143-152) complex were analysed by PISA. This 
gave predicted values of buried surface area and ∆G of formation (table 3.3). PISA 
analysis showed a buried surface area upon PCNA p21 (143-152) interaction of 
1200, 1240 and 1450 Å2 for HsPCNA, SpPCNA and LmPCNA respectively (table 
3.3). The predicted ∆G of formation upon PCNA p21 (143-152) interaction of -37.7, 
-41.8 and -51.5 kJ mol-1 for HsPCNA, SpPCNA and LmPCNA respectively (table 
3.3). The values returned from the PISA analysis show that the computed buried 
surface area and ∆G of formation follow similar trends. The values infer that the 
LmPCNA-peptide interaction may be the tightest with HsPCNA and SpPCNA 
sharing similar affinities. The values determined by PISA are predicted from static 








Figure 3-24. The PIP box binding interfaces of HsPCNA, SpPCNA and 
LmPCNA. 
Figure showing the binding interfaces of PCNA from H. sapiens (top) (Gulbis, J. M. 
et al 1996), S. pombe (centre) (unpublished data) and L. major (bottom). These three 
crystallographic structures show the position of the p21 peptide of varying lengths 
bound to HsPCNA (magenta) SpPCNA (pink) and LmPCNA (orange). The binding 
interactions from all these crystal structures share the p21 (143-152) sequence 
containing the PIP box. This area of the peptide forms the helical region of the 
peptide and is a conserved feature in the interaction of all three PCNA structures. 





CHAPTER 4. The oligomeric state of PCNA 
In this chapter the functional oligomeric state of PCNA is discussed. The 
oligomeric state can be difficult to determine as all subunits are identical and 
crystallographic data may not be a genuine representation of the protein in-vivo. The 
oligomeric state observed by crystallographic analysis may be imposed due to the 
high concentration of protein within a crystal.  
Solution studies of the size of proteins can give information on a more 
genuine interaction. Solution methods include size exclusion chromatography, 
dynamic light scattering and chemical cross-linking. These methods have been 
implemented to give information about the potential oligomeric state of LmPCNA. 
These methods each rely on different facets of protein oligomeric states. Factors 
relating to size, mass, protein interface surface and direct chemical contacts can 
present information of the oligomeric state (Harding, S. E. 1995). The crystal 
structure of LmPCNA presented a potential hexameric state. This could be a 
crystallographic artefact and not the result of a biologically relevant interaction; 
alternatively this could be a mechanism of auto-regulation or providing a different 
platform for PCNA-protein interactions.  
4.1 The potential oligomeric states of PCNA 
PCNA is presented as a ring structure in all homologues studied as discussed 
in section 1.2. This ring structure has differing oligomeric states in different species, 
commonly a trimeric ring in eukaryotes (Gulbis, J. M. et al 1996; Shamoo, Y. and 
Steitz, T. A. 1999) or a dimer in prokaryotes (Kong, X. P. et al 1992). Drosophila 
PCNA has been argued to exist in a hexameric structure as a back-to-back double 
trimer (Henderson, D. S. et al 2000). This was later demonstrated in HsPCNA by 
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activity studies and chemical cross-linking studies (Naryzhny, S. N. et al 2005) 
(discussed below in section 5.1.1). This could give information regarding the actions 
of HsPCNA in-vivo, facilitating the coordination of multiple PCNA binding partners.  
4.1.1 The potential oligomeric states of HsPCNA 
Human PCNA is a trimeric ring structure as first shown in cryo-electron 
microscopy studies (Gogol, E. P. et al 1992). There is an ambiguity in the literature 
about the functional oligomeric state of PCNA. A previously published crystal 
structure of HsPCNA (Kontopidis, G. et al 2005) demonstrates an apparent 
hexameric structure (figure 4.1A); this has been determined to be a weak, but 
genuine interaction (Naryzhny, S. N. et al 2005). The hexamerisation of HsPCNA 
allows the binding interfaces (the front) to be exposed (figure 4.1A). It is believed 
that this can allow HsPCNA to function in both directions and facilitate greater co-
ordination of DNA damage repair mechanisms. HsPCNA has been previously 
determined to bind a single co-factor per trimer, this was shown by competition with 
DNA Ligase I (Pascal, J. M. et al 2004). DNA Ligase I, a protein with a molecular 
weight of ~100kDa, totally encircles DNA occluding all other binding interfaces of 
PCNA. Native HsPCNA molecules have been demonstrated to co-purify with two 
PCNA binding partners in (Naryzhny, S. N. et al 2005), supporting the theory of a 
back-to-back hexameric structure. The existence of the hexameric structure of 
HsPCNA would allow greater speculation about function of PCNA within the cell. 
4.1.2 The potential oligomeric states of LmPCNA 
The oligomeric state of LmPCNA is unknown and had not been studied 
before this work. The X-ray crystal studies of LmPCNA clearly demonstrate a  
 
 109 
      
            
                       
 
Figure 4-1. The potential hexameric structures of HsPCNA and LmPCNA 
 
A) The alignment of the HsPCNA trimeric rings, top; the view along the axis of the DNA, 
middle; the side view shown in slab mode with the measurement of the diameter of the 
trimer and potential hexamer as 90.0Å and 111Å respectively, bottom. 
B) The alignment of the LmPCNA trimeric rings, top; the view along the axis of the DNA 
middle; the side view shown in slab mode with the measurement of the diameter of the 








trimeric ring structure, but also present a doublet of trimers in a hexameric state 
(figure 4.1B) similar to that present in HsPCNA (Kontopidis, G. et al 2005). Within 
the crystal, this could be an energetically favourable form of packing or a pre-
existing hexamer. The question is therefore whether this is a genuine trimer-trimer 
binding interface or a crystallographic artefact. It should be noted that the trimer-
trimer interaction in HsPCNA has a back to back configuration (figure 4.1A top), 
presenting the binding interfaces to the solvent, whereas the LmPCNA trimer-trimer 
interaction is face to face (figure 4.1B top) partially occluding the binding interface. 
4.2 The use of PISA to analyse oligomeric state 
The crystal structure once determined can be used to derive the validity of the 
trimer-trimer interaction. Bioinformatic analysis of X-ray crystal structure protein 
assemblies calculates buried surface area, charged states of the buried surfaces and 
the size of the final complex as opposed to the individual subunits. Balanced against 
these factors is the observation that there is an increased instability of larger protein 
complexes due to increasing entropic cost (Jones, S. and Thornton, J. M. 1996). The 
protein contacts of a test set of protein complexes have been analysed by quantifying 
molecular interactions of a number of protein interfaces and these have been scored 
to provide viability scores (Krissinel, E. and Henrick, K. 2007b). The molecular 
contacts are estimated from buried and free surface areas of the structure. The 
entropic terms of the structure are a sum of the translational entropy, rotational 
entropy, vibrational entropy and side-chain entropy at the binding interface 
(Krissinel, E. and Henrick, K. 2007b). The equations used to estimate these values 
from crystal structure data are given in (Krissinel, E. and Henrick, K. 2007b). In 
broad terms, the greater the increase in complex symmetry, the greater the entropic 
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cost and this is used to derive the Gibbs free energy of dissociation (Krissinel, E. and 
Henrick, K. 2007b). The validation of oligomeric state from crystal structures can be 
accomplished by the use of a computer program: Protein Interfaces, Surfaces and 
Assemblies (PISA) (Krissinel, E. and Henrick, K. 2007b). This program takes into 
account the chemical and physical properties of interactions to determine the 
viability of the protein interaction relative to the complex size. This program will 
return values of the surface area, buried area, Gibbs free energy change (∆G) of 
complex formation, a ∆G of dissociation and an approximation of the stability of the 
complex. Complexes determined to be stable would show a negative ∆G for complex 
formation and a positive ∆G of complex dissociation. This program was shown to be 
80-90% accurate for a test set of 218 previously solved proteins structures with 
experimentally determined oligomeric states (Krissinel, E. and Henrick, K. 2007b).  
4.2.1 Size exclusion chromatography to analyse oligomeric state 
As stated in chapter 2, size exclusion is, in general, a means of separating 
proteins by size. This separation is based on the Stokes radius of the protein and can 
be affected by not only the molecular weight of the protein, but other factors. As 
such, if the assumed molecular weight, based on size exclusion data, appears to have 
a greater molecular weight than the calculated, this could be the result of shape, 
buffer viscosity or oligomeric state (Dai, H. et al 1998).  
A pure protein sample should demonstrate a smooth equidistant peak. This 
peak may broaden or split as a result of different oligomeric states in the protein 
sample. If the protein concentration is sufficiently high, all protein may appear in the 
higher order oligomeric state and result in a shift in the whole peak.  
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4.2.2 Dynamic light scattering as a means to analyse oligomeric state 
Dynamic light scattering is a method of determining the Stokes radius of a 
macromolecule in solution. It relies on similar variables as that of size exclusion 
chromatography but is measured by a significantly different technique. This method 
measures the light scattered by a solution. Light is scattered by macromolecules, and 
the reflected light from these molecules may interfer with other reflections. Where 
two or more reflections combine, there can be constructive or destructive 
interference. The total intensity of scattered light will fluctuate as a result of the 
random movements of the particles in the solution. The light scatter is measured 
again at various time intervals. This intensity of light will differ from the original 
scatter as the time course proceeds. The rate in change of the scatter is the 
correlogram, which in dynamic light scattering can be used to give data on the sizes 
of the species present in the cuvette (Jachimska, B. et al 2008). Rapid changes in 
scatter are indicative of a solution containing species with a high diffusion constant 
and slow changes in scatter are indicative of a solution containing species with a low 
diffusion constant. The correlation function can also give data regarding the quantity 
of each different molecular weight species in the solution using the dynamic Zimm 
plot (Zimm, B. H. 1948).  
This method has similar strengths and weaknesses to those of size exclusion 
chromatography. These methods both determine the Stokes radius of the protein 
sample, and are dependent upon protein shape and buffer viscosity. Dynamic light 
scattering can also present errors in the predicted molecular weight of a protein as the 
samples Stokes radius is computationally calculated from the correlogram (Harding, 
S. E. 1995). Due to the increased scatter resulting from a larger particles, a sample 
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with equal concentrations of two species and order of magnitude difference in 
molecular weight will result in the larger species presenting a signal 106 times 
stronger. As a result, the presence of a large impurity, e.g. dust, will mask signal 
returned form the protein of interest. 
4.2.3 Chemical cross-linking to analyse protein oligomeric state 
Proteins form higher order oligomeric states by close protein interactions. 
The close association of two polypeptide chains can be stabilised by side group 
interactions as in section 5.1. As a result, protein samples can be covalently coupled 
by chemical cross linking. This will occur when protein functional groups are in 
close proximity. The chemical cross links formed by this method are not broken by 
the reducing environment of an SDS-PAGE gel (Melcher, K. 2004). The molecular 
weight shown by SDS-PAGE analysis will be a multiple of the monomer size.  
This method is one of the most widely accepted methods of oligomeric state 
determination and can use a variety of chemical reagents that facilitate the cross-
linking. One of the most common reagents is formaldehyde, which reacts with 
primary amines to form a Schiff base. The Schiff base can react with a variety of 
protein side-chains e.g. tyrosine, histidine, lysine and cysteine (Fujita, N. and Wade, 




This results in an irreversible covalent bond suitable for separation using SDS-PAGE 
gels. Formaldehyde is also a short linker molecule resulting in the only interactions 
determined to be in close proximity (~2Å) (Orlando, V. 2000).  
A common error of chemical cross-linking is the potential of poly-peptide 
monomers to associate due to the addition of the cross-linking reagent. Should 
protein solution be incubated for long periods of time with formaldehyde present, 
then it is possible for protein to form progressively higher order structures when 
analysed by SDS-PAGE gels. These higher order structures may not be a true 
representation of the native protein solution. The imposition of a higher order 
structure can be determined by use of a size exclusion column. Retention volumes of 
the native and non-cross-linked protein solution should remain similar if the protein 
oligomeric state is genuine. 
4.3 Materials and methods of oligomeric state determination of LmPCNA 
In the study of the oligomeric state of LmPCNA, the protein was purified as 
in chapter 2, and prior to any experiment, the sample was size excluded into the 
appropriate buffer using the Superdex S200 10/300. Should protein concentration be 
required, this was achieved using a Vivaspin 20 ultra filtration column (GE 
Healthcare) with a 10kDa molecular weight cut off. These columns were centrifuged 
at 3800rpm at 4°C in a bench top centrifuge. Protein concentrations were determined 
using the NanoDrop™ 2000 (Thermo Scientific) set at 280nm, assuming an 
extinction co-efficient of 20775 M-1cm-1. Analysis of protein interactions using PISA 
were performed as in (Krissinel, E. and Henrick, K. 2007a), accessed 8/8/07.  
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LmPCNA size exclusion analysis: The protein size exclusion analysis was 
performed as in section 2.3.2. The column was thoroughly equilibrated with buffer 
and run at 0.5ml min-1, fractions were collected every minute.  
LmPCNA dynamic light scattering analysis: Dynamic light scattering was 
performed on a series of LmPCNA protein concentrations, 0.025, 0.05, 0.1, 0.2, 0.5, 
1.0 and 2.0mg ml-1. This was performed at Malvern instruments by Andrew Jones on 
the 19/11/2007. This data was obtained using the Malvern ® Zetasizer® Nano ZS™, 
at 25°C in HEPES biochemistry buffer. The data was analysed using the Malvern 
Zetasizer Nano ZS version 5.02 software. All samples were filtered through a 0.2µm 
filter prior to transport and were stored at Malvern at -20°C until use, and data was 
returned as a printed report by mail. 
Results obtained from Malvern were confirmed by the Wyatt DynaPro™ 
plate reader. LmPCNA in HEPES biochemistry buffer was concentrated to 2.0mg ml-
1 and filtered through a 0.2µm filter. Light scattering was determined for this sample 
in a black 384 well plate (Greiner Bio-one) at 25°C with a laser wavelength of 
828nm. The light scattering was measured and repeated every 0.5µs for 
approximately 7seconds, the scatter intensity returned for these measurements were 
then compared. This was then analysed to give a correlation co-efficient by the 
DYNAMICS V6™ version 6.9.1.15 assuming a sample refractive index and 
viscosity of water. 
LmPCNA chemical cross-linking analysis: Protein samples for chemical cross-
linking were concentrated to 1mg ml-1 in chemical cross-linking buffer (50mM 
HEPES, 0.1mM EDTA, pH 8.2). Protein solution had a 0.012M concentration of 
formaldehyde (Fisher) added, pipette mixed and was incubated for 2hours with 
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samples removed at 0s, 10s, 30s, 1min, 2min, 3min, 5min, 10min, 15min, 30min, 
60min and 120min. These samples were quenched with SDS-PAGE loading buffer 
and run on a gel. This experiment determined the time required for the formation of 
higher order structures. 
A 400µl sample of LmPCNA (1mg ml-1) in chemical cross-linking buffer was 
split into two equal samples; sample one was chemically cross-linked by the addition 
of formaldehyde to a final concentration of 0.012M and incubated at 25°C for 
10mins. This sample was then quenched by the addition of a 15 fold molar excess of 
primary amines from Tris to a final concentration of 0.18M, the sample was then 
incubated for a further 5mins at 25°C to couple the remaining formaldehyde 
molecules. This sample was then run over the Superdex S200 10/300 in pre-
equilibrated LmPCNA crystallisation buffer. After this sample was eluted, the 
column was re-equilibrated in LmPCNA crystallisation buffer and the second sample 
was passed over the column. The eluted fractions were collected and analysed by 
12% SDS-PAGE. 
4.4 Oligomeric state determination of LmPCNA 
The oligomeric state of LmPCNA has been determined by the PISA, size 
exclusion chromatography and chemical cross-linking. The results of these methods 
are described below. These experiments have demonstrated the potential oligomeric 
state of LmPCNA in-vitro. 
4.4.1 Oligomeric state determination of LmPCNA by PISA 
PISA analyses whole .pdb files and uses the solved asymmetric unit and 
known unit cell parameters to analyse all possible interfaces. The .pdb file generated 
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in chapter 4 was used as the input for the PISA analysis. This analysis returned 
values for the surface area and buried area (square Å), the Gibbs free energy change 
(∆G) of complex formation and dissociation in kcal mol-1 and an approximation of 
the complex stability based on these values. Within the asymmetric unit, 6 monomers 
were present and formed two trimers. These two trimers, which are known to be a 
genuine interaction, were both found in the crystal structure and determined to be 
genuine (table 4.1). The two trimers of LmPCNA presented different values for the 
surface area, buried area, ∆G of complex formation and ∆G of complex dissociation. 
The differences were only slight for the surface area and buried area (figure 4.2), 
with an average calculated surface area of 35025 ±35 sq. Å (>0.1%) and an average 
calculated buried area of 4130 ±20 sq. Å (>0.5%). The calculated ∆G of formation 
presented an average of -15.2 ±1.25 kcal mol-1 (~8.22%) and the ∆G of dissociation 
presented an average of 2.1 ±1.4 kcal mol-1 (~66.7%). The program determined that 
both trimers were genuine complexes (table 4.1).  
The hexamer (figure 4.1B) demonstrated a significantly greater buried 
surface area (10020sq.Å) (figure 4.2, table 4.1) and a reduced ∆G of formation (-33.4 
kcal mol-1) (table 4.1). This complex also showed a significantly greater surface area 
(68290sq.Å), and a reduced ∆G of dissociation (-2.0 kcal mol-1) (table 4.1). The 
negative ∆G of dissociation was only slight and resulted in the hexameric state of the 
protein to fall within a grey area. As a result, the computational method determined 
that the LmPCNA hexamerisation may or may not be a genuine interaction (table 
4.1).  
The PISA analysis of the hexamer of HsPCNA has been determined to be 
genuine with a buried surface area (15980sq.Å) (table 4.1) and reduced ∆G of 
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The following complexes appear to be genuine 
A3 ACG Yes 35060 4150 -19.0 7.3 
A3 BDE Yes 34990 4110 -15.0 2.4 
 
The following complex falls in a grey region and may or may not be genuine 
A6 ABCDEG No 68290 
10020 
(∆1760) -33.4 -2.0 
The following complexes are genuine in HsPCNA structures 
A3 A3 Yes 34900 4750 -16.0 6.3 
A6 A3B3 Yes 61670 
15980 
(∆6480) -18.8 1.3 
 
Table 4-1. The energetics and binding areas of potential LmPCNA complex 
formations 
Table showing a brief account of the results obtained from an analysis of the protein 
structure, as determined by PISA. This table shows the complex formula, the 
monomers of the crystal structure involved in the interaction, a determination of 
complex stability, the calculated surface area in sq.Å, the calculated buried area in 
sq.Å, the ∆G of formation and the ∆G of dissociation in kcal mol-1. The first two 
complexes were determined to be genuine, as the trimeric rings present in the 
asymmetric unit. The third complex is a determination of the hexameric structure. It 
could not be determined if this complex was genuine or not. The lower panel shows 




 Figure 4-2. The buried surfaces areas at the monomer-monomer and trimer-
trimer interfaces 
Buried surfaces areas at the monomer-monomer interface (A) and the trimer-trimer 
interface (B). Both figures show carbon (green), nitrogen (blue), oxygen (red), 
sulphur (yellow) and the buried atoms (grey). These surfaces show the areas which 
make up the buried surfaces areas of LmPCNA in the crystal structure and give the 





formation (-18.8 kcal mol-1) (table 4.1). This complex also showed a significantly 
greater surface area (61670sq.Å), and a reduced ∆G of dissociation (1.3 kcal mol-1) 
(table 4.1). The HsPCNA hexamer is determined to be genuine when no 
determination could be made regarding the LmPCNA hexamer. The HsPCNA 
interaction is deemed to be genuine due to the greater buried surface area at the 
trimer-trimer interface (6480sq.Å, an increase in 4720sq.Å) and the positive ∆G of 
dissociation (1.3 kcal mol-1) (table 4.1). 
4.4.2 Oligomeric state determination of LmPCNA by size exclusion 
Size exclusion analysis of LmPCNA was performed during purification, 
section 2.3.2. This demonstrated that in HEPES buffer, the protein appeared to have 
a Stokes radius of a globular protein ~94.3kDa, the approximate molecular weight of 
the trimer. When analysed in Tris buffer, LmPCNA appeared to have a Stokes radius 
of a globular protein ~200kDa, the approximate molecular weight of the putative 
hexamer (figure 4.1B). This could indicate that the hexamer formation is condition-
dependent, requiring different concentrations of ionic strengths or protein. This 
analysis, however, agrees with that of the computational method and determines that 
the LmPCNA hexamerisation may or may not be a genuine interaction. 
4.4.3 Oligomeric state determination of LmPCNA by dynamic light 
scattering 
LmPCNA was analysed by dynamic light scattering using a variety of similar 
equipment from different companies. This method gave the determined 
hydrodynamic diameter, double the Stokes radius, and the approximate molecular 
weight for a globular protein of this size. The two systems used returned results 
showing a good agreement. Protein samples were analysed at a concentration series 
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(from 0.025 to 2.0 mg ml-1) in HEPES buffer. Protein concentration gave no 
significant change in hydrodynamic diameter and returned an average hydrodynamic 
diameter of 106Å over all concentrations (figure 4.3). This is the approximate 
diameter of a 165kDa globular protein, the approximate mass of a pentamer which 
can be approximated to the hexameric structure. The determined diameter of 
LmPCNA, from the crystal structure for the trimer is ~89.6Å, and for the hexamer is 
~110Å (figure 4.1B). Thus, the determined diameter from dynamic light scattering is 
in close agreement with the hexameric structure. This data suggests that the 
hexameric structure is genuine; however this method is most sensitive if there is an 
order of magnitude shift in molecular weight which is not the case in this experiment. 
4.4.4 Oligomeric state determination of LmPCNA by chemical cross-
linking 
The chemical cross-linking of LmPCNA was performed using formaldehyde 
solution as the cross-linking reagent. This method requires a 10 fold molar excess of 
formaldehyde to free amines in order to obtain cross-linking, so the number of free 
amines needs to be calculated from the sequence. This was determined to be 54. This 
reaction generated higher order structures at 25°C with 10minute incubation time 
after the addition of formaldehyde, as determined by SDS-PAGE gels. The formation 
of higher order structures is coupled with the reduction of monomeric protein bands 
at 35kDa. Less than 5 seconds after the addition of formaldehyde, two gel bands at a 
molecular weight lower than monomeric LmPCNA were formed. These gel bands 
are most likely due to internal cross-linking within the monomer and resulting in 
LmPCNA to exist in a more compact state, causing more rapid migration through the 











Figure 4-3. The hydrodynamic diameter of species present in different 
concentration solutions of LmPCNA as determined by dynamic light scattering  
 
A chart showing the signal intensity generated from the correlogram resulting from 
the dynamic light scattering of a solution of LmPCNA. This solution was at 
concentrations of 0.025mg ml-1 and 0.6mg ml-1 and repeated three times each. Each 
repeat returns consistent values for the calculated hydrodynamic diameter of ~10nm 
(100Å). The low concentration of LmPCNA shows an increase in the proportion of 
large molecular weight impurities as the signal from the protein becomes less 
significant. A concentration series shows this trend to be repeated and gives an 
average hydrodynamic diameter of 10.6nm (106Å), approximately that of the 
LmPCNA hexamer. This has been correlated to a mass of a globular protein of 
165kDa, similar to that of a hexameric LmPCNA. 





result of the protein existing strongly in a trimeric form and the time required for a 
inter-monomer cross-link to form would result in a larger proportion of molecules 
cross-linked to more than one other poly-peptides. 
A sample was split into two and one was passed over the Superdex 200 size 
exclusion column and a peak was observed to elute at a volume of ~11.5ml. This is 
the native state of the protein in Tris buffer (figure 4.4B). The second portion of this 
same sample was chemically cross-linked as above. The cross-linked sample was 
passed over the Superdex 200 column and presented two elution peaks (figure 4.4C). 
The peaks eluted at 11.1ml and 13.1ml, and when run on a SDS-PAGE gel, the peak 
eluted at 11.1ml corresponded to bands of ~200kDa and ~100kDa, which consist of 
hexameric and trimeric LmPCNA respectively. This data is in agreement with 
(Naryzhny, S. N. et al 2005). The peak eluted at 13.1ml, when run on a SDS-PAGE 
gel, corresponded to bands of ~35kDa and ~32kDa (figure 4.4A), these bands consist 
of the monomer and cross-linked monomer LmPCNA. Change in the elution volume 
from 11.5ml to 11.1ml could be the result of the LmPCNA monomers being cross- 
linked and presenting increased rigidity leading to an increased Stokes radius. The 
chemical cross-linking analysis of LmPCNA demonstrates the clear formation of 
hexameric state protein eluting at the same volume as the native, confirming that this 
is a genuine interaction in the environment of this experiment.  
4.5 Conclusions from the oligomeric state determination of LmPCNA 
These experiments clearly demonstrate that the hexamerisation of LmPCNA 
does occur to some extent in solution. Energetics determined by the PISA analysis of 
the crystal structure contacts showed that the hexamerisation falls in a grey area and 
may or may not be a genuine interaction. The requirement of the formation of a  
 
 123 
           
 
Figure 4-4. Size exclusion and SDS-PAGE of native and cross-linked LmPCNA 
A) 10% SDS-PAGE analysis of the size exclusion fractions (F5-F10 and B11-B4 
indicated by a *). The first size exclusion peak demonstrates hexamers and trimers, 
the second demonstrates monomers and cross-linked monomers. As visualised by 
coomasie stain. B-C) The size exclusion of the native (B) and chemically cross-
linked (C) LmPCNA at a 0.5ml min-1 flow rate, with the elution time shown above 
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genuine interface requires a large buried surface area and the nature of the surface 
gives a negative ∆G of formation and a positive ∆G of dissociation. The hexamer 
showed a slight negative ∆G of dissociation (-2.0 kcal mol-1) however this technique 
has been determined to have a ± error of ~5.0 kcal mol-1 (Krissinel, E. and Henrick, 
K. 2007b). The trimer is shown to be a likely oligomeric state, however the 
hexameric state could not be determined to be genuine or false from this method. 
The size exclusion shows LmPCNA eluting at two volumes in a buffer 
dependent fashion. In high salt buffer (150mM NaCl), LmPCNA elutes to an 
approximate volume of a 94.3kDa globular protein, the approximate molecular 
weight of the trimer. In low salt buffer (25mM NaCl) LmPCNA elutes at a volume of 
a 200kDa globular protein, the approximate molecular weight of the hexamer. When 
the PCNA peak was eluted from the size exclusion column there was no second peak 
so no approximate change in state was observed. A link between buffer ionic 
strength and PCNA hexamerisation has previously been observed in (Naryzhny, S. 
N. et al 2005). 
Dynamic light scattering was performed in high salt buffer and returned a 
hydrodynamic radius of 106Å, the approximate diameter of a 165kDa globular 
protein, in agreement with a potential hexamer. These methods are most capable of 
distinguishing the mass of proteins that differ by an order of magnitude. It is possible 
that these effects upon the size exclusion and dynamic light scattering are the effect 
of the PCNA trimer existing as a ring structure with a central hole, as this can affect 
the diffusion rates. Loop regions present on LmPCNA can also affect the diffusion 
rate of this protein which could account for difference in the Stokes radius. These 
loops could increase the Stokes radius and result in an apparently higher oligomeric 
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state. As a result these methods may present potential errors which must be taken 
into account when determining the oligomeric state for a protein. 
Chemical cross-linking has determined that the protein can form a hexameric 
state. This is a genuine interaction, present in the native sample, as determined by 
comparison of cross-linked and native size exclusion data. LmPCNA forms a 
hexameric structure when at 1mg ml-1, in cross-linking buffer (low salt buffer). The 
link between buffer ionic strength and hexamerisation has been previously observed 
in (Naryzhny, S. N. et al 2005). 
The potential oligomeric states of PCNA were determined with a range of 
PCNA concentrations in DLS and size exclusion analysis. Neither of these 
techniques showed any change with changing concentration which may be the result 
of low sensitivity of these methods. When LmPCNA was analysed by Dynamic 
Scanning Fluorimetry (DSF) (chapter 5), two increasing concentrations of LmPCNA 
gave a slight increase in the melting temperature of the protein (~3°C). This slight 
increase occurred around the 4µM concentration of LmPCNA, which infers a 
potential Kd of interaction of 4µM. Changes in the melting temperatures of HsPCNA 
and SpPCNA were not observed with changing concentration. 
In-vivo it is possible that LmPCNA does not form a hexameric structure and 
remains in a trimeric state. This could be the result of increased ionic strength within 
the system, or the association of other proteins. The crystal structure presented 
demonstrates that this protein may not be in a functional state. The interaction 
interfaces shown in (Kontopidis, G. et al 2005; Naryzhny, S. N. et al 2005) 
determined that the “front” of the PCNA molecule are exposed in HsPCNA hexamer; 
in LmPCNA however these “front” sides are within the binding interface (figure 4.1 
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A and B). A potential reason for the hexamerisation in LmPCNA could be that a 
method of auto regulation prevents the effect of PCNA up-regulation or a novel 
PCNA-protein mode of interaction. This novel interaction could exist as a result of 





















CHAPTER 5. The study of PCNA by melting curve 
The melting curve of a protein can provide information about structure and 
binding properties. Protein melting curves can be analysed by different methods, 
both direct and indirect. These methods involve the measurement of shift in 
secondary or tertiary structure with temperature. Direct methods involve the 
measurement of secondary structure in real-time for example with the use of circular 
dichroism (Chen, Y. H. et al 1974). Indirect methods involve a measurement of the 
shift in fluorescence quenching with an increase in temperature for example 
differential scanning fluorimetry (DSF) (Vedadi, M. et al 2006). The melting curve 
of protein complexes can also be used to determine ligand binding affinities 
(Ericsson, U. B. et al 2006; Lo, M. C. et al 2004).  
5.1 Introduction to Circular Dichroism 
Circular dichroism can be used to quantify the secondary structure of a 
protein in solution. This is achieved by determining the ellipticity of plane polarised 
light at different wavelengths. The shape of the resulting trace (e.g figure 5.2) 
contains information about the relative amounts of helix sheet and coil structures. 
5.1.1 Principles of Circular Dichroism 
Plane polarised light that is produced in the Circular dichroism photo-
spectrometer can be regarded as a mixture of Left and Right (clockwise and 
anticlockwise) circularly polarised light. Practically, incident light is switched 
between the clockwise and anticlockwise components and measured separately, the 
beams are then amalgamated in-silico to give the ellipticity of the resultant beam 
(Kelly, S. M. et al 2005). Should light be absorbed differentially between clockwise  
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 Figure 5-1. Example of the 
formation of ellipticity 
 
A) Shows the formation of 
plane polarised light due to 
the constructive interference 
from both the left and right 
hand form of equal 
magnitude. 
B) Shows the formation of 
ellipticity due to the disproportionate absorption of the left hand form opposed to the 
right, resulting in the reconstructed beam having a lower magnitude with a degree of 






























Figure 5-2. Graph showing the components of the CD spectra  
Graph showing the ellipticity on the y-axis against the wavelength on the x-axis.  
Solid line, α-helix; long dashed line, anti-parallel β-sheet; dotted line, type1 β-turn; 
crossed dashed line, extended 310-helix or polyproline II helix; short dashed line, 




and anticlockwise components, then the re-constructed light will be as elliptically 
polarised (figure 5.1). The two beams of light are absorbed by the protein solution. If 
this absorption occurs due to protein precipitant or dust particles, then the signal will 
show no ellipticity as absorption will occur in both clockwise and anti-clockwise 
components equally.  
The CD spectrum is obtained by scanning the wavelength of the incident light 
commonly from 300nm to 190nm. The absorption maxima of a protein solution by 
peptide bonds occurs at ~190nm (Goldfarb, A. R. and Saidel, L. J. 1951). The 
different amino acid side chains of a protein each have different absorption maxima 
(260-320nm) and disulphide bonds give a broad absorption maxima at ~260nm 
(Kelly, S. M. et al 2005). Absorption as a result of side chains and disulphide bonds 
are only a small component of the CD spectra. Each major type of secondary 
structure has a characteristic CD spectrum (figure 5.2). The absorption curves show 
the ellipticity against the wavelength of the measured light, of which all or some of 
these components will be present at differing levels in a CD spectra.  
5.1.2 Deconvolution of the CD data 
The CD spectra can be de-convoluted using various computer models hosted 
by online servers. Older programs that were in use did not require the use of a 
training set (a set of known CD spectra). These programs however are generally 
more unreliable. Two of the most reliable algorithms will be discussed here, 
SELCON and CDSSTR. The program SELCON (Sreerama, N. and Woody, R. W. 
1993) is a self consistent model. This algorithm uses a reference set of CD spectra 
with known secondary structure. SELCON3 selects the reference set closest to the 
CD spectrum of interest and attributes the same characteristics initially. This is 
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termed the initial guess and these values are used for further calculations. The 
quantity of secondary structure is associated to the CD spectrum with the use of the 
singular value decomposition algorithm and the locally linearised model 
(Vanstokkum, I. H. M. et al 1990). For a model to be accepted using this method, the 
sum of all secondary structure components must be between 0.95 and 1.05 of the 
total protein; the quantity of each fraction must be greater than -0.025 and the RMSD 
of the calculated against the experimental spectra must be less than 0.25 ∆ε (change 
in ellipticity) (Dalmas, B. and Bannister, W. H. 1995). The fractions of each 
secondary structure component are then used as the model and the algorithms are run 
again. This program continues until there is a consistent result returned which has a 
sum of fractions between 0.90 and 1.10 (Sreerama, N. et al 1999). 
CDSSTR (Johnson, W. C. 1999) is a program which uses training sets of CD 
spectra and fits the eight most relevant curves, thus preventing less relevant curves 
from influencing the results. These eight data sets are recombined to form the final 
data and matched to the query data set. The data will be accepted only if the sum of 
characteristics are between 0.952 and 1.05, no characteristic is <-0.03 and the RMSD 
to the query set is less than 0.25 ∆ε (Dalmas, B. and Bannister, W. H. 1995). This 
will present a varied number of combinations, composed of different training data. 
When the combined data are returned, CDSSTR modifies the quantity of α-helix as 
this value usually presents the greatest level of error. The average quantity of α-helix 
returned for this analysis allows the selection of the best training set combinations as 
described in (Johnson, W. C. 1999). Finally the accepted combination was used as 
the model, and as in (Sreerama, N. and Woody, R. W. 1993) and the SELCON 
program, the analysis was performed until the results became self-consistent.  
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5.1.3 Common errors associated to CD analysis of protein structure 
CD spectra can be an unreliable method for secondary structure 
determination as there are numerous components to the shape of the spectra, as 
explained above. Inaccuracies in the CD spectrum arise by most systems which use a 
Xe arc light source, and this does not allow low wavelength measurements (<180nm) 
(Kelly, S. M. et al 2005). The lack of information in the CD spectrum results in only 
five components of the spectra to be deconvoluted. If the data is truncated to 190nm, 
only 3-4 components can be determined (Johnson, W. C. 1999). When each of the 
five individual spectra are recombined, the ∆ε RMSD of the fit is at its lowest 
(Hennessey, J. P. and Johnson, W. C. 1981). There are however four main secondary 
structure forms which which have the greatest contribution upon the CD spectra, and 
as such, all remaining features can still be compensated for with the final variable 
(Johnson, W. C. 1999).  
5.1.4 Melting Curve Measurement Using Circular Dichroism 
The measurement of the melting point of a protein by CD is possible due to 
the reduced level of secondary structure in a melted protein. The reduction of the 
ellipticity of a CD signal to ~0 at a specific wavelength is a result of all secondary 
structure being removed. A melting curve can be plotted by monitoring the ellipticity 
of the protein solution at a specific wavelength, commonly at 222nm or a wavelength 
with a large ∆ε signal from 0. With continual measurement of ellipticity at this 
wavelength, the protein solution is heated by the use of a cuvette thermal jacket and a 
Peltier system. A melting temperature can be determined from a plot of the 
temperature against the shift in ellipticity.  
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5.2 Materials and methods of protein analysis by CD 
CD analysis was performed using a Jasco J-810 spectropolarimeter 
thoroughly flushed with nitrogen to increase signal stability and device lifetime. The 
temperature of the sample was controlled using a Peltier system Jasco PTC-4235. CD 
equipment was controlled using the Spectra manager version 1.53 software (Jasco). 
PCNA was buffer-exchanged into CD buffer (10mM NaF, 10mM NaH2PO4, 
pH7.4) using a G-25 desalting column (Pharmacia). HsPCNA was analysed at 2.04 
mg ml-1, SpPCNA was analysed at 1.86 mg ml-1 and LmPCNA was analysed at 1.25 
mg ml-1. PCNA was placed into a 1mm path-length cuvette and allowed to 
equilibrate to 20°C for 30minutes. CD spectra were obtained from 300 to 175nm 
wavelength and the data was analysed using the DICHROWEB server (Whitmore, L. 
and Wallace, B. A. 2008) and the analysis program SELCON3 (Sreerama, N. and 
Woody, R. W. 1993) using a reference set 3 optimised for 185-240nm. For melting 
temperature determination, the samples were heated to 95°C at 0.5°C intervals. The 
CD signal at 222nm wavelength was recorded upon temperature stabilisation.  
5.3 Results of CD measurements 
5.3.1 CD analysis of HsPCNA 
SELCON analysis of the CD measurement of HsPCNA (figure 5.3A) 
returned values of 19.3% α-helix, 43.6% β-strand, 15.8% turns and 17.8% unordered. 
The secondary structure content determined by x-ray crystallography was 18% α-
helix and 46% β-strand (Gulbis, J. M. et al 1996), showing a good correlation with 
the CD data obtained. The melting curve of HsPCNA (figure 5.3B) showed an 
increase in ellipticity of the sample with an increase in temperature. The ellipticity of 
the HsPCNA sample started increasing at 321K. Once the sample was heated to 
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368K (95°C), the CD spectra was taken once again and this returned secondary 
structure values of 6.5% α-helix, 34.2% β-strand, 9.1% turns and 44.2% unordered 
showing a significant increase in the unordered portion, however maintaining a large 
portion of β-strand. The decrease in the ellipticity of the sample with increasing 
temperature is unexpected. A control experiment with L.mexicana Pyruvate kinase 
shows a more usual behaviour of a protein melting and the ellipticity at the melting 
temperature increasing to zero (figure 5.4). The further decrease in ellipticity 
obtained in HsPCNA may be related to the retention of β-strand structures. 
5.3.2 CD analysis of SpPCNA 
SELCON analysis of the CD measurement of SpPCNA (figure 5.5A) returned values 
of 5.4% α-helix, 42.5% β-strand, 24.9% turns and 25.4% unordered. The secondary 
structure content of S.cerevisiae PCNA (a close homologue of SpPCNA) determined 
by X-ray crystallography was 17% α-helix and 44% β-strand (Vijayakumar, S. et al 
2007), showing a reasonable correlation with the CD data obtained. The melting 
curve of SpPCNA (figure 5.5B) showed an increase in ellipticity of the sample with 
an increase in temperature. The ellipticity of SpPCNA started to shift at 322K, 
demonstrating a similar stability to HsPCNA. Once the sample was heated to 368K, 
the CD spectrum was taken once again and this returned secondary structure values 
of 2.7% α-helix, 37.5% β-strand, 18.1% turns and 39.7% unordered, again showing a 
significant increase in the unordered portion, however maintaining a large portion of 
β-strand. The decrease in the ellipticity of the sample with increasing temperature is 
in contradiction with expected trends (figure 5.4), but is however is in agreement 
with the retention of β-strand. The maintenance of β-strand is consistent with data 





Figure 5-3. The CD analysis of HsPCNA 
A) Top panel, the CD spectra of HsPCNA from 300 to 175nm wavelength. This 
panel shows increased noise in the signal at low wavelengths. Bottom panel, shows 
the laser voltage with a shift in wavelength. As the voltage increase above 600V, this 
is associated with high noise levels; data taken above this level is unreliable. B) Top 
panel, the CD in milli-degrees of HsPCNA at 222nm wavelength with increasing 
temperature, demonstrating an increase in ellipticity with increasing temperature. 
This shift occurs at 321K. Ellipticity of the sample decreased with higher 
temperatures due to the increased voltage demonstrated in the bottom panel. 
 
Figure 5-4. The CD melting curve analysis of Pyruvate Kinase (PYK) 
Top panel, the CD in milli-degrees of PYK at 222nm wavelength with increasing 
temperature. This demonstrates a significant decrease in ellipticity with increasing 
temperature approaching 0mdeg, the expected result of CD analysis of protein 
melting. A significant increase in voltage was required, associated to protein melting, 





Figure 5-5. The CD analysis of SpPCNA 
A) Top panel, the CD spectra of SpPCNA from 300 to 175nm wavelength. Bottom 
panel, shows that the laser voltage increase is responsible for increased noise at 
lower wavelengths. B) Top panel, the CD of SpPCNA at 222nm wavelength with 
increasing temperature, demonstrating an increase in ellipticity with increasing 
temperature at 322K.  
A)  
B)  
Figure 5-6. The CD analysis of LmPCNA 
A) Top panel, the CD spectra of LmPCNA from 300 to 175nm wavelength. Bottom 
panel, shows that the laser voltage increase is responsible for increased noise at 
lower wavelengths. B) Top panel, the CD of LmPCNA at 222nm wavelength with 
increasing temperature, demonstrating an increase in ellipticity with increasing 
temperature at 335K.  
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5.3.3 CD analysis of LmPCNA 
SELCON analysis of the CD measurement of LmPCNA (figure 5.6A) 
returned values of 5.8% α-helix, 37.4% β-strand, 21% turns and 34% unordered. The 
secondary structure content determined by X-ray crystallography was 16% α-helix 
and 33% β-strand (unpublished data), showing a reasonable correlation with the CD 
data obtained. The melting curve of LmPCNA (figure 5.6B) showed an increased 
ellipticity of the sample with an increase in temperature; the ellipticity of LmPCNA 
started to shift at 335K. This demonstrates a significant increase in protein stability 
from HsPCNA and SpPCNA. Once the sample was heated to 368K, the CD spectra 
was taken once again, and this returned secondary structure values of 6% α-helix, 
35.9% β-strand, 19.8% turns and 37.9% unordered. This showed a small increase in 
the level of unordered protein and maintains similar levels of secondary structure. 
LmPCNA did not show a large decrease in α-helix like that observed in HsPCNA 
and SpPCNA. This may be due to the small amounts determined to be present in the 
pre-heated sample. Like results obtained for HsPCNA and SpPCNA, there was the 
retention of β-strand structures in LmPCNA 
5.4 Conclusions from the CD analysis of PCNA 
The calculated secondary structure derived from the CD analyses shows 
reasonable agreement with known secondary structure content of PCNA as 
determined by X-ray analysis. In the cases of SpPCNA and LmPCNA, which contain 
lower α-helix content, the value of α-helix present is underestimated. This 
underestimation is a common error in CD analysis (Johnson, W. C. 1999).  
The melting curve analysis showed an unexpected trend of increasing 
ellipticity with increased temperature for all three proteins. This unexpected shift was 
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not a result of the experimental technique, as demonstrated in figure 5.4, but seems to 
be a genuine characteristic of PCNA. A similar increase in ellipticity with increasing 
temperature has been previously observed (Miller, P. et al 1976), and was 
determined to be an increase in amyloid-like aggregates in the sample (Sadqi, M. et 
al 2002; von Bergen, M. et al 2000). Heated PCNA samples were analysed by a full 
CD spectrum at 95°C in order to determine the effect of heat treatment upon the 
abnormal secondary structure. This demonstrated a significant drop in the quantity of 
α-helix and an increase in the unordered protein, the level of β-strand however 
remained similar to that of the native folded structure. The maintenance of the 
relative quantity of β-strand supports the theory that denatured PCNA forms 
amyloid-like aggregates. Samples were cooled in order to determine if PCNA could 
spontaneously re-fold to a native form: no shift was observed and the quantity of 














5.5 Introduction to DSF protein melting studies 
DSF is a rapid and cheap method of determining small molecules which bind 
and stabilise proteins. Fluorescence of a dye increases with an increase in the 
quantity of unfolded protein and this can be monitored as a function of temperature 
(Lo, M. C. et al 2004). The increased fluorescence is a result of hydrophobic residues 
becoming exposed as the protein melts (Niesen, F. H. et al 2007).  
A fitting procedure outlined in (Lo, M. C. et al 2004) can give the transition 
midpoint. The change in this midpoint when in the presence of a binding partner is 
related to the affinity of the interacting molecule. The stabilising ligand can be a low 
molecular weight small molecule, peptide or nucleic acid (Boeckler, F. M. et al 
2008). DSF can be commonly performed using equipment developed for Real-Time 
PCR (RT-PCR). This method of analysis allows results to be obtained in a single 
day. 
The equipment used in this method was originally designed for the 
monitoring of DNA or RNA production in Real Time PCR (RT-PCR) experiments 
(Wong, M. L. and Medrano, J. F. 2005). This system can rapidly and accurately 
increase the temperature of a 96 well plate with continual measurement of the 
fluorescence of the well. This ability allows this equipment to be used to monitor the 
denaturation of fluorescence based protein in melting curve assays (Niesen, F. H. et 
al 2007). 
5.5.1 Principles of protein melting studies by DSF 
Protein denaturation can be monitored by indirect methods using the shift of 
fluorescence of a dye. The dye used is SYPRO® Orange (Invitrogen), a dye with an 
excitation maximum at 473nm wavelength and emission maximum of 570nm 
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wavelength. This has also been successfully used with an excitation maximum of 
490nm and detection at 575nm (Ericsson, U. B. et al 2006). The structure of this dye 
is proprietary information, however, it is hydrophobic and in association with water, 
fluorescence is quenched. Once a protein is melted, then it is possible to observe an 
increase in the fluorescence of the dye (Ericsson, U. B. et al 2006), as the dye 
associates with the hydrophobic side groups released from the core of the protein 
(figure 5.7).  
Protein solutions require sufficient concentration of protein and dye to obtain 
a signal; this can be determined by trial and error. Some protein concentrations 
previously used have been of 1 µM (Lo, M. C. et al 2004) and 10 µM (Boeckler, F. 
M. et al 2008; Vedadi, M. et al 2006). Once optimum reagent conditions are 
achieved, then it is possible to monitor the unfolding of the protein as the well 
temperature increases. The iQ5-RT-PCR can raise the temperature of the wells by 
increments of 0.1°C, allowing accurate thermal shift data to be measured. In practice, 
this experiment will increase the temperature by increments of 0.5°C with a one 
minute lag time at each step to allow each well to stabilise to the increased 
temperature. After stabilisation, the samples fluorescence is measured. This method 
has been previously adopted to observe interactions with a range of melting 
temperatures e.g. 20°C - 90°C at 0.2°C increments (Ericsson, U. B. et al 2006) and 
25°C - 75°C at 1°C min-1 (Vedadi, M. et al 2006). 
This experiment can be used to determine the Kd of interaction of the melted 
protein with a binding partner from its shift in melting temperature. This shift can be 
used to approximate the Kd of interaction only at the melting temperature of the 
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Figure 5-7. The fluorescence of protein solution in DSF with temperature  
Top) the melting of a protein showing little association of dye to folded protein (LL) 
the association to unfolded protein (UL) and then a reduction due to self association 
of unfolded proteins from (Niesen, F. H. et al 2007)  
Bottom) The curve determined for HsPCNA (showing a curve as above). 
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temperature lacks biological relevance. However, if the enthalpy of interaction at 
298K can be approximated, then a value for Kd at 298K can be determined. This 
method has been used to determine affinities (Kd) for interactions of 140µM at 37°C 
(Boeckler, F. M. et al 2008), 70 nM to 46 µM at 25°C (Lo, M. C. et al 2004). 
5.5.2 Melting curve measurement obtained by DSF 
Data returned from the melting curve experiment is commonly plotted on a 
graph of temperature versus relative fluorescence units (RFU). This shows an 
increase in the RFU with temperature until all protein is unfolded (figure 5.7). This 
method refers to the melting temperature of the protein as the Tm50, temperature at 
which 50% of the protein within the solution has been unfolded. The values of the 
enthalpy of unfolding (∆Hu), specific heat capacity of unfolding (∆Cpu), Tm50, RFU 
after protein denaturation (F(post)) and RFU before denaturation (F(pre)) can be 
determined from the data curve. This is achieved by fitting to equation 5.1. 
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where T is the temperature at any point, F(T) is the RFU at T and R is the universal 
gas constant (Lo, M. C. et al 2004).  
5.5.3 Melting shift as a means to derive Kd 
In order to derive an approximate value of Kd of the protein ligand 
interaction, a further experiment is performed. A protein melting curve is created 
with excess ligand present to obtain a shift in the melting temperature. To derive the 
affinity of the protein-ligand complex, the protein-ligand complex Tm50 (TmL50), ∆Hu, 
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where Ka(TmL50) is the equilibrium association constant at (TmL50) and L(TmL50) is the 
free ligand concentration at TmL50, L(TmL50) can be assumed to be the ligand 
concentration only when ligand concentration is in excess, replicated from (Lo, M. 
C. et al 2004).  
The Ka returned from equation 5.2 can be modified to a value at 298K only with an 
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 where Ka
θ is the equilibrium association constant at the reference temperature, T0 is 
the reference temperature (298K), ∆Hθ is the enthalpy of interaction at the reference 
temperature and ∆Cp
θ is the specific heat capacity of interaction at the reference 
temperature.  
5.6 Materials and methods 
Fluorescence based thermal denaturation was studied using the iQ5 
Multicolor Real-Time PCR Detection System, iCycler (Bio-Rad) set to excite at 
485nm and read at 575nm. SYPRO® Orange was used as the fluorophore, excitation 
wavelength 473nm, emission wavelength 570nm. Data were recorded and viewed by 
the iQ5 optical system software version 2.0 and processed using Microsoft Excel and 
Kaleidagraph version 4.03. 
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5.6.1 Protocols of determining fluorescence based melting curves   
Initial melting curves were obtained with PCNA at concentrations of 0.04 to 
0.12mg ml-1 (1-4µM).  SYPRO® Orange (stored at 1000 fold concentration) is 
diluted to 0.5 fold concentration in the final reaction volume with buffer 10mM 
HEPES, 150mM NaCl, 1%DMSO (Fisher), pH7.4. The solution is made up to a final 
volume of 50µl with buffer. These experiments were used to determine the optimum 
protein concentrations and buffer conditions. 
Protein melting in the presence of peptide was carried out at a protein 
concentration of 0.2mg ml-1 (Hs 6.39µM, Sp 6.56µM, Lm 5.81µM) in 1%DMSO, 
SYPRO® Orange (at a 10 fold concentration), 10mM HEPES, 150mM NaCl, pH7.4. 
In reactions with peptide complex, peptide 0 was present at 50, 5, 0.5µM and 
Peptides 1-5 were present at 100, 50, 5µM. Reaction solutions were pipette-mixed 
and left to stand at room temperature for 2 minutes prior to use.  
The fluorescence of the reaction solution is monitored with increasing 
temperature from 25°C to 85°C. The thermal denaturation experiment was performed 
by equilibration to 25°C and then sample plate will “dwell” at this temperature for 30 
seconds prior to the fluorescence signal being measured. The temperature was 
subsequently increased by 0.5°C and once stabilised the plate would dwell for 30 
seconds and the fluorescence re-measured. This was repeated until the sample 
reached 85°C.  
5.7 Melting curves of PCNA observed using the iQ5-RTPCR 
Melting curves were generated for HsPCNA and SpPCNA. Preliminary 
results were used to determine optimal protein concentrations. HEPES buffer was 
found to give sufficient signal for analysis. LmPCNA was determined to have a Tm50 
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of 342K. The melting temperature of LmPCNA showed a consistent concentration 
dependency, i.e. 239K at 1µM and 342K at 5µM. As discussed in chapter 4, this may 
be representative of a change in the oligomeric state at this concentration. The 
melting temperature of LmPCNA is significantly higher than HsPCNA (~315K) and 
SpPCNA (~316K) (figure 5.8). As stated above, the affinity is determined at the 
protein melting temperature. For this reason, LmPCNA would require high peptide 
concentrations to obtain a shift in the melting temperature. Similarly, peptide 6 (a 
Phe150Ala point mutant) was not tested as the Kd of this interaction would result in 
too high concentration of peptide to be required.   
5.7.1 ∆Tm50 of HsPCNA and SpPCNA peptide complexes 
The associations of six different peptides – 
 Peptide0 –                                  KKRQTSMTDFYHSKRRLIFS 
Peptide1 –                                  KRRQTSMTDFYH 
 Peptide2 –                           Bio-KRRQTSMTDFYH 
 Peptide3 –                  Bio-PEG-KRRQTSMTDFYH 
 Peptide4 –         Bio-PEG-PEG-KRRQTSMTDFYH 
 Peptide5 – Bio-PEG-PEG-Ahx-KRRQTSMTDFYH 
with HsPCNA and SpPCNA were analysed for a change in their melting 
temperature. When HsPCNA and SpPCNA were melted, a smooth curve was 
observed demonstrating an increase in RFU with increasing temperature, as expected 
(figure 5.9). 
The presence of peptides resulted in an increase of melting temperature (figure 5.9). 
These curves were repeated four times with three different peptide concentrations to 
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Figure 5-8.  The melting curves of three uncomplexed PCNAs 
 
Figure showing the melting curves of PCNA from three different species, HsPCNA 
(red circles) SpPCNA (blue squares) and LmPCNA (green diamonds). Fitting these 
curves to equation 5.1 (fit not shown) gives the melting temperature of the 
uncomplexed protein. This figure demonstrates the similar melting temperatures of 
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Temperature (K)  
Figure 5-9.  The melting curve of PCNA, unbound and complexed 
A) Graph showing the RFU of HsPCNA solution with increasing temperature. 
Individual melting curves of HsPCNA alone (red) and peptide complexes all show a 
smooth increase in RFU with temperature. Plotted curves are accurately fit to the 
data points. Complex curves demonstrate a shift in the melting temperature with the 
HsPCNA-peptide0 complex demonstrating the greatest shift. 
B) Graph showing the RFU of SpPCNA solution with increasing temperature. This 
graph shows a similar trend to that of HsPCNA with peptides 2-5 having similar 




HsPCNA (314.5K to 322.5K, a change of 8K) (figure 5.10, table 5.1) and SpPCNA 
(315.7K to 326K, a change of 10.3K) (figure 5.10, table 5.2) when complexed with 
peptide 0. It is clearly demonstrated that the melting temperature of protein 
complexed with peptide 0 was the greatest (figure 5.10). HsPCNA had a ∆Tm50 of 
8°C when complexed with 50µM peptide 0 and 3°C when complexed with 100µM 
peptide 1 (figure 5.10, table 5.4). These changes in the ∆Tm50, of PCNA infer a 
stronger interaction for peptide 0 than peptide 1.  
Melting curves were repeated at each peptide concentration and the standard 
deviations (shown in figure 5.10) were formed from these replicates. The standard 
deviations allowed a T-test to be performed and data which was determined to not be 
statistically significant was not used further. These curves could be fit to equation 5.1 
to give the required values for Kd determination.  
5.7.2 Evaluation of the Kd between HsPCNA and SpPCNA for peptides 
The T-test allowed data which was determined to not be statistically 
significant to be excluded form the calculation of Kd. The Kd at the melting 
temperature of each experiment could then be determined for each significant test 
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For equation 5.2, the ∆H of unfolding, the ∆Cp of unfolding and the Tm50 are required 
as obtained from the data fit for uncomplexed protein. The TmL50 is obtained from the 
melting curve data fit for complexed protein. As the peptide was present in excess, 
















































































SpPCNA + Peptide (µM)
 
Figure 5-10.  The melting temperature of PCNA with a concentration series of 
peptides 
A) The melting temperatures of HsPCNA showing the Tm50 on the y-axis. HsPCNA 
alone is shown in red on the left and three concentrations of peptide, as explained by 
the figure legend. Error bars are generated using replicate runs. B) The melting 
temperature of SpPCNA showing the Tm50 on the y-axis. The order of peptide 
complexes is identical to that of HsPCNA, with error bars generated as above. 




















































































































































   
 Peptide 0    Peptide 1     Peptide 2        Peptide 3        Peptide 4         Peptide 5 
 
 149 
Peptide concentration within series Peptide 












































Table 5-1. The change in melting temperature of HsPCNA with peptides 
 
The peptide concentration series for peptide 0 is 50µM (high) 5µM (medium) and 
0.5µM (low) and peptide 1-5 is 100µM (high) 50µM (medium) and 5µM (low). The 
melting temperature of the protein is shown in Kelvin and the change in melting 
temperature from the uncomplexed protein is shown in brackets in Kelvin. Values in 
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Table 5-2. The change in melting temperature of SpPCNA with peptides 
 
The peptide concentration series for peptide 0 is 50µM (high) 5µM (medium) and 
0.5µM (low) and peptide 1-5 is 100µM (high) 50µM (medium) and 5µM (low). The 
melting temperature of the protein is shown in Kelvin and the change in melting 
temperature from the uncomplexed protein is shown in brackets in Kelvin. Values in 






Peptide 0 Peptide 1 Peptide 2 Peptide 3 Peptide 4 Peptide 5 
High 20.8 75.3 84.8 81.6 76.3 73.9 
Medium 3.89 38.9 57.7  45.6 42.6 
       





Peptide 0 Peptide 1 Peptide 2 Peptide 3 Peptide 4 Peptide 5 
High 0.136 17.5 17.4 16.2 12.1 11.8 
Medium 0.079 9.48 12.6  8.22 7.53 
       
Average 0.107 13.5 15.0 16.2 10.2 9.68 
 
Table 5-3. The Kd (M) of HsPCNA for peptides  
A) The determined Kd of affinity in µM of each peptide for HsPCNA at the TmL50 as 
determined by equation 5.2. Only affinities of statistically significant data are shown. 
The average is the value of each of the peptide concentrations returned 
B) The determined Kd of affinity in µM of each peptide for HsPCNA at 298K as 
determined by equation 5.3. Melting curves determined using lower peptide 
concentrations gave higher affinities, average binding affinities demonstrate peptide 





Peptide 0 Peptide 1 Peptide 2 Peptide 3 Peptide 4 Peptide 5 
High 2.33 15.0 27.0 34.8 34.3 32.8 
Medium 0.834 8.70 31.4 32.8  35.2 
Low 0.282 1.80     
       





Peptide 0 Peptide 1 Peptide 2 Peptide 3 Peptide 4 Peptide 5 
High 0.013 3.12 3.62 4.75 3.91 4.30 
Medium 0.013 1.88 5.44 5.45  5.85 
Low 0.009 0.462     
       
Average 0.012 1.82 4.53 5.10 3.91 5.08 
 
Table 5-4. The Kd (M) of SpPCNA for peptides  
A) The determined Kd of affinity in µM of each peptide for SpPCNA at the TmL50 as 
determined by equation 5.2. Only affinities of statistically significant data are shown. 
The average is the value of each of the peptide concentrations returned 
B) The determined Kd of affinity in µM of each peptide for SpPCNA at 298K as 
determined by equation 5.3. Melting curves determined using lower peptide 
concentrations gave higher affinities, average binding affinities demonstrate a 
binding affinity of peptide 0>>peptide 1>peptides 2-5.  
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peptide (L(TmL50)) at Tm50.  
The determined value for Ka at the melting temperature can be used with 
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The Ka(TmL50) is the equilibrium affinity constant between HsPCNA and peptide 1 at 
the melting temperature. The values are shown for the HsPCNA peptide 1 interaction 
where ∆Hθ is the enthalpy of interaction at 298K. This is assumed to be that 
determined in chapter 8. R is the universal gas constant (8.314472 J K-1 mol-1), T0 is 
the reference temperature (298K) and TmL50 is the melting temperature of HsPCNA 
peptide 1 complex (318K). The value for the ∆Cp
θ is the specific heat capacity of 
HsPCNA peptide interaction (~ -1000 J K-1 mol-1), approximated from the non-linear 
van’t Hoff analysis in chapter 8. The value used for ∆Cp
θ has been previously argued 
to only give a slight effect to the determined Ka of interaction (Lo, M. C. et al 2004). 
Equation 5.3 was used to derive the Kd at 298K represented in tables 5.3B and 5.4B.  
 The final values determined for the Kd of interaction showed similar affinities 
for both HsPCNA and SpPCNA. The Kd of interaction at 298K between HsPCNA 
and the six peptides has been shown to have a range of 107nM to 16.3µM (table 
5.3B). The Kd of interaction at 298K between SpPCNA and the six peptides has been 
shown to have a range of 11.7nM to 5.10µM (table 5.4B). Peptide 0 demonstrated a 
high affinity of interaction for HsPCNA (107nM) and SpPCNA (11.7nM) (table 5.3B 
and table 5.4B). Peptide 0 has a lower Kd of interaction than peptides 1-5 for 
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HsPCNA (9.68µM to 16.3µM) and SpPCNA (1.82µM to 5.10µM). Of the 
interactions of peptides 1-5, peptide 1 had the lowest Kd. 
5.8 Conclusions from the melting curve analysis 
5.8.1 Agreement between melting curves derived from CD and fluorescenc 
The melting curves derived from CD analysis showed melting temperatures 
of 321K, 322K and 335K for HsPCNA, SpPCNA and LmPCNA respectively. The 
melting temperature derived from fluorescence based analysis gave melting 
temperatures of 315K, 316K and 342K for HsPCNA, SpPCNA and LmPCNA 
respectively. The differences between the two measurement techniques e.g. different 
buffers (10mM NaH2PO4, 10mM NaF pH7.4 for CD and 10mM HEPES, 150mM 
NaCl and 1% DMSO pH 7.4 for DSF), the presence of dye and the change in protein 
concentration (1.25 – 2.04 mg ml-1 for CD and 0.2 mg ml-1 for DSF) may be 
responsible for the slight shift in melting temperature. The trends in melting 
temperature are consistent, with HsPCNA and SpPCNA having similar melting 
temperatures and LmPCNA being significantly more stable. This increase in the 
stability of the LmPCNA could be an evolutionary trait as L. major exists in insect 
vectors in tropical areas.  
5.8.2 Peptide binding affinities derived from DSF studies 
Data returned from the DSF experiments had statistical significance verified 
from the shift in melting temperature (figure 5.10). The affinities determined by this 
method were achieved with protein present in HEPES buffer (10mM HEPES, 
150mM NaCl, 1%DMSO, pH7.4). The HEPES buffer is similar to that used for ITC 
(chapter 7) and SPR (chapter 8) experiments and should reduce errors caused by 
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differences in buffer effects. The use of the ∆Hθ value from SPR experiments 
(chapter 8) in equation 5.3 will result in a slight bias toward the values determined 
from section 8. This however will only have a slight effect. The values for ∆Cp
θ used 
in this method were determined in SPR experiments (chapter 7) for peptides 1-5 to 
be in the range of -600 to -1300 J K-1 mol-1. This value was approximated to -1000 J 
K-1 mol-1 and this will not result in any significant modification in the final result as 
explained in (Lo, M. C. et al 2004).  
The affinity for HsPCNA with peptide 0 has been previously determined by 
ITC at 298K as having a Kd of 87.7nM (Zheleva, D. I. et al 2000), this is in close 
agreement to the results obtained here as an average of 107nM (table 5.3 and table 
5.4). The close agreement in value for peptide 0 supports the validity of all the 
affinities determined using this method. 
The values determined in this chapter will be compared with those 












CHAPTER 6. The study of PCNA peptide interaction by ITC 
Isothermal Titration Calorimetry (ITC) can determine the thermodynamic 
properties of protein-ligand binding interactions. ITC can determine the association 
equilibrium constant of an interaction at different temperatures; with this data it is 
possible to ascertain the Gibbs free energy of binding using equation 6.1 
(Okhrimenko, O. and Jelesarov, M. 2008). 
6.1) θ ln aG RT K∆ = −  
where ∆G is the change in Gibbs free energy and the Ka association equilibrium 
constant of the interaction. The interactions determined by ITC use the enthalpy of 
the interaction, with accurately known concentrations of reactants (Jelesarov, I. and 
Bosshard, H. R. 1999). The enthalpy of interaction is a relationship of the bonds 
(intra and inter-molecular) formed to bonds broken. Should the energy required to 
break the number of bonds in the system (desolvation and protein rearrangements) be 
greater than the energy released by bond formation, then the interaction would be 
endothermic (Privalov, Peter L. and Potekhin, Sergey A. 1986). The result of an 
endothermic interaction is to make this an enthalpically unfavourable binding event. 
Strength of binding interactions are also mediated by entropy, this is a reference to 
the level of disorder within the system. The greater the disorder, the more favourable 
the interaction; this is related to the Gibbs free energy and enthalpy shown in 
equation 6.2 (Okhrimenko, O. and Jelesarov, M. 2008). 
6.2) θ θ θG H T S∆ = ∆ − ∆  




The interactions of PCNA with peptides have been documented. Many of 
these interactions have been shown between HsPCNA and the PCNA interacting 
peptide (PIP) box (Warbrick, E. 2000). The interactions of peptides to PCNA have 
been previously shown to be enthalpically favourable and entropically unfavourable 
(Bruning, J. B. and Shamoo, Y. 2004). 
6.1 PCNA interactions previously quantified by ITC 
Previous examples of PCNA-peptide binding studies have been performed by 
ITC. These have shown interactions between peptides and PCNAs of different 
origins, eukaryotic and prokaryotic. The interactions between HsPCNA and peptides 
are mediated by the PIP box, a common sequence in HsPCNA interacting proteins 
(Warbrick, E. 2000). Binding interactions of HsPCNA with p21 (141-160) have 
previously demonstrated a stoichiometry of 1 and a Kd of 87.7nM (Zheleva, D. I. et 
al 2000). These values are in agreement with a more comprehensive analysis 
covering other protein interactors. It has been shown that p21 (139-160), p66 (451-
466) (451-472) and FEN1 (332-353) have Kds of 82.6nM, 15.6µM, 1.54µM and 
59.9µM respectively. These interactions were all shown to have stoichiometries of 1 
and were enthalpically favourable and entropically unfavourable (Bruning, J. B. and 
Shamoo, Y. 2004). HsPCNA has also been shown to bind with DNA polymerase η 
with a Kd of 81µM (Bomar, M. G. et al 2007). Due to the level of conservation of 
PCNA, homologues can also demonstrate similar binding affinities to these peptides. 
E.coli PCNA showed similar thermodynamic values for peptide interactions to that 
of HsPCNA (Georgescu, R. E. et al 2008). This recent work also determined a small 
molecule inhibitor for PCNA (DNA polymerase subunit β) and demonstrates a 
potential site for inhibition. 
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6.2 The principles of ITC experiments 
ITC is a method of very accurately measuring biophysical interactions. ITC 
measures energy released or absorbed as heat upon binding. It is the method of 
choice for the measurement of protein ligand binding events (Okhrimenko, O. and 
Jelesarov, M. 2008). Ligand is contained within a syringe and injected into a solution 
of binding partner and the energetic exchange is measured as a function of 
temperature (MicroCal, LLC 2002). With the subsequent injection of more ligand, 
there is a reduced level of energetic exchange. As the ligand concentration 
approaches saturation, the energetic exchange approaches that of the dilution effect 
of the ligand. This shift allows the determination of stoichiometry, dissociation 
equilibrium constant (Kd), enthalpy of interaction (∆H) and the entropy of interaction 
(∆S) (Jelesarov, I. and Bosshard, H. R. 1999). 
6.2.1 Determination of thermodynamic parameters from raw ITC data 
Thermodynamic parameters of stoichiometry, Ka and ∆H can be determined 
from an ITC experiment. Resolving these values requires raw data to have a baseline 
determined, integrated and fitted to a curve. This is done reliably using the Origin 
software, however, an understanding of the principles of the experiment and method 
of determining these values is ideal (Jelesarov, I. and Bosshard, H. R. 1999). 
Precise volumes of ligand are added at specific, regular time points whilst 
stirred by the injection syringe (figure 6.1). Upon each injection of ligand into 
binding partner, heat energy is either released or absorbed relative to the reference 
cell. This thermal energy is directly related to the enthalpy of the interaction 






Figure 6-1. Schematic representation of ITC equipment and sample positions 
from “VP-ITC MicroCalorimeter users manual” 
 
Schematic diagram showing the reaction cell, reference cell and injection syringe of 
the VP-ITC MicroCalorimeter, MicroCal LLC. The thermal jacket surrounding the 
cells is accurately temperature controlled and the required energy difference between 
the reference and reaction cells are recorded. The thermal jacket is capable of 
maintaining temperatures of 275-353K. The injection syringe is used for the injection 
and stirring of the reaction cell. This syringe holds 780µl of ligand and can inject at a 
minimum of 1.5µl, however this volume can be inaccurate so it is more common for 
10µl injections. The injection syringe maximum stirring speed is 580rpm, but at this 
speed, the potential for applying mechanical stress upon the protein in solution can 






to maintain a constant temperature; this required power is measured in µcal s-1. The 
peaks are recorded as a differential power signal, showing power (µcal s-1) against 
experimental time (minutes) (Freire, E. et al 1990; Okhrimenko, O. and Jelesarov, 
M. 2008). An ITC experiment can span hours and, with fluctuations in ambient 
temperature, there is a constant drift in required power to maintain jacket 
temperature. When the final ITC differential power signal is generated, a baseline 
signal is created comprised of data points prior to each injection. This potentially 
curved baseline is determined to be the level of no differential energy and is plotted 
to 0µcal s-1 (figure 6.2A).  
A single peak from the differential power signal shows the heat change upon 
addition of a known volume of known concentration ligand to the reaction cell. The 
total energy exchange in this peak is the sum of contributions from the energy of 
dilution, energy of non-specific binding and the energy of association. This energy is 
represented by the area of the peak and can be integrated to give a total energy per 
ligand concentration (Jelesarov, I. and Bosshard, H. R. 1999). As ligand 
concentration increases, all available binding partners in the reaction cell become 
occupied. This results in reduced level of energy change in subsequent injections. 
Once all binding partners are occupied, the measured energy change is a dilution 
effect of concentrated ligand into the reaction cell. The energy of dilution can be 
accounted for by performing a second control experiment with ligand injected into a 
buffer sample. The integrated energy of dilution can then be deducted from the 
integrated energy of binding data to determine the energy due to interaction 
(equation 6.3) (Jelesarov, I. and Bosshard, H. R. 1999).  




Figure 6-2. Isotherms of 
SpPCNA binding to peptide0 
 
Figures showing isotherms of 
SpPCNA binding to peptide0. 
(A) Raw ITC data (black) 
demonstrating an exothermic 
interaction upon injection of 
ligand coupled with an 
endothermic dilution effect. 
This isotherm also demonstrates 
a baseline drift (red) over the 
course of the experiment.  
(B) (top) change in applied 
energy from previously 
determined baseline of the 
peptide PCNA interaction 
(black) and peptide buffer 
energetics (green). (bottom) 
integrated binding energy of 
each injection with dilution 







 where ∆Eass is the energy of association, ∆Etot is the total change in energy, ∆Edil is 
the energy of dilution and ∆Ens is the energy related to non-specific interactions. The 
integrated data is fit to a non-linear least squares fit  (figure 6.2B) (Siligardi, G. et al 
2004). Assuming a single uniform set of protein binding sites, the energy of injection 
can be related to thermodynamic parameters using equation 6.4 (Jelesarov, I. and 
Bosshard, H. R. 1999). 
6.4) [ ] . .
ass tot cell tot
E N M V H∆ = ∆ × ¡  
where N is the stochiometery, [M]tot is the total concentration of binding partner in 
the reaction cell, Vcell is the volume of the reaction cell, ∆Htot is the total enthalpy of 
the interaction and ¡  is the root of the quadratic equation. The root of the quadratic 
equation is as equation 6.5 (Jelesarov, I. and Bosshard, H. R. 1999). 
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where [L]bound is the concentration of ligand associated to binding partner, [L]tot is the 
total concentration of ligand in the reaction cell after injection and Ka is the 
equilibrium association constant of the ligand-binding partner interaction. 
Integrated ITC heat data with dilution energies subtracted can therefore be 
accurately fitted to give values of N, ∆H and Ka using equations 6.2 and 6.3. Using 
standard equations the values of Ka and ∆H can also yield the entropy (∆S) of 
interaction. Finally, change in specific heat capacity (∆Cp) due to the interaction can 
be determined as the change in enthalpy of interaction divided by the change in 
temperature. So, should ITC experiments be carried out on a temperature series, a 
∆Cp of the solution due to the interaction can be solved.  
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6.2.2 Sources of experimental error in ITC methodologies 
In previously published data, there have been limitations on the ITC method. 
These limitations have been observed in interactions with little change in enthalpy 
(Knipscheer, P. et al 2007), weak interactions (Li, H. et al 2008; Rainaldi, M. et al 
2007; Siligardi, G. et al 2004), dilution effects (Huang, Shir Ly et al 2005) and due 
to poorly determined concentrations (Rainaldi, M. et al 2007).  
The heat produced or absorbed in an ITC experiment is directly related to the 
enthalpy of an interaction by equation 6.2. In examples of binding interactions that 
present a small ∆H, it is difficult for the integrated data to be fit, as system noise 
would present a proportionally larger effect. Previous experiments with protein-
peptide interactions have shown useable data for one peptide and poor data for a 
second due to low ∆H (Knipscheer, P. et al 2007). In this example, this was a result 
of short peptide sequence resulting in reduced favourable contacts and reduced ∆H. 
Other examples have demonstrated maintenance of peptide length, however changes 
in sequence which resulted in no significant alteration in ∆G. These alterations in 
sequence resulted in significant changes in ∆H (Lim, N. S. et al 2006). This is 
termed an enthalpy-entropy compensation effect (Rainaldi, M. et al 2007; Yamniuk, 
A. P. and Vogel, H. J. 2004) and presents little alterations in Ka. However, should 
∆H become small, (Lim, N. S. et al 2006) then no measurement can be made by ITC. 
6.2.3 The error associated to fitting weak binding interactions  
Weak binding interactions result in poor curve fitting to integrated data. The 
amount of curvature between two baselines, initial injections and injections 
demonstrating only dilution effects, is a result of the Ka, and the weaker this 




 Figure 6-3. Representations of strong and weak ITC data 
 
Interactions of Hsp90 with (A) Sti1, (B) Sba1 showing a strong interaction between 
Hsp90 and Sti1 due to the presence of baseline at both the high and low molar ratios. 
There is a weaker interaction between Hsp90 and Sba1 which does not present a 






concentration is required in the reaction cell to drive the reaction to completeness. 
This can be problematic should ligand concentration be limited due to solubility or 
availability. Protein-peptide interactions have previously been weakened beyond the 
ability of ITC to determine an accurate Ka with reduction in peptide size (Li, H. et al 
2008). Protein peptide interactions have also been shown to weaken with differences 
in ionic strength whilst remaining stable with increased temperature (Rainaldi, M. et 
al 2007). Protein-protein interactions have also been shown to be affected by point 
mutations, where there is no appreciable difference in structure, which resulted in 
binding interactions of such weak Ka that the data was unusable (Siligardi, G. et al 
2004).  
6.2.4 The error in ITC experiments associated to dilution effects 
Dilution effects of high ligand concentration being injected into the reaction 
cell can pose a significant alteration upon the energetics of interaction, as shown in 
equation 6.3. The effects of dilution energy can change the determined energy of 
association. Dilution energies are accumulated by slight differences in temperature, 
ionic strength, detergents and mechanical stress (Huang, Shir Ly et al 2005). These 
differences can result in large dilution energies, however, they are simple to take into 
account by performing ligand-buffer controls. It has been shown that dilution 
enthalpies are increased with high temperatures and ionic strength (Huang, Shir Ly et 





6.2.5 The error related to the sample concentrations 
Should one or both the reactants, ligand or binding partner, have unknown or 
imprecise concentrations, then data returned can be highly unreliable (Jelesarov, I. 
and Bosshard, H. R. 1999). The dependence this method has upon accurate 
concentrations is shown in equation 6.5. Concentrations when using dissolved 
peptides can be difficult to determine. There are three main methods of determination 
of peptide concentration, 1) measuring the mass of lyophilised peptide dissolved, 2) 
measuring the A280 of dissolved peptide solution and 3) quantitative amino acid 
analysis. The first method is simple and common (Rainaldi, M. et al 2007) however 
can be inaccurate due to bound waters in the solid mass or salts. The amount of 
bound water can vary depending upon peptide sequence from 5-40%; this difference 
in mass can vastly change the peptide concentration. The second method of 
determining peptide concentration, measuring the A280, is more accurate provided the 
peptide contains tyrosine or tryptophan. However, if the peptide is long and 
hydrophobic, it may show propensity to fold. Finally, quantitative amino acid 
analysis is not available within many laboratories and can also be expensive, 
requiring peptide that can not be recovered. 
6.2.6 Weak data as a result of low enthalpy of interaction 
ITC isotherms require a significant enthalpic shift with micro-molar affinity 
during binding in order to result in a useable isotherm. Should this isotherm not show 
strong curvature, then it can be difficult to determine thermodynamic properties. In 
some examples, point mutants have reduced the binding affinity too much to 
determine any binding properties using ITC (Knipscheer, P. et al 2007; Li, H. et al 
2008). Protein binding partners can present two binding sites with different affinities. 
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In these examples, the isotherms have contributions from both binding sites which 
can result in poorer determination of each site (Rainaldi, M. et al 2007). Examples 
demonstrating biphasic interactions can also show these poor determinations of 
thermodynamic properties with increasing temperature. Increasing temperature 
should present a fairly uniform effect on enthalpy, however, some published data 
have values which fluctuate high and low with subsequent increases in temperature 
(Rainaldi, M. et al 2007). These fluctuations imply that the results may not be 
completely accurate. Some examples with protein-peptide interactions have 
compared similar peptides and shown significant shifts in thermodynamic values 
with little shift in affinity (Lim, N. S. et al 2006). Many of these peptides, of the 
same length, have very low shifts in enthalpy upon binding. These interactions show 
similar Gibbs free energy and significant fluctuations in entropy, to the extent that 
immobilisation of peptides is entropically favourable. It is highly unlikely that the 
immobilisation of a large flexible peptide will be an entropically favourable event. 
When enthalpic return of the interaction raised to greater levels, the entropy of the 
interaction became unfavourable as would be expected (Lim, N. S. et al 2006). 
6.2.7 Thermodynamic parameters of protein interactions determined by 
ITC 
A wealth of information regarding protein interactions has been determined 
by ITC. This information follows general thermodynamic trends, dependent upon the 
interaction in question, protein-protein (Knipscheer, P. et al 2007; Nishimiya, Y. et 
al 2000; Shiroishi, M. et al 2001; Yokota, A. et al 2003; Zhou, Y. L. et al 2005), 
protein-peptide (Brokx, R. D. et al 2001; Jin, R. S. et al 2006; Rainaldi, M. et al 
2007; Yamniuk, A. P. and Vogel, H. J. 2004) or protein-small molecule (Burnett, J. 
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C. et al 2007; Engel, M. et al 2006; Gulbis, J. M. et al 1996; Yang, F. et al 2007). In 
some cases, there are deviations from the standard (Brokx, R. D. et al 2001; Jin, R. S. 
et al 2006) interactions and appear to get stronger with increased temperature 
(Rainaldi, M. et al 2007; Yamniuk, A. P. and Vogel, H. J. 2004; Zhou, Y. L. et al 
2005). In some cases, weaknesses have also been observed in ITC data which 
resulted in fluctuations in thermodynamic properties returned (Knipscheer, P. et al 
2007; Lim, N. S. et al 2006; Rainaldi, M. et al 2007).  
Protein-protein interactions which demonstrate a negative Gibbs free energy 
have commonly shown to be enthalpically favourable and entropically unfavourable 
(Knipscheer, P. et al 2007; Nishimiya, Y. et al 2000; Shiroishi, M. et al 2001; 
Yokota, A. et al 2003; Zhou, Y. L. et al 2005). Protein-peptide interactions will 
generally show the same trends in enthalpic return and entropic cost (Rainaldi, M. et 
al 2007; Yamniuk, A. P. and Vogel, H. J. 2004). Protein-small molecule interactions 
however, present a small enthalpic return and also be entropically favourable 
(Burnett, J. C. et al 2007; Engel, M. et al 2006; Yang, F. et al 2007). These general 
trends are common, however, this is not always the case. Protein-peptide interactions 
can show fluctuations in thermodynamic properties. Peptide length and 
hydrophobicity can result in thermodynamic parameters deviating from the common 
(Brokx, R. D. et al 2001; Jin, R. S. et al 2006).  
6.2.8 Enthalpy Entropy compensation effects 
Published ITC interactions have demonstrated an increase in Ka with an 
increase in temperature, an effect which seems counter-intuitive. This is reported to 
be due to an enthalpy entropy compensation effect. The interaction shows an increase 
in enthalpy with increasing temperature, which would result in a weaker interaction. 
 
 167 
There is however a greater increase in the T∆S of the interaction; these two factors 
combined result in a slight increase in affinity (Rainaldi, M. et al 2007; Yamniuk, A. 
P. and Vogel, H. J. 2004; Zhou, Y. L. et al 2005). 
6.2.9 Use of ITC to determine changes in specific heat capacity of solutions 
ITC can reveal the change in specific heat capacity (∆Cp) of a solution upon 
protein binding interactions (Jelesarov, I. and Bosshard, H. R. 1999; Liang, Y. 2008). 
This is possible due to fluctuations of ∆H with temperature, as a direct result of the 
∆Cp of an interaction (Zhou, Y. L. et al 2005). Changes in the quantity of 
immobilised waters, the level of solvation, are responsible for the ∆Cp of an 
interaction. The quantity of immobilised waters is a relationship with the number of 
exposed hydrophobic and hydrophilic residues, so the levels of these residues have a 
relationship with ∆Cp (Liang, Y. et al 2001; Loladze, V. V. et al 2001; Rainaldi, M. 
et al 2007; Spolar, R. S. and Record, M. T. 1994; Yokota, A. et al 2003). Protein-
protein interactions have demonstrated a general -∆Cp of interaction, suggesting that 
interactions are driven by the burial of hydrophobic residues (Brokx, R. D. et al 
2001; Jin, R. S. et al 2006; Nishimiya, Y. et al 2000; Yamniuk, A. P. and Vogel, H. 
J. 2004).  
The value of ∆Cp for a protein interaction can be determined by ITC by 
obtaining a value of ∆H at different temperatures. The enthalpy is plotted against the 
temperature and the gradient of this plot is the ∆Cp of the interaction (∆H/∆T). In 
solution, proteins have waters bound to their surfaces, a solvation shell. The quantity 
of immobilised waters is related to the ∆Cp of the solution. During a binding event, 
the total quantity of bound waters could change as peptide side groups become 
solvent accessible, this is the ∆Cp of an interaction. The quantity of bound waters are 
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related to the number of solvent exposed hydrophobic and hydrophilic residues, these 
can be used to approximate ∆Cp. Values for ∆Cp have been determined for full 
protein folding (Liang, Y. et al 2001) which presented a ∆Cp of  -156 kJ mol
-1 K-1. 
This large negative value is a result of a large number of hydrophobic residues 
becoming buried in the centre of a protein structure. Conversely, a large +∆Cp of 
protein unfolding has also been determined using differential scanning calorimetry 
(DSC) (Loladze, V. V. et al 2001). Ubiquitin has been analysed with point 
mutations, some of which increased the number of buried hydrophilics, others which 
increased the number of buried hydrophobics. If hydrophilic residues were buried in 
the centre of the protein, there was a decrease in the ∆Cp of unfolding. If 
hydrophobic residues were buried there was an increase in the ∆Cp of unfolding 
(Loladze, V. V. et al 2001). ∆Cp has been previously determined using structural 
information of binding related to the change in exposed hydrophobics and 
hydrophilics (Spolar, R. S. and Record, M. T. 1994). In other examples, this 
calculation has been shown to be grossly inaccurate, and it is argued that this 
inaccuracy is a result of waters immobilised in the binding interface (Yokota, A. et al 
2003).  
Many protein-protein interactions have been determined, the bulk of which 
have shown to have a negative ∆Cp (Brokx, R. D. et al 2001; Jin, R. S. et al 2006; 
Rainaldi, M. et al 2007; Yokota, A. et al 2003). These interactions demonstrate a 
burial of hydrophobic residues at the binding interface. There are protein interactions 
demonstrating a positive ∆Cp where there are significant numbers of charged 
residues in the binding interface (Nishimiya, Y. et al 2000). Many reasonable values 
for ∆Cp, have been determined using ITC for protein interactions, and commonly 
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these values can be rationalised by the solved complex structures, as are shown in 
(Morton, C. J. and Ladbury, J. E. 1996; Nishimiya, Y. et al 2000; Sleigh, S. H. et al 
1999; Yokota, A. et al 2003). 
6.2.10 Role of bound waters in protein thermodynamic interactions 
Waters within a protein binding site can affect different aspects of the 
interaction. A protein binding site can facilitate binding to peptides with different 
side groups from the ideal as a result of waters compensating for the mutation. The 
immobilisation of waters can result in alterations in the enthalpic, entropic and 
specific heat capacity shifts of interactions (Morton, C. J. and Ladbury, J. E. 1996; 
Nishimiya, Y. et al 2000; Shiroishi, M. et al 2001; Sleigh, S. H. et al 1999; Yokota, 
A. et al 2003).  
Mutations can present decreased binding affinity in protein-peptide 
interactions. Interactions which should be reduced to only very slight affinities can 
still demonstrate binding. These persisting interactions are due to the recovery of 
peptide binding by water. When bound to mutant peptide, water can occupy now 
redundant atom sites and bridge interactions between protein and peptide. Water 
bridges result in binding recovery and can present only slight reductions in affinity 
even with significant alterations in residues e.g. Gln→His (Sleigh, S. H. et al 1999). 
It is documented in published data that waters can be common in many protein-
protein interactions, and be pivotal for tight binding affinity (Yokota, A. et al 2003). 
In antibody-antigen complexes, waters are commonly immobilised at the binding 
interface. When point mutations are introduced to the antibody, significant 
reductions in affinity were not observed and it is argued that this was due to the shift 
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in water position, presenting a compensation for the mutation (Yokota, A. et al 
2003). 
6.2.11 Changes in the thermodynamic values of interaction as a result of 
bound water 
In some interactions which use water in the binding interface, the effect of 
this water has been demonstrated by point mutations to hydrophobic residues. Trans-
water interactions are shown to be enthalpically favourable, however do present an 
entropic cost due to the immobilisation of another molecule (Nishimiya, Y. et al 
2000; Yokota, A. et al 2003). In a similar example, a close homologue in which this 
water is not shown, has been tested. This experiment mutated tyrosine to 
hydrophobics, and resulted in an increased enthalpic return with increased entropic 
cost (Nishimiya, Y. et al 2000). These examples presented data that immobilisation 
of waters in protein binding interactions may return an enthalpic yield but are 
however entropically expensive.  
∆Cp is directly related to the freedom of waters in a system (Liang, Y. 2008; 
Loladze, V. V. et al 2001; Morton, C. J. and Ladbury, J. E. 1996). This freedom is a 
result of solvent exposed hydrophobics, and has previously been calculated from 
crystal structures alone (Spolar, R. S. and Record, M. T. 1994). This theoretical 
derivation of ∆Cp has been shown to be inaccurate in systems when determined 
experimentally by ITC. It is argued that this is a result of water molecules being 
immobilised on the binding interface and result in a decrease of ∆Cp (Brokx, R. D. et 




6.3 Auto-ITC materials and methods 
ITC experiments were carried out on the Auto-ITC HT Microcalorimeter 
(MicroCal) and data was de-convoluted using the Origin7 (SR4) v7.0552 and the 
returned values were graphed using the program KaleidaGraph v4.03. The reference 
cell was given two hours to equilibrate thoroughly with sample prior to the start of 
the experiment. Samples were stored for runs in 96well 2ml round bottom plates 
(Greiner) at 15°C. Protein concentration was determined by A280, and peptide 
concentrations were determined by the dissolved mass and from ±5% A280, assuming 
peptide extinction coefficient (ε=1490M-1cm-1) generated using ProtPram (Gasteiger, 
E. et al 2003). Controls were performed with peptide only to give dilution energy. 
The energy required for dilution was deducted as a constant from sample curves. 
1mg of lyophilised peptide was dissolved in 50µl of DMSO, 10µl of peptide solution 
was diluted in HEPES biochemistry buffer (10mM HEPES, 150mM NaCl, pH7.4) to 
obtain a 1% DMSO final concentration. Higher peptide concentrations required the 
increase to 2% DMSO solutions. 
6.3.1 PCNA peptide interaction quantification by ITC 
The associations of the six different peptides – 
 Peptide0 –                                  KKRQTSMTDFYHSKRRLIFS 
Peptide1 –                                  KRRQTSMTDFYH 
 Peptide2 –                           Bio-KRRQTSMTDFYH 
 Peptide3 –                  Bio-PEG-KRRQTSMTDFYH 
 Peptide4 –         Bio-PEG-PEG-KRRQTSMTDFYH 




with Hs, Sp and LmPCNAs were analysed by ITC to determine the Kd of interaction 
free in solution. This was performed at two temperatures, 283 and 298K, in order to 
determine consistency for BIAcore data (section8). These experiments were 
performed by injecting peptide as ligand into PCNA solution contained within the 
reaction cell, (see section 7.5). These binding affinities could present insight into the 
effect of spacers and differences between the PCNA homologues. 
6.3.2 PCNA peptide concentration determination 
Evaluation of the ITC data was performed using the accurate concentrations 
of protein, determined by A280, and peptide, determined by mass of dissolved 
peptide. This resulted in stoichiometry and entropy which appeared to be incorrect. 
The stoichiometry of this protein to the peptide is known from ITC and crystal 
structures to be 1:1 (Bowman, G. D. et al 2004; Bruning, J. B. and Shamoo, Y. 2004) 
(1AXC,1SXJ) and the entropy is most likely to be negative, demonstrating a 
decrease in the level of disorder in the solution. When the peptide concentration is 
determined by A280 stoichiometry and entropy appear to approach expected values 
(Tables 1.5, appendix). The concentration determined by A280 was always lower than 
that determined by dissolved mass of the peptide. This could be due to salts in the 
lyophilised peptide, or water coordinated around the hydrophilic portions of the 
peptide. The peptide concentration as determined by the A280 is most likely to be 




6.3.3 ITC study of HsPCNA 
Both reference cell and sample cells contained identical solutions of 5µM 
HsPCNA. HsPCNA and peptide solutions were buffered in ITC buffer (10mM 
HEPES, 150mM NaCl, 1%DMSO, pH7.4). 30 times 8µl injections of peptides0-1 
were injected into the sample cell at 600 second increments. 17 times 17µl injections 
of peptides2-5 were injected into the sample cell at 400 second increments. Average 
peptide concentrations were: peptide 0 29.4µM; peptide 1 71.0µM; peptide 2 
64.0µM; peptide 3 59.7µM; peptide 4 51.1µM; peptide 5 54.4µM. 
6.3.4 ITC study of SpPCNA 
SpPCNA in ITC buffer was used in both reaction and reference cell at 5µM 
concentration. 20 times 12µl injections of peptide 0 were injected into the sample 
cell at 400 second increments. 17 times 17 µl injections of peptide 1 were injected 
into the sample cell at 400 second increments. 15 times 18µl injections of peptides 2-
5 were injected into the sample cell at 400 second increments. Average peptide 
concentrations were: peptide 0 27.7µM; peptide 1 78.8µM; peptide 2 72.4µM; 
peptide 3 56.7µM; peptide 4 47.9µM; peptide 5 59.1µM. 
6.3.5 ITC study of LmPCNA 
LmPCNA in 2% DMSO ITC buffer (10mM HEPES, 150mM NaCl, 2% 
DMSO, pH7.4) was used in both reaction and reference cells. 15 times 18µl 
injections of each peptide were injected into the sample cell at 400 second 
increments. Average peptide concentrations were: peptide 0 29.4µM; peptide 1 
156µM; peptide 2 169µM. 
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6.4 Results of PCNA peptide binding affinities determined by ITC 
6.4.1 Results of HsPCNA-Peptide interactions determined by ITC 
The interaction of HsPCNA with different peptides as measured by ITC is 
shown in figure 6.4 with Kd of interaction presented in figure 6.5. The interactions 
were performed at 283K and 298K (figure 6.5) however only those at 283K are 
presented in figure 6.4.  
The data shown in figure 6.4 demonstrates good signal levels (-20 kJ mol(injectant)
-1 for 
peptide 0). The isotherms for peptides (1-5) gave little curvature with increasing 
molar ratio which can reduce the accuracy of the determined values. The lack of 
curvature is a result of the low peptide concentrations used in order to maintain 
DMSO concentrations of 1% (v/v). Due to the lack of curvature in the isotherm, the 
determined Kd of interaction may be error prone. The determined value of Kd is 
largely reliable as it is determined based on the mid-point of the curve and molar 
concentrations. The interaction with peptide 0 demonstrates the lowest Kd of 
interaction (5.15nM) (figure 6.5). Peptides 1-5 have similar affinities (5.57 – 0.97 
µM) showing little effect of the biotin tag across different linker lengths. 
The enthalpy and entropy of interactions are dependent on an accurate 
determination of Kd. With uncertainty in the Kd, the enthalpy and entropy of 
interaction may contain significantly greater levels of error. When peptide 
concentrations were determined by the A280, the determined enthalpy of interaction is 
shown in each peptide to be negative (favourable). The enthalpy of interactions 
between HsPCNA and peptides 1-5 determined from these isotherms had a range of 
31.8 kJ mol-1 (between -19.9 kJ mol-1 and -51.7 kJ mol-1). The entropy of interaction 
for peptides 1-5 deviated by greater levels as this value is determined from the Kd  
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Figure 6-4. The 
ITC isotherms 




Top panel) The 
ITC isotherm 
showing the 
energy input of 
the baseline 
sample (in µcal 
s-1) against time 
(in minutes).  
Bottom panel) 
The integrated 
data of the ITC 
injections fit as 
above plotted, as 
kcal mol(injectant)
-1 
against the molar 
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interactions of 
HsPCNA       for  





that there is a 
cooling upon 
peptide dilution. 
Peptide 3 shows 
a large data 
spike which 
gave an aberrant 
integrated data 
point removed 
from the fitted 
data.  
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Kd at 283K 
(nM) 
Kd at 298K 
(nM) 
0 5.15 4.40 
1 1370 470 
2 965 375 
3 5570 230 
4 1940 1120 
5 2300 670 
 
Figure 6-5. Kd of Peptides for HsPCNA at differing temperatures 
The bar chart (top) shows the Kd of peptide injected into HsPCNA solution with 
error bars demonstrating the shift in Kd due to the use of concentration determined by 
dissolved mass of peptide. This is present for both temperatures tested. The table 
(bottom) shows the figures for the Kd (in nM) using peptide concentration 
determined by the A280. This data demonstrates that peptide0 is the strongest 
interaction, with peptides1-5 having similar Kds. The error in this experimental 





and enthalpy of interaction. The entropies of interaction between HsPCNA and 
peptides 2-5 are in the range of 113 J Kmol-1 (46.9 to -69.5 J Kmol-1). 
Changes in the temperature of interaction resulted in a shift in the measured 
Kd of interaction. The affinity of interaction increased giving a slight (but consistent 
across all peptides) decrease in the Kd (e.g. peptide 0 drops from 5.15 nM to 4.40 
nM). The change in Kd of interaction with temperature does vary greatly from a 1.2 
(peptide 0) to a 24 fold (peptide3) increase in affinity. Peptides 1-5 gave an average 
of ~4-fold increase in affinity of interaction e.g. peptide 1 drops from 1.37 µM to 
0.47 µM and peptide 5 drops from 2.30 µM to 0.67 µM.  
6.4.2 Results of SpPCNA-Peptide interactions determined by ITC 
The interaction of SpPCNA with different peptides as measured by ITC is 
shown in figure 6.6 with Kd of interaction presented in figure 6.7. The interactions 
were performed at 283K and 298K (figure 6.7) however only those at 283K are 
presented in figure 6.6.  
The data shown in figure 6.6 demonstrates reasonable signal levels (-9 kJ mol(injectant)
-
1 for peptide 1). The isotherms for peptides 0, 1 and 2 gave reasonable curvature and 
peptides 3, 4 and 5 gave little curvature with increasing molar ratio. As stated above, 
isotherms with little curvature can reduce the accuracy of the determined values. The 
interaction with peptide 0 demonstrates the lowest Kd of interaction (18.5 nM) 
(figure 6.7). Peptide 1 demonstrated a greater affinity (78 nM) than peptides 2-5 (400 
– 925 nM) (figure 6.7). The presence of the biotin tag slightly reduces affinity, 
however there is little effect of the biotin tag across different linker lengths.  
The enthalpy of interaction is shown in each peptide to be negative 
(favourable). The enthalpy of interactions between SpPCNA and peptides 1-5, 
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determined from these data, had a range of 26.3 kJ mol-1 (between -30.9 kJ mol-1 and 
-57.2 kJ mol-1). The entropy of interaction for peptide 1-5 deviated by greater levels 
as this value is determined from the Kd and enthalpy of interaction. The entropies 
between SpPCNA and peptides 2-5 are in the range of 118 J Kmol-1 (31.5 to -87.0 J 
Kmol-1). Variations in the thermodynamic values determined are consistent between 
HsPCNA and SpPCNA. 
Changes in the temperature of interaction resulted in a shift in the measured Kd 
of interaction. The affinity of interaction increased giving a slight (but consistent 
across all peptides) decrease in the Kd (e.g. peptide 0 drops from 18.5 nM to 9.5 nM). 
The interactions at higher temperatures were however too weak for Kd values to be 
determined. The change in Kd of interaction with temperature does not vary greatly 
from a 1.25 (peptide 0) to a 2.26 fold (peptide 3) increase in affinity. Peptides 1-3 
gave an average of ~1.7 fold increase in affinity of interaction e.g. peptide 1 drops 
from 77 nM to 62 nM and peptide 3 drops from 930 nM to 41 nM. These trends are 
consistent with that of HsPCNA; however with significantly less variation in 
numbers derived from SpPCNA. 
6.4.3 Results of LmPCNA-Peptide interactions determined by ITC 
The interaction of LmPCNA with different peptides as measured by ITC is 
shown in figure 6.8 with Kd of interaction presented in figure 6.9. The interactions 
were performed at 283K and 298K (figure 6.9) however only those at 283K are 
presented in figure 6.8.  
The data shown in figure 6.8 demonstrates poor signal levels (-6 kJ 
mol(injectant)
-1 for peptide 1). The isotherms for peptides 0 and 1 gave reasonable 
curvature and peptide 2 gave little curvature with increasing molar ratio. ITC  
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Figure 6-6. The 
ITC isotherms 




Top panel) The 
ITC isotherm 
showing the 
energy input of 
the baseline 
sample (in µcal 
s-1) against time 
(in minutes).  
Bottom panel) 
The integrated 
data of the ITC 
injections fit as 
above plotted as 
kcal mol(injectant)
-1 
against the molar 
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that there is a 
cooling upon 
peptide dilution. 
Each of these 
interactions fit 
smoothly to a 
curve. 
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Temperature (K)  
 
Peptide 
Kd at 283K 
(nM) 
Kd at 298K 
(nM) 
0 18.5 9.50 
1 77.5 62.0 
2 400 240 
3 925 410 
4 505  
5 625  
 
Figure 6-7.  Kd of Peptides for SpPCNA at differing temperatures 
The bar chart (top) shows the Kd of peptide injected into SpPCNA solution with error 
bars demonstrating the shift in Kd due to the use of concentration determined by 
dissolved mass of peptide. This is present for both temperatures tested. The table 
(bottom) shows the figures for the Kd (in nM) using peptide concentration 
determined by the A280. This data demonstrates that peptide0 is the strongest 
interaction, followed by peptide1, with peptides2-5 having similar Kds. The error in 
this experimental method results in no clear shift as a result of temperature, however 
interactions with peptides 4 and 5 were too weak for accurate values to be 




interactions between LmPCNA and peptides 3, 4 and 5 gave no useable data. The 
interaction with peptide 0 demonstrates the lowest Kd of interaction 408 nM (figure 
6.9). Peptides 1 and 2 had similar affinities (2.46 – 2.50 µM) (figure 6.9) indicating 
little difference due to the presence of the biotin tag. 
The enthalpy of interaction is shown in each peptide to be negative 
(favourable). The enthalpy of interactions between LmPCNA and peptides 1-2 
determined from these isotherms had a range of 13.7 kJ mol-1 (between -17.9 kJ mol-
1 and -31.6 kJ mol-1). The entropy of interaction for peptides 1-5 deviated by greater 
levels as this value is determined from the Kd and enthalpy of interaction. The 
entropies between LmPCNA and peptides 1-2 are in the range of 44.3 J Kmol-1 (40.7 
to -3.60 J Kmol-1). Variations in the thermodynamic values determined are consistent 
between HsPCNA, SpPCNA and LmPCNA. 
Changes in the temperature of interaction resulted in a shift in the measured Kd of 
interaction. The affinity of interaction decreased giving a slight (but consistent across 
all peptides) increase in the Kd (e.g. peptide 0 increases from 408 nM to 426 nM). 
The interactions at higher temperatures were however too weak for Kd values to be 
determined. The change in Kd of interaction with temperature does not vary greatly 
from a 1.04 (peptide 0) to a 6.52 fold (peptide 2) decrease in affinity. Peptides 1-3 
gave an average of ~3.1 fold decrease in affinity of interaction with a 15°C increase 
in temperature e.g. peptide 0 increases from 408 nM to 426 nM and peptide 2 
increases from 2.5 µM to 16.3 µM. This decreasing affinity with increasing 





Figure 6-8. The ITC isotherms of the 
LmPCNA peptide interactions at 
283K 
Top panel) The ITC isotherm showing 
the energy input of the baseline sample 
(in µcal s-1) against time (in minutes). 
Bottom panel) The integrated data of 
the ITC injections fit as above plotted 
as kcal mol(injectant)
-1 against the molar 
ratio of protein and peptide.  
These three different images show the 
ITC interactions of LmPCNA for 
peptides 0-2. The LmPCNA peptide 0 
interaction shows clearly that there is a 
cooling upon peptide dilution. This 
peptide 0 interaction has the greatest 
affinity and peptide 2 gives only slight 
curvature. The isotherm for peptide 2 
also shows a high noise to signal ratio 

































Temperature (K)  
 
Peptide 
Kd at 283K 
(µM) 
Kd at 298K 
(µM) 
0 0.408 0.426 
1 2.46 1.49 
2 2.50 16.3 
3   
4   
5   
 
Figure 6-9.  Kd of Peptides for LmPCNA at differing temperatures 
The bar chart (top) shows the Kd of peptide injected into LmPCNA solution with 
error bars demonstrating the shift in Kd due to the use of concentration determined by 
dissolved mass of peptide. This is present for both temperatures tested. The table 
(bottom) shows the figures for the Kd (in µM) using peptide concentration 
determined by the A280. This data demonstrates that peptide 0 has the strongest 
interaction, in agreement with interactions of Hs and SpPCNA. Weaker data returned 





6.5 Conclusions from the ITC analysis of PCNA-peptide interactions 
All three PCNAs from the different species demonstrated binding action for 
all six peptides. Peptide concentrations based upon the mass of dissolved peptide 
may be inaccurate therefore reliable thermodynamic data are difficult to obtain from 
this method. The available concentrations of peptide was also low, resulting in low 
signal levels. This poor signal level resulted in only affinity data to be determined 
(and Gibbs free energy). There also was a large dilution effect (figure 6.4 peptide 0). 
This is due to slight fluctuations in DMSO concentration between ligand solution and 
cell solution. LmPCNA and the Phe150Ala mutant peptide gave very weak 
interactions and so higher peptide concentrations were used but these still provided 
no reliable data. Higher peptide concentrations were unattainable without significant 
increases in DMSO concentration.  
Robust numbers like those of the Kd and subsequently ∆G general trends can 
be observed. These numbers suggest that the trend in Kd of peptides was peptide 
0<<peptides 1-5 (figure6.10) and that SpPCNA≈HsPCNA<<LmPCNA (figure 
6.10B). The low Kd of peptide0 is most likely the result of the larger binding 
interface and multiple hydrogen bond formations. Conversely, the short peptides 
could demonstrate higher Kds due to less binding surface. The similarity of affinity 
between peptides 1-5 is due to the identical sequence of peptide, and shows that the 
presence of linkers does not present any significant steric hinderance of the peptide 
PCNA interface. The presence of the biotin tag may result in a slight shift in affinity 
however this shift is consistent with all tagged peptides. Thermodynamic values for 
the interaction are more error prone. The determined enthalpy and entropy of 
interaction from these experiments can only infer that the interaction is enthalpically  
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Figure 6-10. The average affinities of the PCNA peptide interactions as 
determined by ITC 
 
A) The average affinity 
of HsPCNA and 
SpPCNA for Peptides 0-
5. This data clearly shows 
the reduction in affinity 
of the shorter peptide 
when compared to the 
longer peptide0. Each of 
the tagged peptides show 
very similar affinities for 
PCNA compared to that 
of the untagged peptide1, 
this demonstrated that 
there is little effect from 
the presence of the biotin 
linker (peptide2) and only 
slight shift with 
associated linkers 
(peptides 3-5). The 
standard deviation of the 
interactions is the 
deviation of affinity 
across all peptide binding data, including different target proteins (HsPCNA and 
SpPCNA) and different temperatures (283K and 298K).  
 
B) The average affinity of 
the different PCNAs 
analysed for peptides with 
accurate data 
determination. This graph 
shows a slight shift 
between HsPCNA and 
SpPCNA however there is 
a significant reduction in 
affinity with LmPCNA. 
The averages and standard 
deviations were created 
using only data returned 
for all PCNAs, e.g. 












0 1 2 3 4 5
























PCNA from different species
 
 186 
favourable and entropically unfavourable. 
As the temperature increased, the Kd of interaction appeared to drop slightly 
in HsPCNA and SpPCNA. This shift may be due to the large potential error in the 
experimental method from the imprecise concentrations of peptide. However, this 
could also be the result of enthalpy-entropy compensation (Rainaldi, M. et al 2007; 
Yamniuk, A. P. and Vogel, H. J. 2004; Zhou, Y. L. et al 2005). The increase in 
affinity with increase in temperature could also be due to potential difference in 
solubility of peptide, resulting in a higher free peptide concentration being injected at 
higher temperatures. 
The values determined in this chapter will be compared with those determined by 














CHAPTER 7. Study of PCNA-peptide interaction using BIAcore T-100 
The method by which ligand is immobilised to the sensor chip surface may 
affect the affinity with binding partners. In the series of experiments described in this 
chapter we investigate PCNA proteins from three different species and their 
interactions with a series of six related peptides (figure 7.1). The peptides (figure 7.1) 
have been selected to examine differences in linker length. The tagged peptides 
(peptides 2-5 figure 7.1) all have an N-terminal biotin tag. Peptide 3 has a ~10Å PEG 
spacer between the biotin and the N-terminus, peptide 4 has a ~20Å PEG spacer 
between the biotin and the N-terminus, whereas peptide 5 has a ~20Å PEG and ~10Å 
hydrophobic spacer between the N-terminus and biotin (figure 7.1). Two peptides 
(peptide 1 and peptide 6) have been selected to examine the effect of a p21 F150A 
point mutant upon affinity.  
HIS-tagged proteins can be immobilised to the sensor surface specifically by 
the N-terminus using NTA sensor chips (Wear, M. A. et al 2005). NTA surfaces can 
suffer from baseline drift as a result of ligand leaching from the sensor surface, 
which is made worse at higher temperatures (Nieba, L. et al 1997). In this work, we 
have adapted a protocol to covalently couple the PCNA to the sensor surface to 
circumvent this problem. The SPR experiments have been carried out with PCNA 
coupled to a NTA sensor surface and with peptide bound to a SA surface. SA 
surfaces have Streptavidin covalently coupled to the dextran matrix and can bind 
ligand using the tight (~1×10-15M) Avidin-Biotin interaction (Green, N. M. et al 
1975), one of the strongest non-covalent biological interactions. Differences in the 
affinity and thermodynamic values of interaction can be determined to be the result 
of the method of immobilisation. Experiments described here set out to examine  
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Peptide1 –                                  KRRQTSMTDFYH 
  Peptide2 –                           Bio-KRRQTSMTDFYH 
  Peptide3 –                  Bio-PEG-KRRQTSMTDFYH 
  Peptide4 –         Bio-PEG-PEG-KRRQTSMTDFYH 
  Peptide5 – Bio-PEG-PEG-Ahx-KRRQTSMTDFYH 




Figure 7-1. The peptides investigated by SPR in this work 
Figure showing the peptides used in SPR experiments carried out in this study.  
Top) Peptides 1-6 showing shorthand forms of all 6 peptides. Peptides 1-6 all have 
the same peptide sequence. Peptide 1 and 6 are untagged and peptide 6 has a F150A 
point mutation. Peptides 2-5 with biotin tags and linkers made of PEG and a 
hydrophobic spacer (Ahx).  
Bottom) Peptides 2-5, showing the biotin tags and the chemical sequence of the 

















whether peptides with short linkers have reduced affinity with immobilised peptide.  
Affinity constants from these experiments can be derived at different 
temperatures 283-313K (10-40°C). Kds derived over a temperature range can allow 
the determination of the enthalpy and entropy (Boysen, R. I. et al 1999) and the 
specific heat capacity of interaction (Murphy, K. P. et al 1990; Privalov, P. L. and 
Gill, S. J. 1988; Yoo, Seung Hyun and Lewis, Marc S. 2002). This series of 
experiments will also allow determination of the effect on binding properties of the 
interaction upon the mutation of Phe150Ala as well as the effect of biotin tags. 
7.1 Materials and Methods of SPR experiments 
All SPR experiments were carried out using the BIAcore T-100 (GE 
healthcare). Buffers used were consistent in all SPR experiments, BIAcore running 
buffer, 50µM EDTA, 0.05% P20 and 1% DMSO. 10mls of 100% DMSO (Fisher 
Scientific), 5mls of 10% v/v P20 (BIAcore) and 100µl of 0.5M EDTA were added to 
100mls of HBS-N Buffer 10× (BIAcore), this was diluted to 1litre with ddH2O 
filtered through a 0.2µm filter. Prior to use, the BIAcore T-100 had the cleaning 
desorb run performed three times and the system was flushed thoroughly with buffer. 
Protein for these experiments was prepared as in chapter 2, eluted from the size 
exclusion column in HEPES biochemistry buffer. Data were evaluated using the 
BIAcore T-100 evaluation software Version 2.0.1 (GE healthcare) for the 
determination of the Kd of interaction. The thermodynamic analysis of interaction 
was performed using KaleidaGraph 4.0 (Synergy Software).  
7.1.1 SPR Study of Triple Protein Sensor Chips 
The study of immobilised PCNA surfaces was performed using NTA sensor 
surfaces (BIAcore). Sensor surfaces were washed for 30 seconds at 30µl min-1 with 
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50mM NaOH a minimum of three times prior to use, and equilibrated with BIAcore 
running buffer. Ni2+ is immobilised to the NTA surface using a 60 second injection at 
10µl min-1 of Ni2+ charging solution; 1× HBS-N, 0.05% P20, 1%DMSO and 500µM 
NiSO4. The sensor surface was activated for primary amine coupling using a 240 
second injection at 5µl min-1 of 0.1M EDC, 25mM NHS solution. Protein at 100nM 
was injected at 30µl min-1 over the activated surface for 100 seconds. The surface 
was stripped with a 180 second injection of EDTA stripping buffer; 1× HBS-N, 
0.05% P20 and 50µM EDTA. The level of immobilised protein was determined and 
if too low, Ni2+ was reloaded and more protein immobilised. Flow cell 2 had 
~850RU of HsPCNA, flow cell 3 had ~800RU of SpPCNA and flow cell 4 had 
~950RU of LmPCNA immobilised. The active surfaces were then quenched with a 
300 second injection at 50µl min-1 of 1M Ethanolamine. Flow cell 1 was activated 
and quenched with no protein immobilised, and functioned as a reference cell. All 
surfaces were extensively washed with buffer untill all surfaces reached a steady 
baseline. 
The peptides 1-5 were serially diluted from 50µM resulting in 25, 12.5, 6, 3, 
1.5, 0.8, 0.4 and 0µM concentrations, peptide 6 was serially diluted from 100µM 
resulting in 50, 25, 12.5, 6, 3, 1.5, 0.8 and 0µM all in BIAcore running buffer. 
Peptides were passed over the surfaces at 50µl min-1 for 30 seconds with a repetition 
of the 3µM concentration. These experimental runs were performed three times at 
283K, 288K, 293K, 298K, 303K, 308K, 313K (10-40°C at 5°C increments). 
Reference corrected data were used to determine the affinity of interaction for each 
peptide using the BIAcore T-100 Evaluation Software version 2.0.1 (GE Healthcare). 
The thermodynamic analysis was performed using KaleidaGraph 4.0. 
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7.1.2 Validation of the immobilised PCNA sensor surface activities 
An NTA surface with 4 flow cells had ~850RU HsPCNA covalently 
immobilised on flow cell 2, ~800RU SpPCNA immobilised on flow cell 3, 950RU 
LmPCNA immobilised on flow cell 4 and flow cell 1 used as a reference cell. Protein 
were associated to the dextran matrix using the N-terminal 6xHIS tag Ni2+ affinity 
and then covalently immobilised using primary amine coupling in order to maximise 
surface activity. The theoretically obtained RUmax can be calculated with the known 
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The steady state fits of these interactions give values of the RUmax. When this is 
compared to theoretical RUmax, this ratio can give the surface activity. Hs, Sp and 
LmPCNA triple surfaces generated were ~57%, 44% and 99% active respectively. 
Three repeat runs were carried out using two separately created protein surfaces all 
of which had similar activities.  
7.1.3 SPR Study of Immobilised Peptide Sensor Chips 
Immobilised peptides were studied using an SA sensor surface which was 
cleaned and equilibrated as in section 7.1.1. Peptide was immobilised to the 
Streptavidin surface with a 15 second injection at 50µl min-1 of 50nM concentration 
of peptide. Injections were performed to reach a surface response of ~40RU on flow 
cells 2 and 4, with flow cells 1 and 3 used as reference cells. SA chip one had 
peptides 2 and 3 immobilised and SA chip two had peptides 4 and 5 immobilised. 
Once peptides were immobilised, the surfaces were equilibrated thoroughly with 
BIAcore running buffer to allow all surfaces to achieve a steady baseline.  
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Serial dilutions were made of HsPCNA and LmPCNA giving 50, 25, 12, 6, 3, 
1.6, 0.8, 0.4 and 0µM concentrations and a dilution of SpPCNA giving 25, 12, 6, 3, 
1.6, 0.8, 0.4, 0.2 and 0µM. These concentrations of PCNA were passed over the 
surfaces in 30 second injections at 30µl min-1 with repeat injections of 3µM PCNA. 
Experimental runs were performed three times at 283K, 288K, 293K, 298K, 303K, 
308K, 313K (10-40°C at 5°C increments). Reference corrected data were used to 
determine the affinity of interaction for each immobilised peptide using the BIAcore 
T-100 Evaluation Software version 2.0.1 (GE Healthcare). The thermodynamic 
analysis was performed using KaleidaGraph 4.0. 
7.1.4 Validation of the immobilised peptide sensor surface activities 
The Kd of the three PCNAs (Hs, Sp and Lm) with surface of immobilised 
peptides were ascertained at seven temperatures. One SA surface had ~39.0RU of 
peptide 2 immobilised in flow cell 2 and ~38.4RU of peptide 3 immobilised in flow 
cell 4, with flow cells 1 and 3 used as reference cells respectively. A second SA 
surface had ~38.8RU of peptide 4 immobilised in flow cell 2 and ~37.6RU of peptide 
5 immobilised in flow cell 4, with flow cells 1 and 3 used as reference cells 
respectively. Immobilisation of biotinylated peptides 2, 3, 4 and 5 to Streptavidin 
surfaces were ~0, 32, 44 and 41% active respectively (as determined using equation 
7.1).  
7.2 Results of SPR experiments 
7.2.1 Determination of Kd between PCNA and free peptides at 25°C 
Each chip with bound Hs, Sp and LmPCNA was used to examine the 
interaction with peptides 1-6 at different temperatures. Sensorgrams of the 
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interaction between PCNA and peptide 1 at 25°C are shown in figure 7.2. The 
immobilised PCNA peptide interactions showed no apparent mass transport 
problems (Karlsson, R. 1999). Analyte-ligand interactions which associate too 
rapidly can give a signal dependent on the rate of analyte delivery to the sensor 
surface. Mass transport problems are represented by the kt of interaction in RU.Ms
-1 
(figures greater than 1×107 RU.Ms-1 for protein-protein interactions infer no mass 
transport problems). Immobilised PCNA gave kt of 3.96×10
15 RU.Ms-1, 4.38×1013 
RU.Ms-1 and 7.61×108 RU.Ms-1 for Hs, Sp and LmPCNA respectively. 
 The interactions presented in figure 7.2 have very fast on and off rates (kon 
and koff) (Oshannessy, D. J. et al 1993). At 25°C, the kon of peptide 1 for Hs, Sp and 
LmPCNA are ~4.69×105 M-1s-1, 1.82×105 M-1s-1, 1.84×104 M-1s-1 respectively. The 
koff of peptide 1 interaction with Hs, Sp and LmPCNA is ~0.8 s
-1, 0.9 s-1 and 1.4 s-1 
respectively. Due to the rapid nature of the PCNA-peptide interactions, the data were 
analysed by the steady state of interaction (Adamczyk, M. et al 2000). 
 The steady-state analysis of the sensorgrams (figure 7.2) was used to 
determine the affinity of interaction. Affinity between HsPCNA, SpPCNA and 
LmPCNA for peptides 1-6 (at different temperatures) are shown in figures 7.4, 7.5 
and 7.6 respectively. In contradiction with ITC data (chapter 6) but in agreement 
with literature data, the HsPCNA-peptide interactions were the strongest and the 
SpPCNA-peptide interactions were approximately 1.5 fold weaker; LmPCNA- 
peptide interactions were approximately 6 fold weaker than SpPCNA. Peptide 1 was 
determined to bind with the greatest affinity and peptides 2-5 demonstrated an 
approximately 5-fold weaker interaction, peptide 6 was shown to have an 






Figure 7-2. BIAcore data for immobilised PCNA with peptide 1 
 
The interactions of peptide 1 for surfaces of BIAcore sensor chips with immobilised 
protein at 298K. A) Reference corrected results of BIAcore interaction plotted as RU 
against time in seconds. Serial dilutions of peptide 1 (50 to 0.4 µM) were passed over 
HsPCNA (top), SpPCNA (middle) and LmPCNA (bottom) immobilised surfaces. 
Peptide at 3 µM was passed over the surface twice in order to ascertain if there was 
any baseline drift or if the surface was losing activity during the course of the 
experiment. This shows the PCNA-peptide interaction is very rapid and gave no 
baseline drift. B) Steady state analysis of data plotting RU against peptide 
concentration was used to give a Kd. This is shown as a black line with the Kd value 
(in µM) inset. 
Kd = 1.12 µM 
  Kd = 2.11 µM 
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Peptide 10 °C 15 °C 20 °C 25 °C 30 °C 35 °C 40 °C 
1 0.263 0.450 0.656 0.843 1.14 1.70 2.39 
2 1.08 1.62 2.33 3.16 5.10 7.25 10.9 
3 1.42 1.80 2.80 3.71 6.61 9.32 12.6 
4 1.13 1.43 2.63 3.72 5.74 9.86 14.7 
5 1.34 1.76 2.65 3.46 6.91 9.84 14.8 
6 54.1 60.7 106 128 188 191 381 
 
Figure 7-3. Kd of peptides to immobilised HsPCNA with shift in temperature. 
 
Figure showing the increase in Kd of peptides for immobilised HsPCNA with 
increase in temperature. Peptides 1-5 are shown on the left y-axis while Peptide 6 is 
shown on the right y-axis. The table (below) shows the Kd values (in µM) for each 
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Peptide 10 °C 15 °C 20 °C 25 °C 30 °C 35 °C 40 °C 
1 0.667 0.821 1.02 1.20 1.81 2.00 3.92 
2 1.27 2.27 2.56 3.64 7.83 10.8 17.4 
3 1.42 2.08 3.28 5.07 8.25 14.7 19.8 
4 1.29 1.85 2.91 4.55 7.64 17.0 19.9 
5 1.68 2.14 2.76 4.90 8.93 16.8 21.7 
6 21.1 32.6 65.6 95.9 161 266 276 
 
Figure 7-4. Kd of peptides to immobilised SpPCNA with shift in temperature. 
 
Figure showing the increase in Kd of peptides for immobilised SpPCNA with 
increase in temperature. Peptides 1-5 are shown on the left y-axis while Peptide 6 is 
shown on the right y-axis. The table (below) shows the Kd values (in µM) for each 
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Peptide 10 °C 15 °C 20 °C 25 °C 30 °C 35 °C 40 °C 
1 3.06 4.84 7.75 10.3 14.3 17.8 26.3 
2 15.8 21.3 31.3 32.5 46.2 54.0 56.4 
3 18.1 24.9 31.2 42.5 49.1 67.5 75.8 
4 13.0 19.5 30.1 40.2 49.8 67.5 78.5 
5 19.8 26.1 34.9 45.9 57.3 69.6 77.7 
6 95.6 174 216 217 278 345 470 
 
Figure 7-5. Kd of peptides to immobilised LmPCNA with shift in temperature. 
 
Figure showing the increase in Kd of peptides for immobilised LmPCNA with 
increase in temperature. Peptides 1-5 are shown on the left y-axis while Peptide 6 is 
shown on the right y-axis. The table (below) shows the Kd values (in µM) for each 
peptide at each temperature, each of these values are the average of three data sets. 
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with a temperature increase of 5K. 
7.2.2 Van’t Hoff analysis of PCNA surfaces with free peptide 
Van’t Hoff analysis of this data gives values of ∆H, ∆S and ∆Cp. The level of effect 
of ∆Cp can be small, so data fitting over a short temperature range is prone to error 
when performing non-linear van’t Hoff analysis. Due to error of the non-linear van’t 
Hoff plot, it is important to determine the shift in ∆H and ∆S by comparing both 
linear and non-linear fitting procedures. The linear (appendix 1.9) and non-linear 
van’t Hoff plots gave similar values of enthalpy and entropy for the Hs, Sp and 
LmPCNA (figures 7.6, 7.7 and 7.8). The values derived from the non-linear van’t 
Hoff plots for the three PCNAs with six peptides are shown in table 7.1. 
7.2.2.1 Differences in the Gibbs free energy of interaction between peptides 
The Gibbs free energy of interaction for all peptides is negative, indicating 
that the interaction is favourable. The Gibbs free energy of interaction demonstrates 
that there is very little effect on binding as a result of linker length (-31.1 to -30.7 kJ 
mol-1) (table 7.1). This small change in the Gibbs free energy of interaction with 
increasing linker size is a result of an enthalpy entropy compensation effect. The 
F150A point mutant gave a significantly increased Gibbs free energy (-31.6 to -22.3 
kJ mol-1) (table 7.1). The F150A point mutation resulted in an increase in the 
entropic cost of interaction and as a result, is a greatly weaker interaction. These 
trends in the Gibbs free energy of interaction are well conserved in both SpPCNA 
and LmPCNA peptide interactions (table 7.1). SpPCNA has very similar affinity to 
HsPCNA, however LmPCNA has a significantly weaker interaction e.g. HsPCNA 
and LmPCNA to peptide 1 is -31.6 and -28.4 kJ mol-1 respectively (table 7.1). 
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7.2.2.2 Changes in enthalpy and entropy with increasing linker length 
All peptides analysed are enthalpically favourable and peptides with 
increasing linker length give a decrease in enthalpy of interaction for HsPCNA (-57.5 
to -65.0 kJ mol-1) (table 7.1). A decrease in enthalpy is consistent with an increase in 
the number of intermolecular bonds being formed between PCNA and the peptide. 
Peptide binding is entropically unfavourable in all cases, and the entropy of 
interaction decreases with increasing linker length (-88.0 to -115 J Kmol-1) (table 
7.1). This decreasing entropy is indicative of a longer more flexible peptide having 
greater disorder. These trends in enthalpy and entropy with increasing linker size are 
consistent with the values determined for binding to SpPCNA and LmPCNA (table 
7.1). 
7.2.2.3 The enthalpy and entropy of p21 (141-152) and F150A mutant for 
PCNA  
There is little change in the enthalpy of interaction between peptide 1 and 
peptide 6 (F150A) for HsPCNA (-49.2 to -49.6 kJ mol-1) (table 7.1). The similar 
values of enthalpy between the two peptide interactions suggest that the 
phenylalanine ring provides little intermolecular contacts. There is a significant shift 
in the entropy of interaction between peptides 1 and 6 (-58.9 to -91.4 J Kmol-1) (table 
7.1). The change in entropy infers that the F150A mutant is either more disordered in 
solution or more ordered when bound to HsPCNA when compared to peptide 1. It is 
possible that the F150A mutation reduces the propensity of helix formation at the PIP 
box and result in greater entropic cost. SpPCNA has a decrease in enthalpy of 
interaction (-41.1 to -66.6 kJ mol-1) and a significantly decreased entropy of 
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(J K-1 mol-1) 
∆Gθ 
(kJ mol-1) 
1 - -49.2 -58.9 -698 -31.6 
2 10 -57.5 -88.0 -668 -31.3 
3 20 -57.7 -90.2 -648 -30.8 
4 30 -65.0 -115 -752 -30.7 
5 40 -63.7 -110 -1310 -30.9 
6 - -49.6 -91.4 -436 -22.3 
 
Figure 7-6. Non-Linear van’t Hoff of HsPCNA for peptides 1-6 
The linear Van’t Hoff plot (top) with lnKd on the y axis versus 1/T on the x axis 
plotted with Kaleidagraph. Table (bottom) shows thermodynamic properties and 
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(J K-1 mol-1) 
∆Gθ 
(kJ mol-1) 
1 - -41.1 -24.6 -2110 -33.8 
2 10 -66.5 -120 -1600 -30.7 
3 20 -67.4 -125 -944 -30.2 
4 30 -77.4 -158 -2010 -30.3 
5 40 -67.8 -127 -1070 -30.0 
6 - -66.6 -147 1290 -22.8 
 
Figure 7-7. Non-Linear van’t Hoff of SpPCNA for peptides 1-6 
The linear Van’t Hoff plot (top) with lnKd on the y axis versus 1/T on the x axis 
plotted with Kaleidagraph. Table (bottom) shows thermodynamic properties and 
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(J K-1 mol-1) 
∆Gθ 
(kJ mol-1) 
1 - -46.6 -61.2 1480 -28.4 
2 10 -34.9 -31.7 138 -25.5 
3 20 -35.1 -33.7 419 -25.1 
4 30 -42.0 -56.8 1390 -25.1 
5 40 -35.2 -34.9 658 -24.8 
6 - -27.2 -22.7 2240 -20.4 
 
Figure 7-8. Non-Linear van’t Hoff of LmPCNA for peptides 1-6 
The linear Van’t Hoff plot (top) with lnKd on the y axis versus 1/T on the x axis 
plotted with Kaleidagraph. Table (bottom) shows thermodynamic properties and 








































































































































































-28.4 -25.5 -25.1 -25.1 -24.8 -20.4 
 
Table 7-1. Thermodynamic values derived from the non-Linear van’t Hoff plots 
of immobilised PCNA interactions with free peptide 
 
Table showing the thermodynamic values of the PCNA peptide interactions 
determined by the non-linear van’t Hoff analysis. The enthalpy, entropy, specific 
heat capacity and Gibbs free energy of interactions are grouped by PCNA species. In 











enthalpy and entropy of these interactions (table 7.1). 
7.2.2.4 Differences in the ∆Cp of interaction between peptides 
The change in the specific heat capacity for every peptide for HsPCNA is 
negative, inferring a release of water (burial of surface hydrophobics). The specific 
heat capacity of interaction with HsPCNA has a slight decrease with linker length (-
668 to -752 J K-1 mol-1). There is a significant decrease upon the addition of a 
hydrophobic spacer region (-752 to -1310 J K-1 mol-1) (table 7.1). These values for 
specific heat capacity are consistent with an increase in the amount of hydrophobic 
surface being removed from the solution. The loss of the phenylalanine ring in the 
peptide resulted in an increase in the specific heat capacity of interaction (-698 to -
436 J K-1 mol-1) (table 7.1). The increase in the specific heat capacity is consistent 
with the loss of the hydrophobic phenylalanine ring. The values of specific heat 
capacity vary greatly for SpPCNA and LmPCNA (table 7.1) and are unreliable due 
to weaker interactions presenting greater variability in the Kd values determined. 
7.2.3 Determination of Affinity of Peptide Surfaces with Free PCNA 
SA surfaces with different peptides immobilised were used to examine the 
affinity with Hs, Sp and LmPCNA at different temperatures. Sensorgrams of the 
interaction between immobilised peptides and HsPCNA at 25°C are shown in figure 
7.9.  
  Peptide2 –                           Bio-KRRQTSMTDFYH 
  Peptide3 –                  Bio-PEG-KRRQTSMTDFYH 
  Peptide4 –         Bio-PEG-PEG-KRRQTSMTDFYH 
  Peptide5 – Bio-PEG-PEG-Ahx-KRRQTSMTDFYH 
 
PCNA peptide interactions showed no apparent mass transport problems 
(Karlsson, R. 1999). Interactions of immobilised peptides with HsPCNA at 25°C 
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gave kt of 1.64×10
14 RU.M-1s-1, 7.76×1015 RU.M-1s-1, and 1.37×1017 RU.M-1s-1 for 
peptide 3, 4 and 5 respectively. Values of kt for immobilised peptide 2 with HsPCNA 
at 25°C could not be determined. 
 The interactions presented in figure 7.9 have very fast on and off rates (kon 
and koff). At 25°C, the kon for HsPCNA with immobilised peptides 3, 4 and 5 are 
~3.96×103 M-1s-1, 3.48×104 M-1s-1, 4.91×104 M-1s-1 respectively. The koff of HsPCNA 
interaction for peptides 3, 4 and 5 are ~1.2 s-1, 0.6 s-1 and 0.9 s-1 respectively. Due to 
the rapid nature of the PCNA-peptide interactions, the data were analysed by the 
steady state of interaction (Adamczyk, M. et al 2000).  
The steady-state analysis of the sensorgrams (figure 7.9) was used to determine the 
affinity of interaction. Affinity between immobilised peptides 2-5 for HsPCNA and 
SpPCNA (at different temperatures) are shown in figure 7.10. This data 
demonstrated that SpPCNA had the strongest affinity for the peptide surfaces, 
HsPCNA and subsequently LmPCNA had weaker affinities. The interaction of 
SpPCNA was ~10 fold tighter than that of HsPCNA which was ~14 fold tighter than 
that of LmPCNA; this is in contradiction with previously determined values (section 
8.2 and chapter 6). The different peptide surfaces also presented a differing range of 
affinities. Peptide 2 gave no data as previously stated, peptide 3 surface gave a weak 
interaction, surfaces of peptide 4 and 5 gave interactions ~30 fold tighter than those 
of peptide 3. The Kd of these interactions demonstrated an average shift of 1.5x for 
an increase of 5K. The thermodynamic values determined from these experiments 











Figure 7-9. BIAcore data for immobilised peptides for HsPCNA 
The interactions of immobilised peptide for HsPCNA at 298K. A) Reference 
corrected results of BIAcore interaction plotted as RU against time in seconds. Serial 
dilutions of HsPCNA (50 to 0.4 µM) were passed over peptide. This shows the 
PCNA peptide interaction is very rapid and repeats of 3 µM of PCNA was passed 
over the surface twice showing no baseline drift. B) Steady state analysis of data 
plotting RU against peptide concentration was used to give a Kd. This is shown as a 
black line with the Kd value (in µM) inset. Data shows no obtainable results from 
surfaces of peptide 2. 
Kd = undetermined 
Kd = 47.2 µM 
Kd = 20.9 µM 
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Temperature (K)  
 
Interaction 10 °C 15 °C 20 °C 25 °C 30 °C 35 °C 40 °C 
HsPCNA-P3 18.9 25.9 46.7 61.8 78.8 115 178 
HsPCNA-P4 8.37 9.18 11.5 16.5 20.6 40.3 111 
HsPCNA-P5 9.27 10.9 14.0 20.0 32.5 67.6 114 
SpPCNA-P3 1.94 2.16 2.95 4.52 7.49 12.6 19.0 
SpPCNA-P4 1.91 1.60 1.67 2.19 2.62 3.52 4.17 
SpPCNA-P5 1.86 1.65 1.81 2.31 3.15 3.95 5.76 
 
Figure 7-10. Kd of PCNA to immobilised peptides across a temperature range  
Figure showing the increase in Kd of immobilised peptides for HsPCNA and 
SpPCNA with increase in temperature. HsPCNA is shown on the left y-axis while 
SpPCNA is shown on the right y-axis. The table (below) shows the Kd values (in 
µM) for each peptide at each temperature, each of these values are the average of 
three data sets. 
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7.2.4 Differences in the enthalpy of interaction between HsPCNA and 
peptides 
The non-linear Van’t Hoff analysis of this data gives values of ∆H, ∆S and 
∆Cp (Yoo, Seung Hyun and Lewis, Marc S. 2002). The linear van’t Hoff plot 
(appendix 1.9) gave similar values of enthalpy and entropy to the non-linear van’t 
Hoff plots (figures 7.6, 7.7 and 7.8). The values derived from the non-linear van’t 
Hoff plots for the three PCNAs with four immobilised peptides are shown in figure 
7.11 (table).  
7.2.4.1 Differences in the Gibbs free energy of interaction between peptides 
 The Gibbs free energy of interaction for all immobilised peptides with 
HsPCNA is negative, indicating that the interaction is favourable. The Gibbs free 
energy of interaction demonstrates that there is an increase in affinity between 
HsPCNA and peptide as a result of increasing linker length (-24.1 to -27.6 kJ mol-1) 
(figure 7.11, table). The corresponding range of binding energies measured with 
immobilised HsPCNA was between -30.7 and 30.9 kJ mol-1 (table 7.1). The small 
(0.3 kJ mol-1) decrease in Gibbs free energy suggests that increasing linker length 
does not affect binding affinity. The large (3.5 kJ mol-1) change in free energy of 
immobilised peptides is most likely the result of the immobilisation method and the 
reduction in the effect of steric hindrance imposed by Streptavidin. Peptide 5 with an 
additional hydrophobic linker had similar (however reduced) Gibbs free energy of 
interaction as peptide 4 (-26.8 and -27.6 kJ mol-1 respectively). This is consistent 
with data obtained with immobilised PCNA.  
The same trend in increasing affinity of interaction with increasing linker 
length is observed in both SpPCNA and LmPCNA. SpPCNA has much greater 
 
 209 
affinity (smaller Gibbs free energy) to HsPCNA e.g. -32.0 and -26.8 kJ mol-1 
respectively for peptide 5 (figure 7.11, table). The increased affinity of SpPCNA is 
not consistent with data shown in section 7.2.1 and could be a result of the method of 
ligand immobilisation. LmPCNA has a significantly weaker interaction e.g. 
HsPCNA and LmPCNA to peptide 5 is -26.8 and -19.5 kJ mol-1 respectively (figure 
7.11, table). The reduced affinity of LmPCNA is consistent with data shown above. 
7.2.4.2 Changes in enthalpy entropy and ∆Cp with increasing linker length 
All peptides analysed are enthalpically favourable and peptides with 
increasing linker length give a decrease in enthalpy of interaction for HsPCNA (-53.8 
to -65.2 kJ mol-1) (figure 7.11, table). A decrease in enthalpy is consistent with 
figures derived for immobilised HsPCNA. Peptide binding is entropically 
unfavourable in all cases and the entropy of interaction decreases with increasing 
linker length (-99.6 to -129 J Kmol-1) (figure 7.11, table). This decreasing entropy is 
indicative of a longer more flexible peptide having greater disorder and is consistent 
with thermodynamic values returned for immobilised HsPCNA. The specific heat 
capacity of interaction with HsPCNA is variable and the figures derived are 
unreliable (figure 7.11, table). These trends in enthalpy and entropy with increasing 
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(J K-1 mol-1) 
∆Gθ 
(kJ mol-1) 
HsPCNA-P3 20 -53.8 -99.6 17.2 -24.1 
HsPCNA-P4 30 -62.2 -116 -4960 -27.6 
HsPCNA-P5 40 -65.2 -129 -3570 -26.8 
SpPCNA-P3 20 -60.8 -102 -2350 -30.4 
SpPCNA-P4 30 -18.4 46.3 -2020 -32.2 
SpPCNA-P5 40 -24.8 24.2 -2460 -32.0 
LmPCNA-P3 20 -246 -766 -2670 -17.3 
LmPCNA-P4 30 -29.7 -25.8 -31.7 -22.0 
LmPCNA-P5 40 -26.3 -22.9 5320 -19.5 
 
Figure 7-11. Non-Linear van’t Hoff of LmPCNA for peptides 1-6 
The linear Van’t Hoff plot (top) with lnKd on the y axis versus 1/T on the x axis 
plotted with Kaleidagraph. Table (bottom) shows thermodynamic properties, at 
standard conditions, and change in specific heat capacity of solution determined for 
each peptide to three significant figures. 
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7.3 Discussion of the SPR data 
7.3.1 Effect of F150A point mutant on thermodynamic values of binding 
The Gibbs free energy of interaction between HsPCNA and peptide 1 (-31.6 
kJ mol-1) and peptide 6 (-22.3 kJ mol-1) shows a significantly weaker interaction for 
peptide 6. The reduction in affinity for HsPCNA can be accounted for by the 
increased entropic cost of interactions with little change in the enthalpy of interaction 
(discussed below). The reduction in affinity (shown in the values of Gibbs free 
energy) between peptide 1 and peptide 6 is also observed in SpPCNA (11.0 kJ mol-1) 
and LmPCNA (8.0 kJ mol-1). This shows remarkably good agreement with Gibbs 
free energy values for SpPCNA and LmPCNA.  
The PIP box sequence forms a helical region at Phe150 as stated above. The 
Phe150Ala mutation could have been hypothesised to present a lower entropic cost 
of interaction due to increased propensity for helix formation of alanine and reduced 
side-chain entropy as shown in (Chellgren, B. W. and Creamer, T. P. 2006; Oneil, K. 
T. and Degrado, W. F. 1990; Padmanabhan, S. et al 1990). Results presented in this 
work show increased entropic cost upon the Phe150Ala mutation (-32.5 J Kmol-1) 
(table 7.1). With the change in the specific heat capacity of interaction (+162 J K-1 
mol-1), the increased entropic cost has been demonstrated to be the result of the 
removal of the phenylalanine solvation shell. A significantly reduced solvation shell 
prior to binding would result in a greater entropic cost of interaction with no net 
change in the enthalpy of interaction. 
From crystal structures, it is known that the peptide forms a small helical 
region in the PIP box section of the peptide. Previous literature shows that alanine is 
a greater promoter of helix formation than phenylalanine (Blaber, M. et al 1994; 
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Blaber, M. et al 1993; Chellgren, B. W. and Creamer, T. P. 2006; Creamer, T. P. and 
Rose, G. D. 1994; Lewis, P. N. et al 1970; Oneil, K. T. and Degrado, W. F. 1990; 
Padmanabhan, S. et al 1990; Richardson, J. M. et al 2005). The significant drop in 
affinity of the mutant demonstrates that helix formation is not required as a precursor 
for peptide binding. 
The F150A mutation in peptide 6 resulted in no significant shift in the 
enthalpy of interaction for HsPCNA compared with peptide 1 (-0.4 kJ mol-1). This 
result demonstrates that the association of the phenylalanine ring provides little 
enthalpic contribution to the global interaction. The lack of enthalpic contribution of 
the phenylalanine side chain may be surprising as crystal structure studies have 
shown that this mutation has resulted in the loss of van der Waals contacts. The 
complex of HsPCNA with p21 R143-H152 and HsPCNA with p21 R143-H152 
(F150A) have buried surface areas of 1200 and 1160Å2 respectively (figure 7.12). 
There is no obvious way to explain why the reduction in buried surface area of 40Å2 
as a result of the F150A mutation would give such a little effect on binding enthalpy. 
SpPCNA and LmPCNA had a reduction (+19.4 kJ mol-1) and increased (-25.5 kJ 
mol-1) changes respectively in the enthalpy of interaction between peptide 1 and 
peptide 6. The variations could be the result of weaker interactions between 
immobilised PCNA surfaces and peptide 6 at higher temperatures. SpPCNA and 
LmPCNA binding to the mutant peptide have a decrease in the buried surface areas 
of 47.4 and 76.4Å2 (figure 7.12). The increased loss in buried surface area of the 
F150A mutant may rationalise the increased enthalpy of this interaction.  
It has been hypothesised that one of the greatest promoters to helix formation 
is the burial of hydrophobic residues (Blaber, M. et al 1994; Blaber, M. et al 1993).  
 
 213 





Figure 7-12. The buried surface areas of Hs, Sp and LmPCNA with peptide 1 
and peptide 6 
Figure showing the buried surfaces areas in grey of the HsPCNA (top), SpPCNA 
(middle) and LmPCNA (bottom). The buried surfaces areas are represented as those 
atoms within 5Å of peptide 1 (left) and the F150A point mutation peptide 6 (right). 
This shows a slightly greater buried surface area for SpPCNA. The figure 
demonstrates the loss of buried surface area due to the point mutation with the 










The importance of the burial of hydrophobics was determined by experimental 
observation of peptide-protein binding. Computer simulation studies determined side 
chain entropy loss was the major determinant of helix formation. The simulations 
were performed in order to determine the increase in entropic cost for each amino 
acid (Creamer, T. P. and Rose, G. D. 1994). This paper determined that there was a 
small contribution from ring structures stacking in aiding helix formation, and little 
contribution was made from the burial of hydrophobics in contradiction to (Blaber, 
M. et al 1994; Blaber, M. et al 1993). This apparent contradiction can be resolved 
using data presented here. The effects of waters upon the system were not 
incorporated in these publications, and values of the specific heat capacity of 
interaction aid to explain these apparent contradictions. 
7.3.2 Effect on thermodynamic values of an N-terminal biotin tag on 
binding peptide 
The Gibbs free energy of interaction between immobilised HsPCNA and free 
peptide 1 and peptide 2 was similar, -31.6 and -31.3 kJ mol-1 respectively (table 7.1). 
Little change in the Gibbs free energy of interaction demonstrates no significant 
change in the affinity of interaction with tagged peptides, due to an enthalpy-entropy 
compensation effect, discussed below. The enthalpy of interaction showed a decrease 
for the tagged peptide (from -49.2 to -57.5 J Kmol-1) (table 7.1). The decrease in 
enthalpy of interaction is likely to be a result of the increased number of interactions 
between HsPCNA and biotin. The entropy of interaction also decreases due to the 
presence of the biotin tag (-58.9 to -88.0 kJ mol-1) (table 7.1). This is the result of the 
tag having greater flexibility in solution (figure 7.9) so the immobilisation to 
HsPCNA will have a greater entropic cost. The specific heat capacity is very similar 
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for both untagged and tagged peptides, -698 and -668 J K-1 mol-1 respectively. Little 
change in specific heat capacity is due to the biotin tag not being either particularly 
hydrophobic or hydrophilic. Trends in enthalpy and Gibbs free energy are conserved 
with all PCNAs. The entropy of interaction between peptide 1 and 2 for LmPCNA 
appears to increase which is in contradiction to data for HsPCNA and SpPCNA. The 
specific heat capacities for SpPCNA and LmPCNA are unreliable values. 
7.3.3 Effect on thermodynamic values of increasing N-terminal biotin 
linker length 
The Gibbs free energy of interaction between HsPCNA and tagged peptides 
with different linker lengths remains very similar, between -31.3 and -30.7 kJ mol-1 
(table 7.1). The similar energies of these interactions show that HsPCNA has similar 
affinities for peptides with any linker length and seems to be a result of enthalpy-
entropy compensation discussed below. Interactions for immobilised HsPCNA show 
a decrease in enthalpy with increasing linker length (from -57.5 to -65.0 kJ mol-1) 
(table 7.1). The decrease in enthalpy may be due to an increase in the potential 
contact area of the peptides with longer linkers. The entropy of interaction between 
tagged peptides and HsPCNA however decreases with increasing linker length (-88.0 
to -115 J Kmol-1) (table 7.1). The decreasing entropy of interaction with increasing 
linker length is likely the result of the longer peptide linkers having greater freedom 
and flexibility. The specific heat capacity of interaction is similar with a slight 
increase for three tagged peptides (2, 3 and 4) -668, -648 and -752 J K-1 mol-1 
respectively. Peptides 2 and 3 were however linked with large fitting errors (table 
7.1, bottom). The small change in specific heat capacity with these linkers suggests 
that these peptide linkers are not particularly hydrophobic or hydrophilic. The trends 
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in Gibbs free energy, enthalpy and entropy of interaction with peptides 2, 3 and 4 are 
well conserved in all three PCNAs (table 7.1).  
7.3.4 Effect on thermodynamic values due to a hydrophobic spacer 
There is little change in the Gibbs free energy of interaction between peptide 
4 and peptide 5. Every interaction (except immobilised HsPCNA) shows a slight 
increase in the Gibbs free energy of interaction from peptide 4 to peptide 5, from -
30.3 to -30.0 kJ mol-1 for SpPCNA (+0.3 kJ mol-1) and -25.1 to -24.8 kJ mol-1 for 
LmPCNA (+0.3 kJ mol-1). HsPCNA showed a decrease of 0.2 kJ mol-1 in the Gibbs 
free energy of interaction with the addition of the hydrophobic spacer (table 7.1). The 
enthalpy of interaction between HsPCNA and peptides 4 and 5 is -65.0 and -63.7 kJ 
mol-1 respectively. The 1.3 kJ mol-1 increase in the enthalpy of interaction suggests 
that HsPCNA can create more non-bonded interactions with peptide directly linked 
to PEG than those directly linked to the hydrophobic octanoic acid linker. The 
entropy of interaction between HsPCNA and peptide 4 and 5 is -115 to -110 J Kmol-1 
respectively. The 5 J Kmol-1 increase in the entropy of interaction may suggest that 
peptide 5 is less flexible than peptide 4 even with increased length or that there is a 
larger solvation shell which can be released after binding (discussed below). Peptide 
5, with the addition of the hydrophobic spacer region, was determined to have a 
significantly reduced specific heat capacity of interaction (from -752 to -1310 J K-1 
mol-1). The large decrease (-558 J K-1 mol-1) in the specific heat capacity between 
peptides 4 and 5 is likely the result of the hydrophobic portion of the peptide linker 
becoming buried. The removal of hydrophobic groups from a system results in the 
release of waters from a solvation shell, which can give these values of specific heat 
capacity and potentially explain those for the entropy of interaction. The trends 
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between the binding of peptides 4 and 5 showing increased enthalpy and entropy of 
interaction are conserved in SpPCNA and LmPCNA (table 7.1). The values for 
specific heat capacity are however unreliable.  
7.3.5 Difference between Gibbs free energy of free and immobilised peptide 
The interaction of immobilised peptides with HsPCNA shows an increased 
(less favourable) Gibbs free energy of interaction when compared with that of 
immobilised HsPCNA (table 7.1, figure 7.11). With peptide 2 immobilised to a 
Streptavidin chip surface, there was only a weak signal and could not be interpreted 
(figure 7.9). Free peptide 3 when compared to immobilised peptide 3 gave an 
increased (less favourable) Gibbs free energy of interaction from -30.8 to -24.1 kJ 
mol-1 respectively. Free peptide 4 when compared to immobilised peptide 4 gave an 
increased Gibbs free energy of interaction from -30.7 to -27.6 kJ mol-1 respectively. 
Free peptide 5 when compared to immobilised peptide 5 gave an increased Gibbs 
free energy of interaction from -30.9 to -26.8 kJ mol-1 respectively. The increase in 
the Gibbs free energy of interaction may be the result of steric hindrance imposed by 
the Streptavidin (figure 7.13). The data suggests that the increase in spacer length has 
little effect on affinity for free peptides (using immobilised PCNA). However, the 
small decrease in the Gibbs free energy of interaction with increasing linker length of 
immobilised peptides (-24.1 to -27.6 kJ mol-1) (figure 7.14) may be associated with 
the method of immobilisation and may also be the result of steric interaction with 









 Dextran         Carboxyl groups 
Glass Slide         Gold Film 
 Figure 7-13. The binding of PCNA to a modified Streptavidin surface 
PCNA bound on the Streptavidin surface showing a slight burial in the dextran 
matrix which could result in greater entropic cost of the interaction. PCNA is 
associated to streptavidin and is coupled to the dextran matrix (black strands with red 
balls). The yellow strip represets the gold film and the blue is the glass slide. 
 
The trends in the Gibbs free energy of immobilised peptides shown for 
HsPCNA are consistent in both SpPCNA and LmPCNA (table 7.1). Gibbs free 
energy of interaction between immobilised peptide and SpPCNA showed a decrease 
with respect to peptide and HsPCNA. For example, immobilised peptide 4 with 
HsPCNA gave -27.6 kJ mol-1 and with SpPCNA gave -32.2 kJ mol-1. This 4.6 kJ 
mol-1 decrease in Gibbs free energy is in contradiction with values determined for 
immobilised PCNA (which had no significant change between these PCNAs). The 
greater affinity between SpPCNA and immobilised peptide could be due to some 
affinity between SpPCNA and the modified Streptavidin.  
7.3.6 Difference in enthalpy and entropy between free and immobilised 
PCNA 
The interaction between immobilised HsPCNA and immobilised peptide 
commonly show similar enthalpy of interactions. The enthalpy of interaction with 
immobilised HsPCNA for peptides 3-5 is within the range of -57.7 to -65.0 kJ mol-1. 
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Figure 7-14. The Gibbs free energy of the HsPCNA peptide interactions  
Thermodynamic properties of HsPCNA with peptides of different linker length (Å). 
Pink) immobilised peptide, Blue) immobilised PCNA. Top) Gibbs free energy, 
Middle) enthalpy and Bottom) entropy of interaction. This figure shows little 
difference in the free energy when PCNA is immobilised however differenaces with 
peptide length when peptide is immobilised. Immobilised peptides are of lower 
affinity as a result of a small increase in enthalpy of interaction and a decrease in 
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range of -53.8 to -65.2 kJ mol-1. The greatest deviation (3.9 kJ mol-1) is with 
interactions of HsPCNA and peptide 3, showing an increased enthalpy of interaction 
with immobilised peptide. This may be the result of part of the peptide being 
occluded from the HsPCNA binding site. Similar trends are shown in both SpPCNA 
and LmPCNA (table 7.1) however values determined for enthalpy are less reliable in 
these interactions. 
The entropy of interaction decreases when peptide is immobilised e.g. 
HsPCNA to free peptide 5 is -110 J Kmol-1 and HsPCNA to immobilised peptide 5 is 
-129 J Kmol-1. The slight increase in entropic cost of the interaction with 
immobilised peptide could be the result of the large PCNA molecule stabilising some 
portions of the dextran matrix. The entropy of interaction for immobilised HsPCNA 
with peptides 3-5 are within the range of -90.2 to -115 J Kmol-1 (∆24.8 J Kmol-1) and 
immobilised peptides 3-5 with free HsPCNA are within the range of -99.6 to -129 J 
Kmol-1 (∆29.4 J Kmol-1). These values demonstrate that the entropy of interaction for 
all peptides are affected similarly and are not dependent on spacer length (figure 
7.14). Similar trends of entropy are shown in both SpPCNA and LmPCNA, however 
values determined for entropy are less reliable. 
The values determined in this chapter will be compared with those 






CHAPTER 8. Conclusions from the PCNA peptide interaction studied 
The work presented in this thesis has been a thorough study of the peptide 
interactions displayed by PCNA from three different species. These studies have 
been performed by dynamic scanning fluorimetry, ITC, SPR and observed 
crystallographically. In this chapter, the results are discussed and differences 
between the analytical methods are analysed. 
The affinities determined in this thesis are put into context and compared to 
literature values. The thermodynamic analysis ascertained by SPR and the van’t Hoff 
plot are also compared to literature values. The PCNA-peptide interaction can then 
be broken down to find the contribution of each section of the peptide. 
8.1 The PCNA peptide interactions observed in this work show HsPCNA to 
have the tightest interaction 
The affinity data determined from this work has determined a series of Kds 
for the PCNA-peptide interactions (tables 8.1). Affinities for the HsPCNA and 
SpPCNA interactions for peptides 0-5 have been determined at a temperature of 
298K using DSF (chapter 5). Affinities for the HsPCNA, SpPCNA and LmPCNA 
interactions for peptides 0-5 have been determined at two temperatures (283K and 
298K) using ITC (chapter 6). Affinities for the HsPCNA, SpPCNA and LmPCNA 
interactions for peptides 1-6 have been determined at a range of temperatures (283K-
313K at 5K intervals) using SPR (chapter 7). These peptides are represented in figure 
8.1. 
The HsPCNA-peptide interactions studied in this work, as determined by 
SPR, DSF and ITC, was shown to have the greatest affinity while the LmPCNA 
interactions have the lowest affinity (table 8.1), see SPR analysis of peptide 2 for  
 
 222 
Peptide0 –                                  KKRQTSMTDFYHSKRRLIFS 
Peptide1 –                                  KRRQTSMTDFYH 
 Peptide2 –                           Bio-KRRQTSMTDFYH 
 Peptide3 –                  Bio-PEG-KRRQTSMTDFYH 
 Peptide4 –         Bio-PEG-PEG-KRRQTSMTDFYH 
 Peptide5 – Bio-PEG-PEG-Ahx-KRRQTSMTDFYH 




Figure 8-1. The peptides investigated in this work 
Figure showing the peptides used in SPR experiments carried out in this study.  
Top) Peptides 0-6 showing shorthand forms of all 6 peptides. Peptides 1-6 all have 
the same peptide sequence. Peptide 1 and 6 are untagged and peptide 6 has a F150A 
point mutation on peptide 6. Peptides 2-5 with biotin tags and linkers made of PEG 
and a hydrophobic spacer (Ahx).  
Bottom) Peptides 2-5, showing the biotin tags and the chemical sequence of the 






















Peptide (SPR) DSF ITC 
0 NI NA 0.107µM 0.004µM 
1 0.84µM NA 13.5µM 0.470µM 
2 3.16µM NI 15.0µM 0.375µM 
3 3.71µM 61.8µM 16.2µM 0.230µM 
4 3.72µM 16.5µM 10.2µM 1.12µM 
5 3.46µM 20.0µM 9.68µM 0.670µM 









0 NI NA 0.012µM 0.010µM 
1 1.20µM NA 1.82µM 0.062µM 
2 3.64µM NI 4.53µM 0.240µM 
3 5.07µM 4.52µM 5.10µM 0.410µM 
4 4.55µM 2.19µM 3.91µM NI 
5 4.89µM 2.31µM 5.08µM NI 









0 NI NA NP 0.426µM 
1 10.3µM NA NP 1.49µM 
2 32.5µM NI NP 1.63µM 
3 42.5µM 805µM NP NI 
4 40.2µM 144µM NP NI 
5 45.9µM 347µM NP NI 
6 217µM NA NP NI 
 
Tables 8-1. The Kd of interaction between PCNA and peptide at 298K 
The interaction of peptides with HsPCNA (top), SpPCNA (middle) and LmPCNA 
(bottom) at 298K. These tables show the affinities determined by the four different 
methods; SPR (immobilised PCNA), SPR (immobilised peptide), DSF and ITC. The 
affinities by these different techniques all show reasonable agreement, within ~1 
order of magnitude. HsPCNA shows the greatest PCNA peptide affinity, and  
LmPCNA shows the lowest PCNA peptide affinity. 
NA - Not Applicable 
NI - Not Interperatable 





HsPCNA (3.16µM), SpPCNA (3.64µM) and LmPCNA (32.5µM). In all methods the 
peptide 0 interaction is the strongest with the interaction with peptide 6 being the 
weakest and peptide 2-5 having similar affinities e.g. DSF analysis of HsPCNA for 
peptide 0 (107nM), SPR analysis of HsPCNA for peptides 2-5 (~3.5µM) and peptide 
6 (128µM) (table 8.1). 
These values clearly demonstrate that HsPCNA has the strongest interaction 
for peptides based on p21 PIP box region. LmPCNA has a significantly weaker 
interaction with these peptide regions. Peptide 0 had the strongest interaction of all 
the peptides as a result of the increased peptide length. Peptides with linker regions 
all showed very similar affinities. 
8.1.1 Comparison of the PCNA peptide affinities gave good agreement 
between different techniques used in this work 
PCNA peptide interactions can be compared between these different 
analytical methods at 298K (table 8.1). This comparison shows reasonable agreement 
between different methods validating the determined values. In all instances, ITC 
presented a greater affinity for the PCNA peptide interaction. The values for the Kd 
of interaction determined by SPR and DSF showed very similar values e.g. HsPCNA 
for peptide 2 gives 3.16µM by SPR and 15.0µM by DSF; SpPCNA for peptide 2 
gives 3.64µM by SPR and 4.53µM by DSF. The similarity of these values validates 
these methods. 
The SPR analysis of immobilised peptides and immobilised PCNA gave 
different values. As discussed in chapter 7, the peptide, when immobilised, shows a 
reduced affinity (table 8.1); likely as a result of steric hindrance from Streptavidin. 
The ITC analysis deviated by the greatest degree from the values determined by SPR 
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and DSF. In all instances, ITC presented a greater affinity and the thermodynamic 
values were unreliable for the PCNA-peptide interactions, discussed in chapter 7, as 
a result of the slight uncertainty in the peptide concentrations. This slight uncertainty 
has a significant effect on the determined thermodynamic values determined by ITC 
experiments. 
8.1.2 Thermodynamic values of the PCNA peptide interaction gave 
consistent results from the van’t Hoff analysis of SPR data 
Thermodynamic values for the PCNA-peptide interaction have been derived 
from this work. The Gibbs free energy of interaction has been determined by DSF, 
ITC and SPR, as this can be calculated from Kd of interaction. The Gibbs free energy 
of interaction can be used to determine the thermodynamic values of the interaction 
as shown in equation 6.2.  
6.2) G H T S∆ = ∆ − ∆  
ITC analysis showed clearly that the interaction was enthalpically favourable and 
entropically unfavourable. The non-linear van’t Hoff analysis of SPR data gave 
values for the enthalpy and entropy of interaction for HsPCNA with peptides 1-6 
(table 8.2). These values showed a logical consistency. There was a decrease 
(increased favourability) in the enthalpy of interaction with increasing linker length 
(-49.2 – -65.0 kJ mol-1). The entropy of interaction decreased (decreased 
favourability) with increasing spacer length (-58.9 – 115 J Kmol-1). The non-linear 
van’t Hoff analysis showed a decreasing (greater freedom of water upon interaction) 
specific heat capacity of interaction with increasing peptide hydrophobicity (-648 – -
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-28.4 -25.5 -25.1 -25.1 -24.8 -20.4 
 
Table 8-2. Thermodynamic values derived from the non-Linear van’t Hoff plots 
of immobilised PCNA interactions with free peptide by SPR 
 
Table showing the values of the thermodynamic values of PCNA-peptide 
interactions determined by the non-linear van’t Hoff analysis. The enthalpy, entropy, 
specific heat capacity and Gibbs free energy of interactions are grouped by PCNA 
species. The values for every peptide are shown. This demonstrates an enthalpically 
favourable, entropically unfavourable and a Gibbs free energy which demonstrates 
this to be a spontaneous interaction. HsPCNA demonstrates an increasingly 
favourable enthalpy and increasingly unfavourable entropy with increasing peptide 
length. This is consistent with increasing number of non-covalent interactions and 






 The thermodynamic analysis of HsPCNA with peptide 1 and peptide 6 (the 
point mutant) showed some clear differences. There was little change in the enthalpic 
contributions, however a substantial increase in entropic cost of interaction with 
peptide 6. Peptide 1 showed a greater entropy and ∆Cp than peptide 6, due to the 
increased freedom of waters with peptide 1. 
8.2 Literature values for the PCNA peptide interaction have been studied with 
a range of peptides 
The PCNA-peptide interaction has been previously investigated to give the 
peptide consensus sequence and the affinity of interaction. These have determined 
the positions of the p21 protein involved in the PCNA interaction (figure 8.2) (Chen, 
J. J. et al 1996b). This work showed that only the C-terminus is required for the 
binding activity of p21 to PCNA. This early evidence showed the region of p21 
which contained the PCNA interacting protein (PIP) box (figure 8.2) (Chen, J. J. et al 
1996b; Warbrick, E. et al 1995).  
 PCNA from different sources e.g. H. sapiens, S.cerevisiae, S.pyogenes, E.coli 
and RB69 phage; have been analysed for the interaction from a variety of peptides 
(table 8.3). Peptides have been analysed from a variety of sources from different 
proteins and different species. H. sapiens proteins (p21, p66 and FEN1) have been 
analysed. S.pyogenes (DNA polymerase C), S.aureus (DNA polymerase C), E.coli 
(DNA polymerase III, DNA polymerase II) and RB69 (gp43) have also been 
analysed (table 8.3, figure 8.3).  
Point mutants of these peptides have also been studied. The p21 mutants 
(M147A) and (D149A) (Zheleva, D. I. et al 2000) and the p21 mutants (D52A) and 




p21  (1-164)       + 
p21  (1-90)        - 
p21N1  (1-129)       - 
p21N2  (1-150)       - 
p21C  (87-164)               + (15.4nM) 
p21C1  (106-164)               + (10.0nM) 
p21C2  (126-164)               + (12.0nM) 
p21M  (55-150)       - 
p21M1  (55-129)       - 
 
Figure 8-2. The interaction of HsPCNA with sections of p21 
The interaction of different sections of the p21 protein with HsPCNA as determined 
in (Chen, J. J. et al 1996b). This figure shows the requirement of the C-terminal 
region for the association to PCNA in H. sapiens. It is also demonstrated that there is 
no other section in the p21 protein which is essential for PCNA association. The Kd 
of interaction between PCNA - p21C (189-164) was determined to be 15.4 nM and 
p21C2 (126-164) was 12nM at 37°C (Chen, J. J. et al 1996b). Modified from (Chen, 





   Hs p21   GRKRRQTSMTDFYHSKRRLIFS  (139-160) 
   Hs p66   GKANRQVSITGFFQRK    (451-466) 
   Hs FEN1  RQGSTQGRLDDFFKVTGSLSSA  (332-353) 
   S.py DNA polC MPEDNQLSLFDDFF    (1452-1465) 
   S.au DNA polC LPDKAQLSIFDM    (1427-1438) 
   Ec DNA pol III LIGSEQVELEFD    (1149-1160) 
   Ec DNA pol II TLMTGQLGLF    (774-783) 
   RB69 gp43      ASLDFLFG    (891-898) 
 
Figure 8-3. PIP box sequences of different PCNA interaction proteins 
A selection of some of the peptide sequences used in the characterisation of the 
PCNA binding interface. These interacting peptides are from H. sapiens proteins 
(p21, p66 and FEN1), S.pyogenes (DNA polymerase C), S.aureus (DNA polymerase 
C), E.coli (DNA polymerase III, DNA polymerase II) and RB69 (gp43). The Hs p21 
peptide has the residues involved in the PIP box sequence, Q-x-x-h-x-x-a-a, where x 














Peptide Sequence Affinity Method Ref 
Hs p21 Full length  (1-164) 2.55nM SPR 1 
Hs p21 Full length  (1-164) 320nM SPR 2 
Hs p21 Full length  (1-164)  (D52A) 240nM SPR 2 
Hs p21 Full length  (1-164) (H152A, K154A, R155A, R156A) 39.0µM SPR 2 
Hs p21  (75-164) 4.10µM SPR 2 
Hs p21  (87-164) 15.4nM Rad* 3 
Hs p21  (106-164) 10nM SPR 4 
Hs p21  (126-164) 12.0nM Rad* 3 
Hs p21  (139-160)         GRKRRQTSMTDFYHSKRRLIFS  2.30nM SPR 1 
Hs p21  (139-160)         GRKRRQTSMTDFYHSKRRLIFS  82.6nM ITC 5 
Hs p21  (141-160)           KRRQTSMTDFYHSKRRLIFS  82.6nM ITC 5 
Hs p21  (141-160)           KRRQTSMTDFYHSKRRLIFS  87.7nM ITC 6 
Hs p21  (141-160) (M147A)   KRRQTSATDFYHSKRRLIFS  - ITC 6 
Hs p21  (141-160) (D149A)   KRRQTSMTAFYHSKRRLIFS  1.28µM ITC 6 
Hs p66  (451-466)         GKANRQVSITGFFQRK  15.6µM ITC 5 
Hs p66  (451-472) GKANRQVSITGFFQRKRRLIFS  1.54µM ITC 5 
Hs FEN1 Full length  (1-370) 60nM SPR 4 
Hs FEN1  (- C terminal region) (1-363) - SPR 4 
Hs FEN1  (332-353)         RQGSTQGRLDDFFKVTGSLSSA  59.9µM ITC 5 
H. sapiens 
Synthetic                     SAVLQKKITDYFHPKK 100nM ITC 6 
Hs p21 Full length (1-164) ~40nM SPR 1 S.cerevisiae 
Hs p21  (139-160)         GRKRRQTSMTDFYHSKRRLIFS  ~200nM SPR 1 
Spy Pol C  (1446-1465) MGILGNMPEDNQLSLFDDFF  1.50µM Fluor 7 
S.pyogenes 
Sa Pol C            DELGSLPNLPDKAQLSIFDM (1419-1438) 2.70µM Fluor 7 
Ec Pol III  GATWRVSPSDRLLNDLRGLIGSEQVELEFD (1131-1160) 3.95µM ITC 7 
Ec Pol III            RLLNDLRGLIGSEQVELEFD (1141-1160) 3.06µM ITC 7 
Ec Pol III                       SEQVELEFD (1152-1160) 910nM ITC 7 
Ec Pol III                       IGQADMFGV (918-926) ≥15µM ITC 7 
Ec Pol II                    TLMTGQLGLF (774-783) 1.70µM ITC 7 
E.coli 
Synthetic                        LQLELELDF 1.80µM ITC 7 
gp43 Full length (wild type) 1.10µM ITC 8 
RB69 
Synthetic                       CSLDFLFG 7.00µM ITC 8 
 
Table 8-3. Previous affinities determined in the PCNA peptide interaction 
 
Table showing the PCNA-peptide interaction partners with species of PCNA, the 
interaction partner species, and the source protein. The sequences of the peptide with 
PIP box are aligned. The affinity of interaction is shown, as well as the analysis 
method in each publication. These results are organised by PCNA species and 
peptide. 
 
The source protein represents the source organism where Hs is H. sapiens, Spy is 
S.pyogenes, Sa is S.aureus, Ec is E.coli 
 
Methods are represented where Rad* is a radioactivity pull-down assay as described 
in (Chen, J. J. et al 1996b) and Fluor is a fluorescence based assay as described in 
(Georgescu, R. E. et al 2008). 
 
Ref are References: 1 is (Gibbs, E. et al 1997), 2 is (Knibiehler, M. et al 1996), 3 is 
(Chen, J. J. et al 1996b), 4 is (Chen, J. J. et al 1996a), 5 is (Bruning, J. B. and 
Shamoo, Y. 2004), 6 is (Zheleva, D. I. et al 2000), 7 is (Georgescu, R. E. et al 2008) 







investigated. These mutations allowed the contribution of the residues to be 
investigated (table 8.3). 
8.2.1 A broad range of affinities have been previously determined for the 
PCNA peptide interaction 
Literature values for the analysis of peptide binding to PCNA have been 
determined using peptides from a diverse number of sources, including synthetic 
peptides for a broad selection of PCNAs. These affinities have been derived by 
different techniques e.g. ITC and SPR (table 8.3). The affinities derived from the 
range of PCNAs and peptides are from 2.3nM (HsPCNA with H. sapiens p21 (139-
160) as analysed by SPR) (Gibbs, E. et al 1997) to 59.9µM (HsPCNA with H. 
sapiens FEN1 (332-353) as analysed by ITC) (Bruning, J. B. and Shamoo, Y. 2004). 
The table of interactions (table 8.3) shows a range of affinities for S.cerevisiae 
PCNA of 40-200nM, S.pyogenes 1.5-2.7µM, E.coli 0.91-15µM and RB69 1.1-
7.0µM.  
8.2.2 Different methods of affinity analysis have given different ranges of 
the HsPCNA peptide interaction 
 Early affinity values for the PCNA-peptide interaction were obtained by pull-
down assays of radio-labelled PCNA (Chen, J. J. et al 1996b). This method involved 
the incubation of radio-labelled PCNA with peptides (figure 8.2) and the quantity of 
PCNA pulled down was measured. This technique gave values for the Kd of 
interaction at 37°C: the affinity of p21 (89-164) was 15.4nM and p21 (126-164) was 
12.0nM (figure 8.2 and table 8.3). 
 ITC has been used to determine affinity data for this interaction. The 
HsPCNA H. sapiens p21 (139-160) (Bruning, J. B. and Shamoo, Y. 2004) and (141-
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160) (Zheleva, D. I. et al 2000) have been determined in different publications. 
These different publications gave values for this interaction very similar to each 
other, 82.6nM and 87.7nM respectively (table 8.3).  
 SPR analysis of the HsPCNA p21 interaction has given affinity data. 
Interactions with p21 (106-164) (Chen, J. J. et al 1996a) (139-160) (Gibbs, E. et al 
1997) has given values of 10nM and 2.3nM respectively. This is in close agreement 
to values previously determined (table 8.3). Within values determined from SPR 
data, there is variance. The interaction of the HsPCNA and full length p21 had a 
wide range of affinities from 2.55nM (SPR) (Gibbs, E. et al 1997) to 320nM (SPR) 
(Knibiehler, M. et al 1996). 
SPR analysis of the PCNA peptide interactions gave some values for the 
kinetics of the interaction (Knibiehler, M. et al 1996). This analysis of full length p21 
with HsPCNA gave a kon of 1.1×10
3 M-1s-1 and a koff 3.7×10
-4 s-1. The kinetics of p21 
derivatives are also presented e.g. p21 (D52A) gave a kon of 1.1×10
3 M-1s-1 a koff 
2.7×10-4 s-1, p21 (H152A, K154A, R155A, R156A) gave a kon of 1.0×10
2 M-1s-1 a koff 
3.9×10-3 s-1 and p21 (75-164) gave a kon of 2.1×10
3 M-1s-1 and a koff 8.7×10
-3 s-1 
(Knibiehler, M. et al 1996). The affinities given here show relatively slow on and off 
rates. This slow rate is the result of large peptide lengths and reformations of the PIP 
box binding sequence. 
8.2.3 A broad range of thermodynamic values have been derived in the 
literature using ITC 
HsPCNA-p21 interactions: Thermodynamic values derived from different methods 
in the literature show that this interaction is enthalpically favourable and entropically 
unfavourable. The enthalpic contribution has a greater effect upon the Gibbs free 
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energy than the entropic. Two previous examples have shown a slight entropic 
favourability of this interaction (Zheleva, D. I. et al 2000). The interaction of 
HsPCNA with p21 (141-160) and with a synthetic consensus sequence have shown 
entropies of 0.356 and 2.55 J Kmol-1 respectively (table 8.4) (Zheleva, D. I. et al 
2000). These entropically favourable interactions are in contradiction to other 
interactions outlined in the literature (table 8.4). The literature shows a broad range 
of thermodynamic values which infers these may not be reliable. 
HsPCNA interactions with peptides from other sources: The interaction of 
HsPCNA with a series of peptides derived from different protein sources have all 
demonstrated to be enthalpically favourable and entropically unfavourable (Bruning, 
J. B. and Shamoo, Y. 2004). p21a (139-160), p21b (141-160), p66a (451-466), p66b 
(451-472) and FEN1 (332-353) have been analysed. Interaction of HsPCNA with all 
these ranges of peptides give a consistently negative enthalpy and entropy (Bruning, 
J. B. and Shamoo, Y. 2004) (table 8.4). 
E.coli PCNA-peptide interactions: The binding of E.coli DNA polymerase III 
peptides to the E.coli DNA polymerase β subunit have shown an enthalpically 
favourable and are entropically unfavourable (Georgescu, R. E. et al 2008). The 
interaction of E.coli PCNA for peptides of different lengths derived from DNA 
polymerase III (1131-1160), (1141-1160) and (1152-1160) were analysed. 
Interaction of E.coli PCNA with DNA pol III (1131-1160), (1141-1160) and (1152-
1160) shows a negative enthalpy and negative entropy of interaction (table 8.4) 
(Georgescu, R. E. et al 2008). These values show a similar mode of interaction 
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(141-160) 1.0 87.7nM -40.8 0.36 -40.9 
(Zheleva, D. 




0.8 1.28µM -47.2 -42.8 -34.4 (Zheleva, D. I. et al 2000) 
p66 
(451-466) 




















0.7 100nM -39.8 2.55 -40.6 (Zheleva, D. I. et al 2000) 
E.coli DNA polymerase β interacting with E.coli peptides 
DNA pol III 
(1131-1160) 
1.3 3.95µM -37.5 -24.3 -30.3 
(Georgescu, 
R. E. et al 
2008) 
DNA pol III 
(1141-1160) 
1.2 3.06µM -38.2 -19.9 -32.2 
(Georgescu, 
R. E. et al 
2008) 
DNA pol III 
(1152-1160) 0.9 0.91µM -47.4 -47.2 -33.4 
(Georgescu, 
R. E. et al 
2008) 
RB69 phage PCNA interacting with gp43 protein 
gp43 0.8 1.10µM -58.6 -82.8 -33.9 (Alley, S. C. 
et al 2001) 
 
Table 8-4. Thermodynamic values of interactions determined by ITC in the 
literature 
Table showing the previously published thermodynamic values of the PCNA peptide 
interaction as determined by ITC. This table gives stoichiometry, Kd, enthalpy, 
entropy, Gibbs free energy and the published reference presenting these values.  
The values shown here are split between the human (top), E.coli (middle) and RB69 
phage (bottom). All these interactions are enthalpically favourable and commonly 





RB69 PCNA interactions: The interaction of GP45 (W92F/Y165W/W199F) phage 
PCNA with GP43 (a DNA polymerase) has been analysed by ITC and demonstrated 
an enthalpically favourable and entropically unfavourable (table 8.4) (Alley, S. C. et 
al 2001). This interaction shows that the PCNA interaction for this, the most 
structurally divergent PCNA, has a similar mode of interaction. 
8.3 The comparison of literature values and those derived in this work showed 
similar affinities and thermodynamic values 
 Literature values showed close agreement with values in this work. The well 
characterised HsPCNA peptide 0 interaction has been determined to have an affinity 
of 87.7nM (table 8.4) (Zheleva, D. I. et al 2000) which is in close agreement to the 
107nM affinity determined by DSF in this work (table 8.1).  
 HsPCNA has been shown to have a 10-fold greater affinity for p21 than 
lower eukaryotes (Gibbs, E. et al 1997). This work has shown a similar affinity of 
HsPCNA and SpPCNA for p21 peptide with an average of ~0.2 to 0.4 fold weaker 
for a truncated peptide (p21 (141-152)). Surprisingly, the longer p21 peptide (141-
160) demonstrated a greater affinity for SpPCNA than HsPCNA in both DSF and 
ITC. The shorter peptides were not analysed against HsPCNA, the most similar 
interaction studied was that of the 9mer peptide for E.coli PCNA. This interaction 
gave a Kd of 0.91µM (table 8.3) whereas the HsPCNA to p21 (141-152) interaction 
gave a Kd of 0.84µM (table 8.1). 
 There is reasonable agreement between the thermodynamic values 
determined in this work (table 8.2) and those of the literature values (table 8.4). All 
interactions determined in this work give a negative enthalpy (favourable) and 
negative entropy (unfavourable) of interaction. Literature values show the same trend 
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(table 8.4) as determined by ITC. The interaction of the greatest similarity in this 
work, measuring the thermodynamic values of HsPCNA with peptide 0 by ITC, gave 
an enthalpy of -88.5 kJ mol-1; entropy of -159 J Kmol-1; and Gibbs free energy of -
43.7 kJ mol-1. These values are in reasonable agreement with those determined in the 
literature; with an enthalpy of -122 kJ mol-1; entropy of -267 J Kmol-1; and Gibbs 
free energy of -42.3 kJ mol-1 (table 8.4) (Bruning, J. B. and Shamoo, Y. 2004). The 
shorter peptides were not analysed against HsPCNA, the most similar interaction 
studied was that of the 9mer peptide for E.coli PCNA. This interaction gave an 
enthalpy of -47.4 kJ mol-1; entropy of -47.2 J Kmol-1; and Gibbs free energy of -33.4 
kJ mol-1 (table 8.4) (Georgescu, R. E. et al 2008). The HsPCNA to p21 (141-152) 
interaction gave an enthalpy of -49.2 kJ mol-1; entropy of -58.9 J Kmol-1; and Gibbs 
free energy of -31.6 kJ mol-1 (table 8.2). The similarity of these values increases the 
confidence in the data obtained in this work. 
8.3.1 Differences between some literature values and those derived in this 
work may be due to broad range of values given in the literature 
Some values of the PCNA peptide interaction (discussed above, section 8.3) 
agree closely with those determined in this work. Other values shown in the literature 
(table 8.3) differ e.g. the interaction of the HsPCNA and full length p21 had a wide 
range of affinities from 2.55nM (SPR) (Gibbs, E. et al 1997) to 320nM (SPR) 
(Knibiehler, M. et al 1996). The most similar analysis to those carried out in this 
work was the interaction of HsPCNA to p21 (141-160) (Zheleva, D. I. et al 2000) 
which returned similar affinities. The interaction of the short peptides were not 
analysed for HsPCNA; however the interaction of E.coli PCNA for 9mer peptides 
(table 8.3) gave affinities similar to that determined in this work (table 8.1). 
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The thermodynamic values derived in this work for the HsPCNA peptide 
interactions (table 8.2) were self-consistent. These values gave increasing enthalpic 
return and increasing entropic cost with increasing peptide length (table 8.2) which is 
the logical progression due to longer more flexible molecules being taken out of 
solution and forming more intermolecular bonds to stabilise this. Thermodynamic 
values presented in the literature are less consistent with some interactions showing 
an entropically favourable interaction (table 8.4) (Zheleva, D. I. et al 2000). Values 
with little similarity to published data may well be the result of published values 
being poorer. 
8.3.2 HsPCNA and PCNA from lower eukaryotes have been shown to have 
significantly different affinities which is not observed in this work 
The interaction of HsPCNA with p21 peptides are in close agreement with 
the literature values. There has been a previous study comparing the binding affinity 
of p21 (139-160) to HsPCNA and S.cerevisiae PCNA (Gibbs, E. et al 1997). This 
study demonstrated that the interaction with S.cerevisiae PCNA had an ~100 fold 
reduction in affinity (2.3nM-200nM) (table 8.3). There is a disagreement with 
literature values showing a slight increase in affinity for the interaction of peptide 0 
with fungal PCNA compared to that of HsPCNA (table 8.1). This may be the result 
of specific differences in the PIP box binding interface of SpPCNA and ScPCNA.  
The SpPCNA interactions for p21 (141-152) in this work only gave a slight 
reduction in affinity compared to that of HsPCNA (table 8.1). This slight reduction in 
affinity may be a result of the similarity of the core interactions at this PIP box 
region. With the increase in the peptide length, literature values give a 
disproportional increase in affinity for HsPCNA; this may be the result of larger 
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number of interactions between the peptide and IDCL which are lost when p21 
interacts with SpPCNA. This is demonstrated in chapter 3, as the core section of the 
p21 peptide PIP box (141-152) forms the same number of hydrogen bonds. There has 
been no previous literature on the Leishmania PCNAs affinity; however, this 
interaction is clearly weaker than that of eukaryote PCNA. The reduction in affinity 
could be the result of poorly conserved residues at the PIP box binding interface also 
discussed in chapter 3. 
8.4 Thermodynamic contributions of different sections of the p21 peptide can 
be determined 
A large quantity of binding data and thermodynamic analysis has been carried 
out on the interaction between PCNA and peptides derived from p21. This 
information has been obtained with peptides of differing lengths and with point 
mutations. Thermodynamic analysis of point mutants and peptides of differing 
lengths have allowed the energetic contribution of different sections to be analysed. 
The thermodynamic values of the two main sections and two side chains are 
summarised in this section.  
8.4.1 Peptides of different lengths have different thermodynamic 
contributions to the binding interaction 
Thermodynamic values of the large peptides used in this study and in the 
literature (p21 (141-160)) have been shown (table 8.5). The thermodynamic values of 
the shorter peptide (p21 (141-152)) have also been shown in this study (table 8.5). 
The interaction with the weaker binding peptide resulted in a difference in Kd of 
776nM, enthalpy of -34.6 kJ mol-1, entropy of -83.1 J Kmol-1 and Gibbs free energy 
of -10.7 kJ mol-1. 
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The thermodynamic values derived for the different peptides infer that the C-
terminal section of the p21 peptide (153-160), which interacts with the IDCL, 
provides -34.6 kJ mol-1 of enthalpy and -83.1 J Kmol-1 of entropy. This increases the 
favourability of the interaction by a Gibbs free energy of -10.7 kJ mol-1. 
8.4.2 Different point mutations have been analysed in literature and in this 
work to give the thermodynamic contribution of these side chains 
Thermodynamic values of peptides derived from p21 have been analysed 
(table 8.5) with point mutations in specific sites. The thermodynamic values of the 
point mutant peptides (141-160, D149A and 141-152 F150A) have been derived in 
the literature and in this work (table 8.5). The thermodynamic values of the p21 
(141-160, D149A) mutant peptide and that of the average p21 (141-160) peptide 
have been determined and can be compared (table 8.5). The thermodynamic values 
of the p21 (141-152, F150A) mutant peptide and that of the p21 (141-152) peptide 
have been determined and can be compared (table 8.5). The result of the D149A 
mutation in the thermodynamic values gave a difference in Kd of 1.22 µM, enthalpy 
of -36.6 kJ mol-1, entropy of -100 J Kmol-1 and Gibbs free energy of -7.9 kJ mol-1. 
The result of the F150A mutation in the thermodynamic values gave a difference in 
Kd of 127 µM, enthalpy of 0.4 kJ mol
-1, entropy of 32.5 J Kmol-1 and Gibbs free 
energy of -9.3 kJ mol-1. 
The thermodynamic values derived for the different peptides give information 
about the D149 side-chain of the p21 peptide (141-160), which exists at the helix 
region of the p21 peptide. This side-chain provides -36.6 kJ mol-1 of enthalpy and -
100 J Kmol-1 of entropy. The D149 side-chain increases the favourability of the 
interaction by a Gibbs free energy of -7.9 kJ mol-1. The F150 side chain of the p21  
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HsPCNA interacting with H. sapiens peptides 
p21 
(141-160) 
1.0 82.6nM -122 -267 -42.3 ITC 
(Bruning





(141-160) 1.0 87.7nM -40.8 0.36 -40.9 ITC 
(Zheleva










0.8 1.28µM -47.2 -42.8 -34.4 ITC 
(Zheleva
, D. I. et 
al 2000) 
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Table 8-5. Thermodynamic values of interactions in the literature 
Table showing the energetic properties of different peptides based on the H. sapiens 
p21. This table shows the effect of peptide length and point mutations. The 
energetics of the p21 (141-160) interaction have been published twice and given 
vastly different values (Bruning, J. B. and Shamoo, Y. 2004; Zheleva, D. I. et al 
2000). A similar peptide has been studied in this work and has given energetic values 
which lie between these published values, suggesting that those presented here may 
be correct. The p21 (141-160) (D149A) mutant is significantly weaker binding than 
the wild-type (Zheleva, D. I. et al 2000) and the differences in the thermodynamic 
values from the above average are the result of this point mutation. A peptide based 
on p21 (141-152) investigated in this work has given thermodynamic data and an 
F150A point mutation has shown differences in the thermodynamic values as a result 









peptide (141-152), associates to a hydrophobic surface at the PIP box binding 
interface. This side-chain provides 0.4 kJ mol-1 of enthalpy and 32.5 J Kmol-1 of 
entropy. The F150 side-chain increases the favourability of the interaction by a Gibbs 
free energy of -9.3 kJ mol-1. 
8.4.3 The energetic contributions of different sections of the p21 peptide 
have biochemical reasons which affect the overall binding interaction 
Contribution of p21 (141-152): The interaction of p21 (141-152) to HsPCNA gives 
an enthalpy of -49.2 kJ mol-1, entropy of -58.9 J Kmol-1 and a Gibbs free energy of -
31.6 kJ mol-1 (table 8.5) (figure 8.4). The thermodynamic values for this interaction 
are the result of the structural interactions taking place, which has been shown in 
chapter 3. The interaction with the section of p21 (143-152) has been studied in 
HsPCNA, SpPCNA and LmPCNA. The interaction between p21 (143-152) and 
HsPCNA gives a buried surface area of 1200 sq.Å and allows the formation of seven 
hydrogen bonds (figure 8.5) (Gulbis, J. M. et al 1996).  
Contribution of p21 (153-160): The interaction of p21 (153-160) to HsPCNA gives 
an enthalpy of -34.6 kJ mol-1, entropy of -83.1 J Kmol-1 and a Gibbs free energy of -
10.7 kJ mol-1 (table 8.5) (figure 8.4). The thermodynamic values for this interaction 
are the result of the structural interactions taking place which has been shown in 
chapter 3. The interaction with the section of p21 (153-160) has been studied in 
HsPCNA and SpPCNA. The interaction between p21 (143-152) and HsPCNA gives 
a buried surface area of 1060 sq.Å and allows the formation of thirteen hydrogen 
bonds (figure 8.5) (Gulbis, J. M. et al 1996). This section of peptide is shorter than 
p21 (143-152), yet it is however more entropically unfavourable, as a result of the 






Figure 8-4. The energetic contributions of the p21 (141-160) peptide 
 
Figure showing the PCNA trimer (green lines) bound with the p21 (141-160) 
(cartoon and stick) with the 143-152 section (yellow), D149 (cyan), F150 (blue) and 
153-160 section (red). The energetics are shown for these sections in the appropriate 
colour with the addition of the point mutant side chains as a difference from alanine.  
 
 
∆∆H -34.6 kJ mol-1 
∆∆S -83.1 J Kmol-1 
∆H -49.2 kJ mol-1 
∆S -58.9 J Kmol-1 
∆∆H -36.6 kJ mol-1 
∆∆S -100 J Kmol-1 
∆∆H 0.4 kJ mol-1 
∆∆S 32.5 J Kmol-1 
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 Figure 8-5. The four sections of 




Figure showing the different 
sections of the p21 (143-160) 
analysed in this work. The hydrogen 
bonds are represented in yellow for 
each of these sections which are 
coloured as in figure 8.4. These 
peptides are shown in the PIP box 
binding interface of HsPCNA 
shown in an electrostatic surface and 
colours 
 
A) The p21 (143-152) section 
represented in yellow.  Forming 
seven hydrogen bonds at the 
interface and gives a buried surface 
area of 1200 sq.Å. 
 
B) The p21 (153-160) section 
represented in red.  Forming thirteen 
hydrogen bonds at the interface and 
gives a buried surface area of 1060 
sq.Å. 
 
C) The p21 D149 side chain section 
represented in cyan.  This forms two 
hydrogen bonds with solvent not 
shown and results in no additional 
buried surface area. 
 
D) The p21 F150 side chain section 
represented in blue.  This forms no 
additional hydrogen bonds however 
results in an additional buried 
surface area of 170 sq.Å. The 
analysis of the interaction of this 
side-chain with HsPCNA by PISA 










Contribution of p21 (D149 side chain): The interaction of p21 (D149 side chain) to 
HsPCNA gives an enthalpy of -36.6 kJ mol-1, entropy of -100 J Kmol-1 and a Gibbs 
free energy of -7.9 kJ mol-1 (table 8.5) (figure 8.4). The thermodynamic values for 
this interaction are error prone as this is a result observed in only a single publication 
(Zheleva, D. I. et al 2000). The interaction of the D149 side-chain of p21 has been 
observed in HsPCNA, SpPCNA and LmPCNA. The interaction between the p21 
D149 side-chain and HsPCNA results in no additional buried surface areas and forms 
two hydrogen bonds via waters to other areas in the peptide (figure 8.5) (Gulbis, J. 
M. et al 1996). This residue forms on the helix in the p21 (141-152) peptide, and 
Alanine is a stronger promoter of helix formation than Aspartic acid (Blaber, M. et al 
1994; Blaber, M. et al 1993; Chellgren, B. W. and Creamer, T. P. 2006; Creamer, T. 
P. and Rose, G. D. 1994; Lewis, P. N. et al 1970; Oneil, K. T. and Degrado, W. F. 
1990; Padmanabhan, S. et al 1990; Richardson, J. M. et al 2005). Mutation to A150 
may increase the propensity for the peptide to be formed as a helix, increasing 
favourability of the interaction by reducing the entropic cost. 
Contribution of p21 (F150 side chain): The interaction of p21 F150 side-chain to 
HsPCNA gives an enthalpy of 0.4 kJ mol-1, entropy of 32.5 J Kmol-1 and a Gibbs 
free energy of -9.3 kJ mol-1 (table 8.5) (figure 8.4). The thermodynamic values for 
this interaction are the result of the structural interactions taking place, which have 
been shown in chapter 3. The interaction with the section of p21 F150 side-chain has 
been studied in HsPCNA, SpPCNA and LmPCNA. The interaction between p21 
F150 side-chain with HsPCNA gives a buried surface area of 170 sq.Å and allows 
the formation of no hydrogen bonds (figure 8.5) (Gulbis, J. M. et al 1996). The 
hydrophobic interaction of the F150 ring to the HsPCNA would be expected to 
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provide some favourable enthalpic contribution to the interaction. It can be argued 
that the solvation shell that surrounds the F150 ring would be held together by 
hydrogen bonds and impose an enthalpic cost to the complex formation. The release 
of waters can allow a favourable entropic contribution to the complex formation and 



















CHAPTER 9.  Conclusions and future work 
9.1 Overall coclusions of this work 
In this work PCNA from these three species have been prepared in milligram 
quantities for biochemical and biophysical studies. The previously unknown 
structure of LmPCNA has been solved in an uncomplexed form and also complexed 
with a dodecapeptide to a resolution of 3.0Å. A comparison of PCNA structures and 
their peptide complexes for the three species identifies structural differences which 
may be relevant in analysing thermodynamic contributions of binding.  
The binding affinities for these three PCNAs have been determined with a 
selection of peptides derived from the Hs p21 protein. This work has shown, using a 
selection of different techniques including Surface Plasmon Resonance (SPR), 
Isothermal Titration Calorimetry (ITC) and Dynamic Scanning Fluorimetry (DSF); 
that HsPCNA and SpPCNA have similar affinities for a 12mer peptide (Kd of ~1µM) 
however LmPCNA shows significantly weaker interactions (Kd of ~10µM). This is 
most likely due to divergence in the sequence and structure of LmPCNA. 
A systematic investigation by SPR on the effect of peptide linker length on 
binding has been carried out using a series of synthesised peptides with different 
lengths of chemical spacer. The series of streptavidin immobilised peptides show that 
longer spacers are required for the recovery of the PCNA peptide binding affinity. 
The results presented in this work indicate that a linker length of at least 20Å is 
required for measurable protein binding activity. This interaction is improved with 
longer peptide spacers.  
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9.2 Possible improvements to the crystal structure solutions 
The crystal structure described in chapter 3 had a low resolution and low 
completeness. It is likely that this is the result of the high (~70%) solvent content of 
these crystals. The loose crystal packing may be the result of the flexible loop 
domains holding the PCNA rings apart and not allowing a tight packing form. 
The problems associated to this flexible loop region may be alleviated by the 
limited proteolysis of the LmPCNA prior to crystallisation. Alternatively, a deletion 
mutant can be created to produce LmPCNA without this region and improve the 
crystal packing, and by extension, the crystal structure. 
9.2.1 Benefits of the improved structure of LmPCNA 
With a significantly more accurate structure solved, including the position of 
immobilised waters, modification to the PIP box binding interface upon peptide 
binding can be more accurately observed. These changes can reveal information 
regarding the mode of binding and account for the thermodynamic values determined 
in this work. 
The accurate protein structure of the L. major PCNA can also be used for 
structure based drug design. This can be used with the PIP box binding interface in 
both the complexed and uncomplexed forms. A study of this type may create new 
novel small molecule inhibitors which may lead to potential cures for Leishmaniasis 
detailed in chapter 1.  
9.3 Possible improvements to the thermodynamic values determined 
The thermodynamic values determined in this work appear to be genuine for 
the HsPCNA peptide interaction. This has, however, been solved by the van’t Hoff 
analysis of SPR affinity data. It is preferable for thermodynamic values to be 
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determined by ITC. ITC was attempted in this work, however slight uncertainties in 
the peptide concentrations and the high demand on the available peptide resulted in 
no thermodynamic values being determined by this method. Accurate peptide 
concentration can be obtained by quantitative amino acid analysis, allowing these 
experiments to be repeated with greater accuracy. 
9.3.1 Benefits of improved ITC data 
The ITC data cannot only give accurate determination of the enthalpy and 
entropy of an interaction, but also, when performed over a temperature range, the 
specific heat capacity of interaction. The values that may be determined using this 
method can validate those determined by SPR. This may also allow data to be 
determined for the SpPCNA and LmPCNA peptide interactions. Thermodynamic 
information on all three PCNAs can allow differences in the mode of interaction to 
be ascertained. These possible differences can then be exploited in the process of 
designing small molecule inhibitors. 
9.4 Further investigation into the effect of spacers in SPR experiments 
The effect of spacers on peptide affinity when immobilised to a sensor surface 
is apparent as shown in this work. The shorter peptides result in the PCNA peptide 
affinity to be drastically diminished. It has been clearly demonstrated that 
biotinylated peptides require spacers of >20Å in order to give reasonable affinities. 
This has however only been demonstrated in this peptide PCNA-interaction.  
The effect of spacers on the SPR data determined may fluctuate for protein-
DNA interactions or interactions with other peptides or other proteins. It is possible 
to study the effect of spacers in other interactions and determine if these effects are 
consistent in different interactions.  
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9.4.1 Benefits of further investigation into the effect of spacers in SPR 
experiments 
The immobilisation of ligand by Streptavidin in SPR experiments is simple 
and does not damage the interacting molecule. As a result, this method has 
significant advantages over other methods e.g. amine coupling. The requirement of 
the spacer is commonly assumed, however, values for the minimum spacer length for 
different interactions have not been determined. If this information were resolved, 
the method of SPR can be made more accessible to other divisions of sciences by the 
increased simplicity of ligand immobilisation and increased reliability of the 
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1.1 DNA and protein sequence details of PCNA 
1.2 DNA and protein sequence details of HsPCNA 
















Protein sequence of HsPCNA construct used in this work 
MGSSHHHHHH SSGLVPRGSH MLEMFEARLV QGSILKKVLE ALKDLINEAC 
WDISSSGVNL QSMDSSHVSL VQLTLRSEGF DTYRCDRNLA MGVNLTSMSK 
ILKCAGNEDI ITLRAEDNAD TLALVFEAPN QEKVSDYEMK LMDLDVEQLG 
IPEQEYSCVV KMPSGEFARI CRDLSHIGDA VVISCAKDGV KFSASGELGN 
GNIKLSQTSN VDKEEEAVTI EMNEPVQLTF ALRYLNFFTK ATPLSSTVTL 
SMSADVPLVV EYKIADMGHL KYYLAPKIED EEGS* 
 
 
1.3 Protein sequence details of SpPCNA 
Protein sequence of SpPCNA construct used in this work 
MRGSHHHHHH GIPMLEARFQ QAALLKKLLD AIKELVTDAN FDCNDNGISL 
QAMDSSHVAL VSMLIKSDGF EPYRCDRNIA LGINLNALSK VLRCAQNEDL 
VTLKAEDTPE VLNLVFESEK NDRISDYDVK LMDIDQEHLG IPDIEYDATI 
TMPAAEFQRI TRDLLTLSDS VTINASKEGV RFSCKGDIGN GSTTLKQHTD 
LSDQDQSIEI SLTQAVTLTF SLKYLAQFTK ATPLATRVTL SMSNDVPLLV 
EYKMESGFLR FYLAPKIGEE DEE* 
 
 
1.4 DNA and protein sequence details of LmPCNA 
















Protein sequence of LmPCNA construct used in this work 
MGSSHHHHHH SSGLVPRGSH MLEAQVQYAS LWKRLVECIN GLVNEANFDC 
NPGGLSIQAM DSSHVALVHM LLRDDCFVKY QCERNIILGL NLASLSKVLK 
IVDGNDSLSL RHDDDSDVVT LTSENPEKTR KCEYQLKLLE IEAESMGIPE 
MDYRSTVTLN SAEFAKIVRD MQVFGDTVTI AISKEGVKFS SSGDVGQGYT 
FLQAAGVSDR SAKSEVKSEV KAEARDEDEH EPISRRYNKA EGGNGAIGVE 

































1.5 ITC values derived for PCNA 
1.6 ITC values derived for HsPCNA 
[Peptide] 
(µM) 









Peptide0       
[87.75] 2.03 0.0213 -38.46 11.09 3.140 -41.60 
[33.81] 0.795 0.011 -96.99 -190.0 -53.76 -43.23 
[37.37] 0.882 0.0092 -88.53 -158.6 -44.88 -43.66 
Peptide1       
[154.5] 2.12 3.31 -46.48 -59.41 -16.81 -29.67 
[60.51] 0.829 1.3 -118.9 -307.1 -86.91 -32.00 
[66.88] 0.916 1.43 -107.6 -268.2 -75.90 -31.67 
Peptide2       
[145.9] 2.03 2.81 -26.18 13.81 3.9100 -30.09 
[47.63] 0.734 0.92 -80.17 -167.8 -47.48 -32.68 
[52.65] 0.664 1.01 -72.55 -141.4 -40.02 -32.53 
Peptide3       
[125.3] 3.9 -0.154 -9.270   -9.270 
[52.90] 0.995 5.29 -78.37 -175.7 -49.73 -28.64 
[58.46] 1.1 5.85 -70.88 -150.2 -42.51 -28.37 
Peptide4       
[113.2] 1.49 3.46 -37.37 -27.45 -7.770 -29.60 
[54.65] 0.72 1.68 -77.40 -162.8 -46.06 -31.34 
[60.41] 0.797 1.85 -70.00 -137.7 -38.96 -31.04 
Peptide5       
[103.7] 2.21 4.37 -26.22 10.00 2.830 -29.05 
[51.84] 1.1 2.18 -52.43 -76.99 -21.79 -30.64 
[57.30] 1.22 2.41 -47.45 -59.83 -16.93 -30.51 
 
Stoichiometry closest to 1.00 
[Peptide] 
(µM) 









P0 [37.37] 0.882 0.0092 -88.53 -158.6 -44.88 -43.66 
P1 [66.88] 0.916 1.43 -107.6 -268.2 -75.90 -31.67 
P2 [47.63] 0.734 0.92 -80.17 -167.8 -47.48 -32.68 
P3 [52.90] 0.995 5.29 -78.37 -175.7 -49.73 -28.64 
P4 [60.41] 0.797 1.85 -70.00 -137.7 -38.96 -31.04 
P5 [51.84] 1.1 2.18 -52.43 -76.99 -21.79 -30.64 
 
Biophysical characteristics of HsPCNA-peptide interactions at 283K. Each ITC 
result was solved for the concentrations based on dissolved mass (first), +5% A280 
(middle) and -5% A280 (bottom). The results for each peptide showing a 
stochiometery closest to 1.0 is shown in the lower table. This data demonstrates at 
283K the Kd of peptide0 in the low nM region and the shorter peptides in the µM, 














Peptide0       
[88.54] 1.61 0.018 -28.74 46.86 13.97 -42.72 
[26.29] 0.29 0.0054 -90.79 -162.34 -48.37 -42.43 
[29.05] 0.322 0.0034 -80.92 -123.43 -36.78 -44.14 
Peptide1       
[129.0] 4.09 1.36 -13.35 65.27 19.46 -32.80 
[42.36] 1.34 0.45 -40.63 -21.97 -6.53 -34.10 
[46.82] 1.48 0.49 -36.78 -9.12 -2.7196 -34.06 
Peptide2       
[148.1] 1.01 1.18 -30.92 13.89 4.14 -35.06 
[58.19] 0.396 0.47 -71.80 -132.21 -39.41 -32.38 
[64.31] 0.502 0.28 -50.04 -51.46 -15.36 -34.69 
Peptide3       
[120.9] 1.12 1.47 -19.87 41.51 12.38 -32.26 
[63.63] 0.663 0.22 -24.85 39.71 11.84 -36.69 
[70.33] 0.733 0.24 -22.47 47.28 14.10 -36.57 
Peptide4       
[114.1] 2.22 2.46 -21.55 31.21 9.29 -30.84 
[45.54] 0.888 0.98 -54.02 -75.73 -22.55 -31.46 
[50.34] 0.992 1.25 -51.71 -69.45 -20.71 -31.00 
Peptide5       
[104.2] 2.75 0.41 -11.17    
[47.52] 0.817 0.27 -28.87 23.68 7.07 -35.94 
[52.52] 1.2 1.07 -39.08 -23.72 -7.07 -32.01 
 
Stoichiometry closest to 1.00 
[Peptide] 
(µM) 









P0 [88.54] 1.61 0.018 -28.74 46.86 13.97 -42.72 
P1 [42.36] 1.34 0.45 -40.63 -21.97 -6.53 -34.10 
P2 [148.1] 1.01 1.18 -30.92 13.89 4.14 -35.06 
P3 [120.9] 1.12 1.47 -19.87 41.51 12.38 -32.26 
P4 [50.34] 0.992 1.25 -51.71 -69.45 -20.71 -31.00 
P5 [52.52] 1.2 1.07 -39.08 -23.72 -7.07 -32.01 
 
Biophysical characteristics of HsPCNA-peptide interactions at 298K. Each ITC 
result was solved for the concentrations based on dissolved mass (first), +5% A280 
(middle) and -5% A280 (bottom). The results for each peptide showing a 
stochiometery closest to 1.0 is shown in the lower table. This data demonstrates at 
298K the Kd of peptide0 greater than that at 283K, the shorter peptides consistently 
in the µM region, with the untagged peptide showing a greater affinity, also a Gibbs 




1.7 ITC values derived for SpPCNA 
[Peptide] 
(µM) 









Peptide0       
[88.54] 1.05 0.046 -30.88 31.46 8.912 -39.79 
[30.04] 0.355 0.016 -90.04 -168.6 -47.70 -42.34 
[33.20] 0.395 0.021 -83.55 -148.1 -41.92 -41.63 
Peptide1       
[147.4] 0.673 0.133 -50.63 -47.28 -13.39 -37.24 
[77.15] 0.352 0.070 -96.78 -205.0 -58.03 -38.74 
[85.27] 0.390 0.085 -88.78 -178.2 -50.46 -38.33 
Peptide2       
[150.2] 0.647 0.68 -38.33 -17.28 -4.895 -33.43 
[68.76] 0.290 0.34 -85.27 -177.4 -50.21 -35.06 
[76.00] 0.313 0.46 -83.14 -172.4 -48.79 -34.35 
Peptide3       
[116.7] 1.70 1.75 -31.80 -2.050 -0.5858 -31.21 
[58.73] 0.856 0.88 -63.22 -107.1 -30.29 -32.93 
[64.91] 0.946 0.97 -57.20 -87.03 -24.64 -32.55 
Peptide4       
[114.1] 1.80 1.07 -24.69 27.20 7.699 -32.38 
[45.54] 0.711 0.45 -60.63 -92.47 -26.15 -34.48 
[50.34] 0.791 0.56 -56.99 -81.59 -23.10 -33.89 
Peptide5       
[104.5] 1.75 0.89 -22.89 35.02 9.916 -32.80 
[56.16] 0.948 0.69 -45.65 -43.51 -12.30 -33.35 
[62.07] 1.03 0.56 -37.61 -13.26 -3.766 -33.85 
 
Stoichiometry closest to 1.00 
[Peptide] 
(µM) 









P0 [88.54] 1.05 0.046 -30.88 31.46 8.912 -39.79 
P1 [147.4] 0.673 0.13 -50.63 -47.28 -13.39 -37.24 
P2 [150.2] 0.647 0.68 -38.33 -17.28 -4.895 -33.43 
P3 [64.91] 0.946 0.97 -57.20 -87.03 -24.64 -32.55 
P4 [50.34] 0.791 0.56 -56.99 -81.59 -23.10 -33.89 
P5 [62.07] 1.03 0.56 -37.61 -13.26 -3.766 -33.85 
 
Biophysical characteristics of SpPCNA-peptide interactions at 283K. Each ITC 
result was solved for the concentrations based on dissolved mass (first), +5% A280 
(middle) and -5% A280 (bottom). The results for each peptide showing a 
stochiometery closest to 1.0 is shown in the lower table. This data demonstrates at 
283K the Kd of peptide0 greater than that for HsPCNA, the shorter peptides in the 
µM range, with the untagged peptide showing a greater affinity, also a Gibbs free 















Peptide0       
[88.54] 1.32 0.043 -30.04 34.81 10.38 -40.42 
[22.63] 0.334 0.007 -109.5 -230.1 -68.58 -40.96 
[25.02] 0.373 0.012 -106.0 -223.0 -66.44 -39.58 
Peptide1       
[148.2] 0.874 0.154 -52.47 -54.81 -16.32 -36.15 
[72.61] 0.424 0.056 -102.5 -223.0 -66.44 -36.02 
[80.25] 0.470 0.068 -93.89 -194.1 -57.86 -36.02 
Peptide2       
[150.3] 0.917 0.50 -34.94 -2.812 -0.837 -34.10 
[68.76] 0.419 0.23 -76.40 -142.7 -42.51 -33.89 
[76.00] 0.464 0.25 -69.12 -118.0 -35.15 -33.97 
Peptide3       
[116.6] 1.27 0.61 -23.81 34.85 10.38 -34.18 
[48.94] 0.542 0.36 -62.05 -95.81 -28.53 -33.51 
[54.10] 0.603 0.46 -57.99 -83.26 -24.81 -33.18 
Peptide4       
[]       
[]       
[]       
Peptide5       
[]       
[]       
[]       
 
Stoichiometry closest to 1.00 
[Peptide] 
(µM) 









P0 [88.54] 1.32 0.043 -30.04 34.81 10.38 -40.42 
P1 [148.2] 0.874 0.154 -52.47 -54.81 -16.32 -36.15 
P2 [150.3] 0.917 0.50 -34.94 -2.812 -0.837 -34.10 
P3 [116.6] 1.27 0.61 -23.81 34.85 10.38 -34.18 
P4 []       
P5 []       
 
Biophysical characteristics of SpPCNA-peptide interactions at 298K. Each ITC 
result was solved for the concentrations based on dissolved mass (first), +5% A280 
(middle) and -5% A280 (bottom). The results for each peptide showing a 
stochiometery closest to 1.0 is shown in the lower table. This data demonstrates at 
298K the Kd of all peptides to be lower than that for 283K, peptide0 is the strongest 





1.8 ITC values derived for LmPCNA 
[Peptide] 
(µM) 









Peptide0       
[88.54] 2.51 0.990 -17.41 53.56 15.15 -32.55 
[26.29] 0.808 0.386 -57.53 -80.33 -22.72 -34.81 
[29.05] 0.894 0.429 -52.17 -62.34 -17.66 -34.52 
Peptide1       
[142.4] 2.05 3.91 -18.74 37.32 10.54 -29.29 
[84.71] 1.22 2.33 -31.55 -3.60 -1.004 -30.54 
[93.63] 1.35 2.58 -28.53 6.19 1.757 -30.29 
Peptide2       
[300.2] 3.03  -4.351    
[142.8] 1.31 3.72 -17.91 40.67 11.51 -29.41 
[157.9] 1.36 1.27 -24.64 6.611 1.883 -26.53 
Peptide3       
[]       
[]       
[]       
Peptide4       
[]       
[]       
[]       
Peptide5       
[]       
[]       
[]       
 
Stoichiometry closest to 1.00 
[Peptide] 
(µM) 









P0 [29.05] 0.894 0.429 -52.17 -62.34 -17.66 -34.52 
P1 [84.71] 1.22 2.33 -31.55 -3.60 -1.004 -30.54 
P2 [142.8] 1.31 3.72 -17.91 40.67 11.51 -29.41 
P3 []       
P4 []       
P5 []       
 
Biophysical characteristics of LmPCNA-peptide interactions at 283K. Each ITC 
result was solved for the concentrations based on dissolved mass (first), +5% A280 
(middle) and -5% A280 (bottom). The results for each peptide showing a 
stochiometery closest to 1.0 is shown in the lower table. This data demonstrates at 
283K the Kd of peptide0 greater than that for both HsPCNA and SpPCNA, in the sub 
µM range, the shorter peptides in the µM range, with the untagged peptide showing a 














Peptide0       
[177.1] 1.75 0.794 -16.32 58.99 17.57 -33.89 
[90.22] 0.89 0.405 -32.05 9.163 2.720 -34.77 
[99.72] 0.98 0.446 -29.00 19.12 5.690 -34.69 
Peptide1       
[294.8] 1.19 1.99 -19.12 41.55 12.38 -31.51 
[208.5] 0.84 1.41 -27.07 16.44 4.895 -31.97 
[230.4] 0.93 1.56 -24.48 24.77 7.364 -31.84 
Peptide2       
[300.5] 0.68 25.4 -34.77 -34.77 -10.38 -24.39 
[179.2] 0.37 15.5 -64.85 -137.2 -40.88 -23.97 
[198.0] 0.42 17.0 -56.07 -106.7 -31.80 -24.27 
Peptide3       
[]       
[]       
[]       
Peptide4       
[]       
[]       
[]       
Peptide5       
[]       
[]       
[]       
 
Stoichiometry closest to 1.00 
[Peptide] 
(µM) 









P0 [99.72] 0.98 0.446 -29.00 19.12 5.690 -34.69 
P1 [230.4] 0.93 1.56 -24.48 24.77 7.364 -31.84 
P2 [300.5] 0.68 25.4 -34.75 -34.77 -10.38 -24.37 
P3 []       
P4 []       
P5 []       
 
Biophysical characteristics of LmPCNA-peptide interactions at 298K. Each ITC 
result was solved for the concentrations based on dissolved mass (first), +5% A280 
(middle) and -5% A280 (bottom). The results for each peptide showing a 
stochiometery closest to 1.0 is shown in the lower table. This data demonstrates at 







1.9 Linear van’t Hoff analysis of SPR data 







0.0031 0.0032 0.0033 0.0034 0.0035 0.0036 0.0037






















1 - -49.8 -50.9 -34.6 
2 10 -57.3 -87.9 -31.1 
3 20 -57.9 -91.2 -30.7 
4 30 -66.6 -120 -30.8 
5 40 -64.1 -113 -30.6 
6 - -49.7 -92.0 -22.3 
 
The linear Van’t Hoff plot (top) with lnKd on the y axis verses 1/T on the x axis 
plotted with Kaleidagraph. Table (bottom) shows thermodynamic properties 
determined for each peptide to three significant figures. 
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0.0031 0.0032 0.0033 0.0034 0.0035 0.0036 0.0037
























1 - -41.3 -26.6 -33.4 
2 10 -62.6 -108 -30.5 
3 20 -65.0 -117 -30.1 
4 30 -71.7 -140 -30.0 
5 40 -65.9 -121 -29.9 
6 - -70.3 -159 -22.9 
 
The linear Van’t Hoff plot of SPR data (top) with lnKd on the y axis verses 1/T on 
the x axis plotted with Kaleidagraph. Table (bottom) shows thermodynamic 
properties determined for each peptide to three significant figures. 
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0.0031 0.0032 0.0033 0.0034 0.0035 0.0036 0.0037























1 - -45.5 -56.5 -28.6 
2 10 -34.8 -31.5 -25.5 
3 20 -34.9 -33.0 -25.1 
4 30 -47.2 -73.7 -25.3 
5 40 -36.8 -40.1 -24.8 
6 - -33.0 -41.2 -20.7 
 
The linear Van’t Hoff plot of SPR data (top) with lnKd on the y axis verses 1/T on 
the x axis plotted with Kaleidagraph. Table (bottom) shows thermodynamic 
properties determined for each peptide to three significant figures. 
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HsPCNA-P3 20 -53.8 -99.6 -24.1 
HsPCNA-P4 30 -58.8 -108 -26.7 
HsPCNA-P5 40 -62.8 -123 -26.1 
SpPCNA-P3 20 -59.2 -97.6 -30.1 
SpPCNA-P4 30 -17.1 49.6 -31.9 
SpPCNA-P5 40 -23.1 28.3 -31.6 
LmPCNA-P3 20 -101 -284 -16.5 
LmPCNA-P4 30 -29.5 -25.3 -22.0 
LmPCNA-P5 40 -55.1 -119 -19.7 
 
The linear Van’t Hoff plot of SPR data (top) with lnKd on the y axis verses 1/T on 
the x axis plotted with Kaleidagraph. Table (bottom) shows thermodynamic 
properties determined for each peptide to three significant figures.  
